0001654954-24-006425.txt : 20240515 0001654954-24-006425.hdr.sgml : 20240515 20240515170555 ACCESSION NUMBER: 0001654954-24-006425 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 58 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 374Water Inc. CENTRAL INDEX KEY: 0000933972 STANDARD INDUSTRIAL CLASSIFICATION: MOTORS & GENERATORS [3621] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 880271109 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41420 FILM NUMBER: 24952412 BUSINESS ADDRESS: STREET 1: 701 W. MAIN STREET STREET 2: SUITE 410 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 919-888-8194 MAIL ADDRESS: STREET 1: 3710 SHANNON RD #51877 STREET 2: SUITE 410 CITY: DURHAM STATE: NC ZIP: 27717 FORMER COMPANY: FORMER CONFORMED NAME: POWERVERDE, INC. DATE OF NAME CHANGE: 20080820 FORMER COMPANY: FORMER CONFORMED NAME: VYREX CORP DATE OF NAME CHANGE: 19951206 10-Q 1 scwo_10q.htm FORM 10-Q scwo_10q.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

Form 10-Q

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the Quarterly Period ended March 31, 2024

 

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Commission file number: 000-27866

 

374WATER INC.

(Exact name of Registrant as specified in its charter)

 

Delaware

 

88-0271109

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

 

701 W Main Street, Suite 410

Durham, NC 27701

(Address of principal executive offices)

 

(919) 888-8194

(Registrant’s telephone number including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.0001

 

SCWO

 

The Nasdaq Capital Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

Large accelerated filer

Accelerated filer

Non-accelerated Filer

Smaller reporting company

 

 

Emerging Growth Company

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No

 

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: As of May 15, 2024, the issuer had 132,670,446 shares of common stock outstanding.

 

 

 

 

Index to Form 10-Q

 

 

 

 

Page

 

PART I

FINANCIAL INFORMATION

 

 

 

 

 

 

 

 

Item 1.

Condensed Consolidated Financial Statements (Unaudited)

 

4

 

 

Condensed Consolidated Balance Sheets at March 31, 2024 (Unaudited) and December 31, 2023

 

4

 

 

Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023 (Unaudited)

 

5

 

 

Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three months ended March 31, 2024 and 2023 (Unaudited)

 

6

 

 

Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023 (Unaudited)

 

7

 

 

Notes to Unaudited Condensed Consolidated Financial Statements

 

8

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

21

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

 

23

 

Item 4.

Controls and Procedures

 

23

 

 

 

 

 

 

PART II

OTHER INFORMATION

 

 

 

 

 

 

 

 

Item 1.

Legal Proceedings

 

24

 

Item 1A.

Risk Factors

 

24

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

24

 

Item 3.

Defaults upon Senior Securities

 

24

 

Item 4.

Mine Safety Disclosures

 

24

 

Item 5.

Other Information

 

24

 

Item 6.

Exhibits

 

25

 

 

 

 

 

SIGNATURES

 

26

 

 

 
2

Table of Contents

 

Cautionary Note Regarding Forward-Looking Information

 

This Quarterly Report on Form 10-Q (the “Form 10-Q”) contains certain statements related to future results of 374 Water, Inc. (the “Company”) that are considered “forward-looking statements'' within the meaning of the Private Litigation Reform Act of 1995. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties, including, but not limited to, changes in political and economic conditions; interest rate fluctuation; competitive pricing pressures within the Company’s market; equity and fixed income market fluctuation; technological changes; changes in law; changes in fiscal, monetary, regulatory, and tax policies; monetary fluctuations as well as other risks and uncertainties detailed elsewhere in this Form 10-Q or from time-to-time in the filings of the Company with the Securities and Exchange Commission. Such forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events.

 

 
3

Table of Contents

 

PART I FINANCIAL INFORMATION

 

Item 1. Condensed Consolidated Financial Statements

 

374Water Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

March 31, 2024 (Unaudited) and December 31, 2023  

 

 

 

March 31,

2024

 

 

December 31, 2023

 

Assets

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

Cash

 

$7,936,161

 

 

$10,445,404

 

Accounts receivable, net of allowance

 

 

84,324

 

 

 

64,792

 

Unbilled accounts receivable

 

 

1,771,609

 

 

 

1,494,553

 

Other accounts receivable

 

 

34,161

 

 

 

39,749

 

Inventory, net

 

 

2,601,658

 

 

 

2,276,677

 

Prepaid expenses

 

 

921,365

 

 

 

581,085

 

Total Current Assets

 

 

13,349,278

 

 

 

14,902,260

 

Long-Term Assets:

 

 

 

 

 

 

 

 

Property, and Equipment, net

 

 

223,339

 

 

 

230,971

 

Intangible asset, net

 

 

971,691

 

 

 

988,029

 

Total Long-Term Assets

 

 

1,195,030

 

 

 

1,219,000

 

Total Assets

 

$14,544,308

 

 

$16,121,260

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$755,721

 

 

$572,297

 

Accrued contract loss provision

 

 

600,000

 

 

 

500,000

 

Accrued legal settlement

 

 

135,000

 

 

 

135,000

 

Unearned revenue

 

 

132,768

 

 

 

130,000

 

Other liabilities

 

 

10,408

 

 

 

36,787

 

Total Current Liabilities

 

 

1,633,897

 

 

 

1,374,084

 

Total Liabilities

 

 

1,633,897

 

 

 

1,374,084

 

Commitments and contingencies (Note 9)

 

 

 

 

 

 

 

 

Stockholders’ Equity

 

 

 

 

 

 

 

 

Preferred stock: 50,000,000 convertible Series D preferred shares authorized; par value $0.0001 per share, nil issued and outstanding at March 31, 2024 and December 31, 2023

 

 

 

 

 

 

Common stock: 200,000,000 common shares authorized, par value $0.0001 per share, 132,670,446 and 132,667,107 shares outstanding at March 31, 2024 and December 31, 2023, respectively

 

 

13,266

 

 

 

13,266

 

Additional paid-in capital

 

 

30,872,643

 

 

 

30,684,943

 

Accumulated deficit

 

 

(17,977,969 )

 

 

(15,953,504)

Accumulated other comprehensive loss

 

 

2,471

 

 

 

2,471

 

Total Stockholders’ Equity

 

 

12,910,411

 

 

 

14,747,176

 

Total Liabilities and Stockholders’ Equity

 

$14,544,308

 

 

$16,121,260

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

Table of Contents

 

374Water, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

For the three months ended March 31, 2024 and 2023

(Unaudited)

 

 

 

Three months ended March 31,

 

 

 

2024

 

 

2023

 

 

 

 

 

 

 

 

Revenue

 

$315,278

 

 

$801,458

 

Cost of goods sold

 

 

617,298

 

 

 

720,146

 

Gross margin

 

 

(302,020)

 

 

81,312

 

Operating Expenses

 

 

 

 

 

 

 

 

Research and development

 

 

535,147

 

 

 

355,905

 

Compensation and related expenses

 

 

651,604

 

 

 

718,760

 

Professional fees

 

 

252,705

 

 

 

99,572

 

General and administrative

 

 

459,727

 

 

 

585,659

 

Total Operating Expenses

 

 

1,899,183

 

 

 

1,759,896

 

 

 

 

 

 

 

 

 

 

Loss from Operations

 

 

(2,201,203 )

 

 

(1,678,584 )

 

 

 

 

 

 

 

 

 

Other Income

 

 

 

 

 

 

 

 

Interest income

 

 

104,620

 

 

 

37,859

 

Other income

 

 

72,118

 

 

 

382

 

Total Other Income

 

 

176,738

 

 

 

38,241

 

Net Loss before Income Taxes

 

 

(2,024,465 )

 

 

(1,640,343 )

Provision for Income Taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss

 

$(2,024,465 )

 

$(1,640,343 )

 

 

 

 

 

 

 

 

 

Other comprehensive income

 

 

 

 

 

 

 

 

Foreign currency translation gain

 

 

-

 

 

 

824

 

Unrealized gain on marketable securities

 

 

-

 

 

 

18,967

 

Total other comprehensive loss

 

 

-

 

 

 

19,791

 

Total comprehensive loss

 

 

(2,024,465 )

 

 

(1,620,552 )

Net Loss per Share - Basic and Diluted

 

$(0.02 )

 

$(0.01 )

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding - Basic and Diluted

 

 

132,668,777

 

 

 

127,146,695

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 
5

Table of Contents

 

374Water Inc. and Subsidiaries

Condensed Consolidated Changes in Stockholders’ Equity

For the three months ended March 31, 2024 and 2023

(Unaudited)

 

For the three months ended March 31, 2024

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Additional

 

 

 

 

 

Other

 

 

Total

 

 

 

Number of

 

 

 

 

 

Number of

 

 

 

 

 

Paid in

 

 

Accumulated

 

 

Comprehensive

 

 

Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Income

 

 

Equity

 

Balances, December 31, 2023

 

 

 

 

$

 

 

 

132,667,107

 

 

$13,266

 

 

$30,684,943

 

 

$(15,953,504)

 

$2,471

 

 

$14,747,176

 

Issuance of shares for services

 

 

 

 

 

 

 

 

3,339

 

 

 

 

 

 

4,500

 

 

 

 

 

 

 

 

 

4,500

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

183,200

 

 

 

 

 

 

 

 

 

183,200

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,024,465)

 

 

 

 

 

(2,024,465))

Balances, March 31, 2024

 

 

 

 

 

 

 

 

132,670,446

 

 

$13,266

 

 

$30,872,643

 

 

$(17,977,969)

 

$2,471

 

 

$12,910,411

 

 

For the three months ended March 31, 2023

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Additional

 

 

 

 

Other

 

 

Total

 

 

 

Number of

 

 

 

 

Number of

 

 

 

 

Paid in

 

 

Accumulated

 

 

Comprehensive

 

 

Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Income

 

 

Equity

 

Balances, December 31, 2022

 

 

 

 

$

 

 

 

126,702,545

 

 

$12,669

 

 

$16,110,221

 

 

$(7,849,982 )

 

$(19,296 )

 

$8,253,612

 

Issuance of shares of common stock for cash

 

 

 

 

 

 

 

 

2,137,876

 

 

 

214

 

 

 

8,294,494

 

 

 

 

 

 

 

 

 

8,294,708

 

Stock-based compensation 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

214,924

 

 

 

 

 

 

 

 

 

214,924

 

Foreign currency gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

824

 

 

 

824

 

Unrealized gain on investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18,967

 

 

 

18,967

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,640,343 )

 

 

 

 

 

(1,640,343)

Balances, March 31, 2023

 

 

 

 

 

 

 

 

128,840,421

 

 

$12,883

 

 

$24,619,639

 

 

$(9,490,325 )

 

 

495

 

 

$15,142,692

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 
6

Table of Contents

 

374Water Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

For the three months ended March 31, 2024 and 2023 (Unaudited)

 

 

 

2024

 

 

2023

 

Cash Flows from Operating Activities

 

 

 

 

 

 

Net loss

 

$(2,024,465 )

 

$(1,640,343)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization expense

 

 

24,560

 

 

 

29,105

 

Issuance of common stock for services

 

 

4,500

 

 

 

-

 

Stock-based compensation

 

 

183,200

 

 

 

214,924

 

Gain on foreign currency translation

 

 

-

 

 

 

824

 

Increase in inventory reserve

 

 

50,000

 

 

 

-

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(19,532 )

 

 

(26,188)

Unbilled accounts receivable

 

 

(277,056 )

 

 

(754,290)

Other receivables

 

 

5,588

 

 

 

(308,374)

Inventory

 

 

(374,981)

 

 

(127,309)

Prepaid expenses

 

 

(340,280)

 

 

23,285

 

Accounts payable and accrued expenses

 

 

183,424

 

 

 

(581,582)

Accrued contract loss provision

 

 

100,000

 

 

 

-

 

Unearned revenue

 

 

2,768

 

 

 

5,000

 

Other liabilities

 

 

(26,379 )

 

 

(13,528)

Net Cash Used In Operating Activities

 

 

(2,508,653 )

 

 

(3,178,176)

 

 

 

 

 

 

 

 

 

Cash Flows from Investing Activities

 

 

 

 

 

 

 

 

Purchase of equipment

 

 

-

 

 

 

(7,303 )

Increase in intangible assets

 

 

(590)

 

 

(2,705 )

 

 

 

 

 

 

 

 

 

Cash Used In Investing Activities

 

 

(590)

 

 

(10,008)

 

 

 

 

 

 

 

 

 

Cash Flow from Financing Activities

 

 

 

 

 

 

 

 

Proceeds from the sale of common stock

 

 

-

 

 

 

8,294,708

 

Cash Provided by Financing Activities

 

 

-

 

 

 

8,294,708

 

 

 

 

 

 

 

 

 

 

Net (Decrease) Increase in Cash

 

 

(2,509,243)

 

 

5,106,224

 

Cash, Beginning of the Period

 

 

10,445,404

 

 

 

4,046,937

 

Cash, End of the Period

 

$7,936,161

 

 

$9,153,161

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL CASH FLOW DISCLOSURES:

 

 

 

 

 

 

 

 

Cash paid for interest

 

$

 

 

$

 

Cash paid for taxes

 

$

 

 

$

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 
7

Table of Contents

 

374Water Inc. and Subsidiaries

 

Notes to Unaudited Condensed Consolidated Financial Statements

 

Note 1 – Nature of Business and Presentation of Financial Statements

 

Description of the Company

 

374Water Inc. (the “Company”, “374Water”, “We”, or “Our”) is a Delaware corporation which was formed in September 2005 as PowerVerde, Inc. At that time, the Company was focused on developing, commercializing and marketing a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a pressure-driven expander motor and related organic rankine cycle technology.

 

On April 16, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger”) with 374Water Inc., a privately held company based in Durham, North Carolina, (“374Water Private Company”) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde.

 

Following the Merger, 374Water offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., “per-and polyfluoroalkyl substances” or “PFAS”) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals.  We are developing AirSCWO, a proprietary treatment system based on “supercritical water oxidation.”

 

Presentation of Financial Statements

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) for interim financial information. It is management’s opinion that the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q and include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report on Form 10-K of 374Water Inc. as of and for the year ended December 31, 2023 filed with the SEC on March 29, 2024.

 

The results of operations for the three months ended March 31, 2024, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of 374Water Inc., 374Water Systems Inc, and 374Water Sustainability Israel LTD, each a wholly-owned subsidiary of 374 Water. Intercompany balances and transactions have been eliminated in consolidation.

  

Note 2 – Summary of Significant Accounting Policies

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held $7,936,161 and $10,445,404 in cash and cash equivalents as of March 31, 2024 and December 31, 2023, respectively.

 

 
8

Table of Contents

 

Accounts Receivable and Unbilled Accounts Receivable

 

Accounts receivables consist of balances due from service revenues. Unbilled accounts receivables are from revenues earned but not yet billed. The Company monitors accounts receivable and provides allowances for expected credit losses when considered necessary. As of  March 31, 2024 and December 31, 2023, accounts receivable were considered to be fully collectible but in accordance with the allowance for credit losses, the Company recorded an allowance for credit losses based on a reserve of current and aged receivables which was not significant as of March 31, 2024 and December 31, 2023.  

 

Other Accounts Receivable

 

Other accounts receivable consist of accrued interest income from the cash held in an interest bearing money market account with a financial institution. We typically receive payment for accrued interest one month in arrears. 

 

Inventories

 

Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. The majority of our inventory is raw materials and work in progress.  Net realizable value is the value of an asset that can be realized upon the sale of the asset, less a reasonable estimate of the costs associated with either the eventual sale or the disposal of the asset in question.  We utilize third-party suppliers to produce our products. Costs associated with fabrication, and other costs associated with the manufacturing of products, are recorded as inventory. We periodically evaluate the carrying value of our inventories in relation to estimated forecasts of product demand, which takes into consideration the life cycle of product releases. Further, as we continue to hence and develop are AirSCWO systems we may replace materials and parts with upgrades to enhance the units. If it is not probable that the replacement part will be used , we establish a reserve against the material or part or dispose of it. When quantities on hand exceed estimated sales forecasts, we perform an analysis to determine if a write-down for such excess inventories is required.  Once inventory has been written down, it creates a new cost basis for inventory.  Inventories are classified as current assets in accordance with recognized industry practice. Based on our evaluation we estimated an inventory allowance of $50,000 and $0 as of March 31, 2024 and December 31, 2023, respectively.

 

 
9

Table of Contents

 

 

Property and Equipment

 

Property and Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred. 

 

The following table presents property and equipment as of March 31, 2024 and December 31, 2023:

 

 

 

March 31,

2024

 

 

December 31,

2023

 

Computers

 

$16,489

 

 

$16,489

 

Equipment

 

 

190,748

 

 

 

190,748

 

Vehicles

 

 

44,510

 

 

 

44,510

 

Total property and equipment

 

 

251,747

 

 

 

251,747

 

Less: accumulated depreciation

 

 

(28,408 )

 

 

(20,776 )

Total property and equipment, net

 

$223,339

 

 

$230,971

 

 

Depreciation expense related to property and equipment was as follows:

 

 

 

Period Ended March 31,

 

 

 

2024

 

 

2023

 

Depreciation

 

$7,632

 

 

$9,525

 

 

Intangible Assets

 

Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment.” Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. As of March 31, 2024 and December 31, 2023, there was no impairment.

 

Long-Lived Assets

 

The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2024 and December 31, 2023, there were no impairments.

 

 
10

Table of Contents

 

 

Concentrations of Credit Risk

 

Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (“FDIC”). The Company’s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.

 

Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues and purchases.  One customer made up approximately 94% and 99% of revenue for the three month periods ended March 31, 2024 and 2023, respectively.

 

During the three months ended March 31, 2024 and 2023, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros Fabrication, LLC (“Merrell Bros.”) (see Note 8).

 

Refer to Note 9 for a license agreement we have with Duke University for the SCWO technology used in our systems.

  

Revenue Recognition

 

The Company follows the revenue standards of Codification (ASC) Topic 606: “Revenue from Contracts with Customers (Topic 606).” The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation using the input method.

 

The Company generates revenue from the sale of equipment (AirSCWO units) and services, specifically the completion of treatability studies. In the case of equipment revenues, the Company’s performance obligations are satisfied over time over the life of the contract which are typically long-term fixed price contracts. Revenue is recognized over time by measuring the progress toward complete satisfaction of the performance obligation using specific milestones. These milestones within the contract are assigned revenue recognition percentages, based on overall expected cost-plus margin estimates of those milestones compared to the total cost of the contract. Equipment sale related contract revenues are recognized in the proportion that contract costs incurred bear to total estimated costs. This method is used because management considers the input method to be the best available measure of progress on these contracts.

 

Changes in our overall expected cost estimates are recognized as a cumulative adjustment for the inception-to-date effective of such change. If these changes in estimates result in a possible loss being incurred on the contract, we accrue for such a loss in the period such an outcome becomes probable. 

 

Services revenues are recognized when all five revenue recognition criteria have been completed which is generally when we deliver a completed treatability study report to the customer.

 

Contract costs include all direct material, labor and subcontractor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs, and depreciation. General, selling, and administrative costs are charged to expenses as incurred.

 

Revenues for the three-month period ended March 31, 2024 in the amount of $296,096 was generated from the progress towards completion of the AirSCWO system and $19,182 was generated from the sale of treatability services.

 

Revenues for the three-month period ended March 31, 2023 in the amount of $793,458 was generated from the sale of the AirSCWO system and $8,000 was generated from the sale of treatability services. 

 

 
11

Table of Contents

 

 

Accrued Contract Loss Provision and Onerous Contracts

 

Onerous contracts are those where the costs to fulfill a contract exceed the consideration expected to be received under the contract. The revenue standard does not provide guidance on the accounting for onerous contracts or onerous performance obligations. US GAAP contains other applicable guidance on the accounting for onerous contracts, and those requirements should be used to identify and measure onerous contracts.

 

Our outstanding equipment manufacturing contract is a fixed price contract. Due to the nature of the contract, including customer specific equipment design, we applied ASC 605-35, Revenue Recognition—Provision for Losses on Construction-Type and Production-Type Contract (ASC 605-35). ASC 605-35 requires the recognition of a liability for anticipated losses on contracts prior to those losses being incurred when a loss is probable and can be estimated.

 

As of March 31, 2024 and December 31, 2023, we evaluated the total costs incurred on this contract to date and the estimated costs we anticipate incurring to complete the contract.  Based on this analysis, we accrued a total accrued loss provision of $600,000 and $500,000 as of March 31, 2024 and December 31, 2023, respectively, which has been presented on the accompanying unaudited condensed consolidated balance sheets and is recorded within cost of revenues on the accompanying unaudited condensed consolidated statements of operations.

 

Stock-based Compensation and Change in Accounting Policy

 

The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

 

Prior to January 1, 2024, the Company had elected to estimate options granted for which the requisite service period would not be rendered, due to the option being forfeited or expiring. The forfeiture rate estimate was based on the percentage of cumulative forfeitures to the total award grants.  During the quarter ended December 31, 2023, we compared our actual forfeiture rate to our estimated forfeiture rate and made a cumulative adjustment of approximately $55,000 in the quarter ended December 31, 2023 to reduce our forfeiture rate estimate to approximately 5% of the total stock-based compensation recognized during the year

 

Effective January 1, 2024, the Company made a change in their accounting policy to recognize forfeitures on service-based stock award instruments as they occur.  Due to the lack of history available to adequately estimate our forfeiture rate and the fact that the majority of our serviced based options include a one-year cliff vesting and monthly vesting after, we believe recognizing forfeitures as they occur will result in more accurate financial reporting. The change in this accounting policy did not have a significant impact on the current or prior period financial statements. During the three months ended March 31, 2024, no forfeitures occurred.

 

Income Tax Policy

 

The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.

 

Accounting for Uncertainty in Income Taxes

 

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2024 and December 31, 2023.

 

 
12

Table of Contents

 

 

Research and Development Costs

 

The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $535,147 and $355,905 for the three months ended March 31, 2024 and 2023, respectively.

 

Loss Per Share

 

Loss per share is computed in accordance with ASC Topic 260, “Earnings per Share” Basic weighted-average number of shares of common stock outstanding for the three- months ended March 31, 2024 and 2023  include the shares of the Company issued and outstanding during such periods, each on a weighted average basis. The basic weighted average number of shares of common stock outstanding excludes common stock equivalent incremental shares, while diluted weighted average number of shares outstanding includes such incremental shares. However, as the Company was in a loss position for all periods presented, basic and diluted weighted average shares outstanding are the same, as the inclusion of the incremental shares would be anti-dilutive.  As of March 31, 2024 and March 31, 2023, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 10,740,250 and 13,025,000  shares of common stock and 1,235,000 and 1,250,000 warrants, respectively.

 

Financial Instruments

 

The Company carries cash, accounts, unbilled and other receivables, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.

  

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, service revenue, accrued contract loss provisions, and valuation allowance against deferred tax assets.

 

 
13

Table of Contents

 

 

Recent Accounting Pronouncements - Not Yet Adopted

 

In December 2023 FASB issued Accounting Standards Update (ASU) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09). The ASU focuses on income tax disclosures around effective tax rates and cash income taxes paid. ASU 2023-09 requires public business entities to disclose, on an annual basis, a rate reconciliation presented in both dollars and percentages. The guidance requires the rate reconciliation to include specific categories and provides further guidance on disaggregation of those categories based on a quantitative threshold equal to 5% or more of the amount determined by multiplying pretax income (loss) from continuing operations by the applicable statutory rate. For entities reconciling to the US statutory rate of 21%, this would generally require disclosing any reconciling items that impact the rate by 1.05% or more. ASU 2023-09 is effective for public business entities for annual periods beginning after December  15, 2024 (generally, calendar year 2025) and effective for all other business entities one year later. Entities should adopt this guidance on a prospective basis, though retrospective application is permitted. The adoption of ASU 2023-09 is expected to have a financial statement disclosure impact only and is not expected to have a material impact on the Company’s financial statements.

 

In November 2023 the FASB issued ASU 2023-07, Segment Reporting – Improvements to Reportable Segment Disclosures.  The ASU will now require public entities to disclose its significant segment expenses categories and amounts for each reportable segment. Under the ASU, a significant segment expense is an expense that is:

 

 

·

significant to the segment,

 

·

regularly provided to or easily computed from information regularly provided to the chief operating decision maker (CODM), and

 

·

included in the reported measure of segment profit or loss.

 

The ASU is effective for public entities for fiscal years beginning after December 15, 2023 and interim periods in fiscal years beginning after December 15, 2024 (calendar year public entity will adopt the ASU in its 2024 Form 10 K). The ASU should be adopted retrospectively unless it’s impracticable to do so. Early adoption of the ASU is permitted, including in an interim period. The adoption of ASU 2023-07 is expected to have a financial statement disclosure impact only and is not expected to have a material impact on the Company’s financial statements.

 

The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.

 

Note 3 – Liquidity, Capital Resources and Going Concern

 

As of March 31, 2024, the Company had working capital of $11,715,381 and an accumulated deficit of $17,977,969. For the three months ended March 31, 2024, the Company incurred a net loss of $2,024,465 and used $2,508,653 of net cash in operations for the period.  These conditions raise substantial doubt regarding our ability to continue as a going concern.

  

Since inception, we have financed our operations principally through the sale of debt and equity securities and operating cash flows. We have an at-the-market (ATM) equity offering under which we may issue up to $100 million of common stock, which is not currently active. However, we are in the process of activating the ATM. During the year end December 31, 2023, we raised approximately $13.4 million of net proceeds through this ATM.

 

 
14

Table of Contents

 

While no assurance can be provided, management believes that these actions provide the opportunity for the Company to continue as a going concern and to grow its business and achieve profitability with access to additional capital funding. Ultimately, the success of the Company as a going concern is dependent upon the ability of the Company to continue executing its plan and obtaining capital that will enable the Company to complete its in-process AirSCWO units and begin manufacturing further units. If the Company is unable to obtain additional financing in sufficient amounts or under acceptable terms, the Company's operating results could be adversely affected.

 

These consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Based upon the Company’s current business plan, we believe that our current cash balance and access to liquidity are sufficient for the Company to meet its financial obligations as they become due for at least the next 12 months from the date of the report. 

 

Note 4 – Inventory

 

Inventory, net consists of:

 

Name

 

Balance at

March 31,

2024

 

 

Balance at

December 31,

2023

 

Raw materials

 

$717,052

 

 

$457,393

 

Work-in-process

 

 

1,934,606

 

 

 

1,819,284

 

Less: inventory reserves

 

 

(50,000)

 

 

 

Total

 

$2,601,658

 

 

$2,276,677

 

  

Note 5 – Intangible Assets

 

Intangible assets, net,  are comprised of the following as of March 31, 2024 and December 31, 2023 :

 

Name

 

Estimated

Life

 

Balance at

December 31,

2023

 

 

Additions

 

 

Amortization

 

 

Balance at

March 31,

2024

 

License agreement

 

17 Years

 

$901,929

 

 

$

 

 

$(15,732)

 

$886,197

 

Patents

 

20 Years

 

 

86,100

 

 

 

590

 

 

 

(1,196)

 

 

85,494

 

Total

 

 

 

$988,029

 

 

$590

 

 

$(16,928)

 

$971,691

 

 

Amortization expense for the three months ended March 31, 2024 and 2023, was $16,928 and $16,910, respectively.

 

 
15

Table of Contents

 

Estimated future amortization expense as of March 31, 2024:

 

 

 

March 31,

 

 

 

2024

 

2024 (remaining)

 

$50,784

 

2025

 

 

67,933

 

2026

 

 

67,933

 

2027

 

 

67,933

 

2028

 

 

67,933

 

Thereafter

 

 

649,175

 

Intangible assets, Net

 

$971,691

 

 

Note 6 – Revenue 

 

The following is a summary of our revenues by type for the period ended March 31, 2024 and March 31, 2023:

 

Name

 

March 31,

2024

 

 

%

 

 

March 31,

2023

 

 

%

 

Equipment revenue

 

$296,096

 

 

 

94%

 

$793,458

 

 

 

99%

Service revenue

 

 

19,182

 

 

 

6%

 

 

8,000

 

 

 

1%

Total

 

$315,278

 

 

 

100%

 

$801,458

 

 

 

100%

 

Unearned Revenue

 

The following is a summary of our unearned revenue activity for the period ended March 31, 2024 and year ended December 31, 2023: 

 

Name

 

Balance at

March 31,

2024

 

 

Balance at

December 31,

2023

 

Unearned revenue at beginning of the period

 

$130,000

 

 

$200,109

 

Billings deferred

 

 

2,768

 

 

 

58,000

 

Recognition of prior unearned revenue

 

 

 

 

 

(128,109 )

Unearned revenue at end of period

 

$132,768

 

 

$130,000

 

 

 
16

Table of Contents

 

Unbilled Accounts Receivable

 

The following is a summary of our unbilled accounts receivable activity for the period ended March 31, 2024 and the year ended December 31, 2023:

 

Name

 

Balance at

March 31,

2024

 

 

Balance at

December 31,

2023

 

Unbilled accounts receivable at beginning of the period

 

$1,494,553

 

 

$918,164

 

Services performed but unbilled

 

 

296,096

 

 

 

1,061,612

 

Services billed

 

 

(19,040 )

 

 

(485,223)

Unbilled accounts receivable at end of the period

 

$1,771,609

 

 

$1,494,553

 

 

Note 7 – Stockholder’ Equity

 

The Company is authorized to issue 50,000,000 preferred stock shares and 200,000,000 common stock shares both with a par value of $0.0001.

 

Preferred Stock

 

On October 30, 2020, the Company designated 1,000,000 shares as Series D Convertible Preferred Stock with a par value of $0.0001.

 

As of March 31, 2024, there were no shares of Preferred Stock issued and outstanding.

 

Common Stock

 

The holders of common stock are entitled to one vote per share on all matters submitted to a vote of shareholders, including the directors’ election. There is no right to cumulative voting in the election of directors. The holders of common stock are entitled to any dividends that may be declared by the board of directors out of funds legally available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions the Company has against the payment of dividends on common stock. In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and have no right to convert their common stock into any other securities. As of March 31, 2024, there were 132,670,446 shares of common stock issued and outstanding.

 

In December 2022, the Company entered into an equity distribution agreement with an underwriter pursuant to which the Company may offer and sell shares of its common stock from time to time through the underwriter as its sales agent. Sales of common stock, if any, will be made at market prices by any method permitted by law deemed to be an “at-the-market” offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended. The Company has no obligation to sell any shares of common stock under the equity distribution agreement, and may at any time suspend offers under the equity distribution agreement, in whole or in part, or terminate the equity distribution agreement.

 

During the three months ended March 31, 2024, we issued 3,339 fully vested shares of common stock to a service provider with a fair value of $4,500 based on the market price of our common stock on date of grant.

 

During the three months ended March 31, 2023, a total of 2,137,876 shares of common stock were sold pursuant to the open market sale agreement resulting in a total of $8.35 million in proceeds, net of $0.11 million of commission fees and $0.05 million of accounting and legal fees. No such common stock sales occurred during the three months ended March 31, 2024.

 

As of March 31, 2024, a total of 3,766,422 shares of common stock have been sold pursuant to the open market sale agreement and approximately 86,560,000 remained available under the Company’s at-the-market public facility, subject to various limitations.

 

 
17

Table of Contents

 

 

Stock-based compensation

 

During the three months ended March 31, 2024, and 2023, the Company recorded stock-based compensation of $183,200 and $214,924, respectively, related to common stock issued or vested options to employees and various consultants of the Company. For the three months ended March 31, 2024, $138,586 was charged as general and administrative expenses and $44,614 as research and development expenses in the accompanying unaudited condensed consolidated statements of operations.  For the three months ended March 31, 2023, $189,283 was charged as general and administrative expenses and $25,641 as research and development expenses in the accompanying unaudited condensed consolidated statements of operations.

 

Stock Options

 

Stock option activity for the three months ended March 31, 2024 is summarized as follows:

 

 

 

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Aggregate

Intrinsic

Value

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

Options outstanding at December 31, 2023

 

 

10,828,174*

 

$0.83

 

 

$6,374,433

 

 

 

4.66

 

Granted

 

 

50,000

 

 

$1.40

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Expired/forfeit

 

 

(137,924)

 

$2.65

 

 

 

 

 

 

 

Options outstanding at March 31, 2024

 

 

10,740,250 *

 

$0.81

 

 

$4,826,248

 

 

 

4.35

 

Options Exercisable at March 31, 2024

 

 

8,696,519*

 

$0.50

 

 

$6,609,354

 

 

 

1.74

 

 

*Includes 6,700,000 options granted in connection with the Merger (see Note 1) and were not granted under the 2021 Plan.

 

As of March 31, 2024, intrinsic value is computed based on the difference between weighted average exercise price and the market price of our common stock as of March 31, 2024 of $1.26 per share multiplied by the total common stock options outstanding and exercisable.

 

Total unrecognized compensation associated with these unvested options is approximately $1,696,066 which will be recognized over a period of 2.82 years.

 

The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:

 

 

 

March 31,

2024

 

Dividend yield

 

 

0.00%

Expected life

 

6.25 Years

 

Expected volatility

 

26.3626.38%

 

Risk-free interest rate

 

4.094.31%

 

 

 
18

Table of Contents

 

 

Stock Warrants

 

As of March 31, 2024, there were 1,235,000 warrants outstanding which relate to the Series 1 offering executed in December 2021, where investors were offered a warrant for every two common shares purchased during the offering at an exercise price of $2.50 per share.

 

During the three months ended March 31, 2024 and 2023, no warrants were issued or exercised. 

 

A summary of warrant activity during the three months ended March 31, 2024, is as follows:

 

 

 

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Aggregate

Intrinsic

Value

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

Balance at December 31, 2023

 

 

1,235,000

 

 

 

2.50

 

 

$

 

 

 

0.96

 

Issued

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Balance at March 31, 2024

 

 

1,235,000

 

 

 

2.50

 

 

$

 

 

 

0.71

 

 

Note 8 - Related Party Transactions

 

In 2021, the Company entered into a manufacturing and service agreement to fabricate and manufacture the AirSCWO systems (the “Original M&S Agreement”) with Merrell Bros. The initial term of the Original M&A Agreement ends July 7, 2024 with a one-year automatic renewal unless terminated by either party with at least a sixty-day notice prior to expiration. As part of the agreement, the Company appointed Terry Merrell to its board of directors. As of March 31, 2024, Merrell Bros. or their affiliates own stock below 5% of the outstanding common stock.

 

During the period ended March 31, 2024, the Company incurred $130,321 in related party expenses related to the manufacturing of the AirSCWO systems. As of March 31, 2024, accounts payable and accrued expenses includes $119,343 of amounts owed to Merrell Bros. for the manufacturing services provided.

 

On March 27, 2024, we executed a supplemental manufacturing and services agreement (the “Supplemental M&S Agreement”) with Merrell Bros. as Merrell Bros. has indicated to us their intent to not renew the Original M&S Agreement and we have indicated our desire to relocate to a larger manufacturer facility with more square footage dedicated to expanding our manufacturing operations. Simultaneous to executing the Supplement M&S Agreement, Merrell Bros. provided us with a written non-renewal notice. Accordingly, the manufacturing and service agreement will terminate on its original expiration date of July 7, 2024 and will not be renewed.

 

The Supplemental M&S Agreement will become effective on July 7, 2024 and will replace the Original M&S Agreement. Under the Supplemental M&S Agreement, our relationship and the manufacturing services provided by Merrell Bros. will continue on an as needed basis based on statements of work to be agreed upon by both parties to fulfill future and current manufacturing orders.  The term of the Supplemental M&S Agreement is one year from July 7, 2024 with a one-year renewal upon a mutually executed written extension.  Either party may terminate this Supplement M&S Agreement upon written notice of such a termination, specifying the extent to which performance of work is terminated and the effective date of termination.

 

 
19

Table of Contents

 

Note 9 - Commitments

 

License Agreement

The patented technology underlying 374Water’s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (“Duke”), where Dr. Deshusses is a professor. The SCWO technology is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the “License Agreement”). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small number of common stock in the Company (See Note 5). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. As of March 31, 2024, the Company has not incurred any expenses in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days’ written notice. 

 

Legal Settlement

In 2023, the Company was named in a lawsuit filed against our former stock transfer agent (“Former TA”) by certain unrelated individuals asserting claims for negligence, conversion, and various breaches. Our Former TA issued 175,000 shares of our common stock to the State of Delaware in accordance with escheat laws after the Former TA was unable to issue the shares of common stock to the individuals. While the Company was not at fault in the matter, due to certain indemnification clauses between the Company and the Former TA, we are in the process of settling the matter with the individuals.

 

Based on the settlement discussions currently in process, we believe this matter will be settled with 275,000 common stock options with an exercise price equal to the market price when granted and an exercise period of five years. As of March 31, 2024 and December 31, 2023, we have $135,000 as an accrued legal settlement, as presented on the accompanying unaudited condensed consolidated balance sheet, for this pending settlement based on the estimated grant-date fair value of these options using a Black-Scholes valuation model and the following assumptions: stock price and exercise price of $1.33, risk free rate 4.43%, expected term five years, and volatility of 26.36%. 

 

We note that in the ordinary course of business we may be the subject of, or party to, various pending or threatened legal actions which could result in a material adverse outcome for which the related damages may not be estimable.  We do not believe any legal action would have a significant impact on the financials other than the matter disclosed above.  However, there is inherent uncertainty regarding such matters.  

 

Note 10 - Subsequent Events

 

Employment Agreement

 

On April 19, 2024, 374Water Inc. the Company entered into an employment agreement with Christian Gannon (the “Employment Agreement”), for Mr. Gannon to serve as President and Chief Executive Officer of the Company effective April 22, 2024 (the “Start Date”). The Employment Agreement provides for an initial annual salary for Mr. Gannon of $450,000. Mr. Gannon is also eligible to earn an annual fiscal year performance bonus for each whole or partial fiscal year of his employment period with the Company; for the initial year under the Employment Agreement in accordance with certain milestones set forth by the Company, and thereafter as determined by the compensation Committee of the Company and the Board of Directors of the Company. Mr. Gannon is eligible to earn a performance bonus up to 125% of Mr. Gannon's then-current base salary (the “Annual Bonus”) if certain milestones are met as defined in the Employment Agreement.

  

Under the Employment Agreement and subject to the terms of the Company's 2021 Equity Incentive Plan (the “Plan”), Mr. Gannon was granted up to 2,250,000 Restricted Stock Units (as defined in the Plan) under the Plan, vesting as follows: (a) 250,000, on the first annual anniversary of the Start Date; (b) 750,000, in equal increments on the last day of every month thereafter over the following 36 months, subject to Mr. Gannon's continued employment with the Company on each vesting date; and (c) 1,250,000, pursuant to certain milestones set forth by the Company and defined in the Employment Agreement (collectively, the “Gannon Restricted Stock Units”). Additionally, pursuant to the Employment Agreement and the terms of the Plan, Mr. Gannon was granted 5,250,000 Options (as defined in the Plan) under the Plan vesting as follows: (a) 625,000, on the first annual anniversary of the Start Date; (b) 1,875,000, in equal installments on the last day of every month thereafter over the following 36 months subject to Mr. Gannon's continued employment with the Company on each vesting date; and (c) 2,750,000, pursuant to certain milestones set forth by the Company  and defined in the Employment Agreement (collectively, the “Gannon Options”, and together with the Gannon Restricted Stock Units, the “Gannon Equity Awards”).

 

If the Employment Agreement is terminated by the Company without “Cause” or by Mr. Gannon for “Good Reason” (each as defined in the Employment Agreement, subject to the Company’s right to cure), he will be entitled to termination benefits, pursuant to which the Company will be obligated to (i) pay Mr. Gannon 100% of his then-current annual base salary in 12 equal installments; (ii) any earned but unpaid Annual Bonus; (iii) coverage to Mr. Gannon and his dependents under the Company’s then current medical, health, and vision insurance plans for 12 months; and (iv) if such separation occurs on the day of Mr. Gannon’s first year anniversary of employment or after the first anniversary of the Start Date, (x) a pro-rated Annual Bonus for the fiscal year in which the employment is terminated equal to the pro-rated Annual Bonus that Mr. Gannon would have received based on actual performance for such fiscal year if Mr. Gannon was employed by the Company, and (y) accelerated vesting with respect to the Gannon Equity Awards as if Mr. Gannon had remained employed by the Company through the first anniversary of the date of such separation.

 

The Employment Agreement contains covenants for the benefit of the Company relating to the protection of the Company’s confidential information and standard Company indemnification obligations.

 

 
20

Table of Contents

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward Looking Statements

 

Readers are cautioned that the statements in this Report that are not descriptions of historical facts may be “forward-looking statements” that are subject to risks and uncertainties. This Report contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements are based on the beliefs of our management, as well as on assumptions made by and information currently available to us as of the date of this Report. When used in this Report, the words “plan,” “will,” “may,” “anticipate,” “believe,” “estimate,” “expect,” “intend,” “project” and similar expressions are intended to identify such forward-looking statements. Although we believe these statements are reasonable, actual actions, operations and results could differ materially from those indicated by such forward-looking statements as a result of the risk factors included in our 2023 Annual Report on Form 10-K filed with the SEC on March 29, 2024, or other factors. We must caution, however, that this list of factors may not be exhaustive and that these or other factors, many of which are outside of our control, could have a material adverse effect on us and our ability to achieve our objectives. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above.

 

The following discussion and analysis should be read in conjunction with the financial statements and notes thereto appearing elsewhere herein.

 

Critical Accounting Policies

 

In preparing the condensed consolidated financial statements, we have made estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenues, costs, and expes, and the disclosure of contingent assets and liabilities as in our condensed consolidated financial statements. Actual results may differ from these estimates. A summary of our critical accounting estimates and policies is included in our 2023 Form 10-K under "Management’s Discussion and Analysis of Financial Condition and Results of Operations." During the three months ended March 31, 2024, there have been no significant changes to these estimates and policies previously disclosed in our 2023 Form 10-K. For disclosure regarding recent accounting pronouncements and the anticipated impact they will have on our operations, please refer to Note 2 of the condensed consolidated financial statements included in this Form 10-Q.

 

Overview

 

374Water offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. We consider ourselves pioneers in a new era of waste management that supports a circular economy and enables organizations to achieve their environment, social, and governance (ESG) goals. Our vision is a world without waste and our mission is to help create and preserve a clean and healthy environment that sustains life.

 

We have developed proprietary waste stream treatment systems based on Supercritical Water Oxidation (SCWO). The term used for the process is AirSCWOTM. SCWO leverages the unique properties of water in its supercritical phase (above 374 oC and 221 Bar) to convert organic matter to energy and safe products that can be recovered and used. The AirSCWOTM systems are essentially waste stream agnostic and able to treat a variety of complex, hazardous and non-hazardous waste streams, opening up opportunities for multiple applications in diverse market verticals on an international scale. Most pertinently, the technology is shifting the landscape in addressing environmental challenges that, until now, have been considered unsurmountable (due to science/engineering or cost barriers), one good example being the global PFAS crisis.

 

We currently outsource manufacturing of the AirSCWOTM systems to our strategic partner in the US, Merrell Bros., Inc., that have the facilities and capability to rapidly ramp-up manufacturing volumes and also support system modifications and deployment as required per market and clients. We envision in the future applying an outsourced manufacturing model in a few territories,and may consider establishing our own manufacturing capability in geographies where this is needed to adequately grow our market share.

 

 The systems will be supplied to multiple market verticals, and our revenue model includes both capital equipment sales and long-term service agreements based on throughput and capacity (Waste Purchase Agreements). Our market penetration strategy is combined of direct client and channel partner sales routes, depending on the specific market and territory. In some cases, the systems may be white labeled and sold as part of a broader solution package.

 

 
21

Table of Contents

 

Results of Operations

 

The following table sets forth, for the periods presented, the consolidated statements of operations data, which is derived from the accompanying unaudited condensed consolidated financial statements: 

 

 

 

Three Month Period Ended March 31,

 

 

 

2024

 

 

2023

 

 

$ Change

 

 

% Change

 

Revenue

 

$315,278

 

 

$801,458

 

 

$(486,180)

 

(61

%)

Cost of revenues

 

 

617,298

 

 

 

720,146

 

 

 

(102,848)

 

(14

%)

Net revenue

 

 

(302,020)

 

 

81,312

 

 

 

(383,332)

 

(471

%)

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

535,147

 

 

 

355,905

 

 

 

179,242

 

 

 

50%

Compensation and related expenses

 

 

651,604

 

 

 

718,760

 

 

 

(67,156)

 

(9

%)

Professional fees

 

 

252,705

 

 

 

99,572

 

 

 

153,133

 

 

 

154%

General and administrative

 

 

459,727

 

 

 

585,659

 

 

 

(125,932)

 

(22

%)

Total operating expenses

 

 

1,899,183

 

 

 

1,759,896

 

 

 

139,287

 

 

 

8%

Loss from operations

 

 

(2,201,203 )

 

 

(1,678,584 )

 

 

(522,619 )

 

 

31%

Other income, net

 

 

176,738

 

 

 

38,241

 

 

 

138,497

 

 

 

362%

Loss before income taxes

 

 

(2,024,465 )

 

 

(1,640,343 )

 

 

(384,122 )

 

 

23%

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

0%

Net loss

 

$(2,024,465 )

 

$(1,640,343 )

 

$(384,122 )

 

 

23%

 

Three Months Ended March 31, 2024, as Compared to the Three Months Ended March 31, 2023

 

Our business has been focused on development and commercialization of 374Water’s supercritical water oxidation (SCWO) systems. We generated $315,278 and $801,458 in revenue from manufacturing assembly services and from treatability services during the three months ending March 31, 2024 and March 31, 2023, respectively. During the three months ended March 31, 2024, we reached fewer milestones and thus incurred less direct contract costs. Costs associated with our sold unit have started to decline as we reach the end of our fabrication and testing, which have had a direct correlation to the reduced revenue recognized this year. This has had a direct impact on our change in revenue year-over-year.

 

Our general and administrative expenses decreased to $459,727 during the three months ending March 31, 2024, as compared to $585,659 in the same period of 2023, primarily because of decreased stock-based compensation expense and a decrease in advertising and marketing expenses due to our onsite SCWO system demonstration in Kokomo, Indiana for employees, contractors and customers during the three months ended March 31, 2023.

 

Our compensation and related expenses decreased to $651,604 during the three months ending March 31, 2024, as compared to $718,760 in the same period of 2023, primarily because of decreased payroll and fringe benefit expenses due to fluctuations in headcount and bonuses paid during the three months ended March 31, 2023 that were not provided during the three months ended March 31, 2024.

 

Our professional fees increased to $252,705 during the three months ending March 31, 2024, as compared to $99,572 in the same period of 2023, primarily because of increased legal fees as a result of a litigation settlement and an increase in audit related fees.

 

Our research and development expenses increased to $535,147 during the three months ending March 31, 2024, as compared to $355,905 in the same period of 2023, primarily because of the increase in engineering expenses and our continued efforts to commercialize our systems.

 

 
22

Table of Contents

 

Liquidity, Capital Resources and Going Concern

 

As of March 31, 2024, the Company had working capital of $11,715,381 and an accumulated deficit of $17,977,969. For the three months ended March 31, 2024, the Company incurred a net loss of $2,024,465 and used $2,508,653 of net cash in operations for the period.  These conditions  raise substantial doubt regarding our ability to continue as a going concern.

 

Since inception, we have financed our operations principally through the sale of debt and equity securities and operating cash flows. We have an at-the-market (ATM) equity offering under which we may issue up to $100 million of common stock, which is not currently active. However, we are in the process of activating the item.  During the year end December 31, 2023, we raised approximately $13.4 million of net proceeds through this ATM.

 

While no assurance can be provided, management believes that these actions provide the opportunity for the Company to continue as a going concern and to grow its business and achieve profitability with access to additional capital funding. Ultimately, the success of the Company as a going concern is dependent upon the ability of the Company to continue executing its plan and obtaining capital that will enable the Company to complete its in-process AirSCWO units and begin manufacturing further units. If the Company is unable to obtain additional financing in sufficient amounts or under acceptable terms, the Company operating results could be adversely affected.

 

These consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Based upon the Company’s current business plan, we believe that our current cash balance and access to liquidity are sufficient for the Company to meet its financial obligations as they become due for at least the next 12 months from the date of the report. 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Not applicable.

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective.

 

Management’s Annual Report on Internal Control Over Financial Reporting

 

Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our internal control over financial reporting as of March 31, 2024. Our management’s evaluation of our internal control over financial reporting was based on the framework in Internal Control-Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission.

 

Based on this evaluation, our management concluded that our internal control over financial reporting was effective as of March 31, 2024.

 

No Attestation Report

 

This quarterly report does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this quarterly report.

 

Changes in Internal Control Over Financial Reporting

 

There have been no other changes in our internal control over financial reporting during the first three months of 2024 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 
23

Table of Contents

 

PART II OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

Plaintiffs, Peter Somers and Peter Schalken, filed a lawsuit against Defendants 374Water and Computershare in the United States District Court for the District of Delaware, C.A. No. 23- 969-JLH (the “Lawsuit”) asserting claims for negligence, conversion, breach of contract, breach of the implied covenant of good faith and fair dealing, breach of fiduciary duty (against 374Water only), violations of state securities laws, and violations of 42. U.S.C. § 1983, relating to the alleged escheatment of Plaintiffs’ shares of PowerVerde stock to the State of Delaware. The Lawsuit alleged damages in the combined amount of $562,500. 374Water and Computershare deny the allegations in the Lawsuit and specifically deny any wrongdoing or liability regarding the claims alleged in the Lawsuit. A settlement has been agreed to in principle which involves providing Plaintiffs certain stock options. However, under the terms of the current settlement, no money would be paid to Plaintiffs by 374Water.

 

Item 1A. Risk Factors.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item. 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

Not applicable

 

 
24

Table of Contents

 

Item 6. Exhibits.

 

(a)

Exhibits

 

10.1

 

Employment Agreement, dated April 19, 2024, between the Company and Christian Gannon (filed as Exhibit 10.1 to the Company's Form 8-K filed on April 19, 2024)

 

 

 

31.1

 

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

31.2

 

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.1

 

Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.2

 

Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

101.INS

 

XBRL INSTANCE DOCUMENT

 

 

 

101.SCH

 

XBRL TAXONOMY EXTENSION SCHEMA

 

 

 

101.CAL

 

XBRL TAXONOMY EXTENSION CALCULATION LINKBASE

 

 

 

101.DEF

 

XBRL TAXONOMY EXTENSION DEFINITION LINKBASE

 

 

 

101.LAB

 

XBRL TAXONOMY EXTENSION LABEL LINKBASE

 

 

 

101.PRE

 

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

 

 
25

Table of Contents

 

SIGNATURES

 

In accordance with Section 13(a) or 15(d) of the Exchange Act, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

374WATER INC

 

 

 

 

 

Dated: May 15, 2024

By:

/s/ Christian Gannon

 

 

 

Christian Gannon

 

 

 

Chief Executive Officer

 

 

 

 

 

Dated: May 15, 2024

By:

/s/ Adrienne Anderson

 

 

 

Adrienne Anderson

 

 

 

Chief Financial Officer

 

 

 
26

Table of Contents

  

Exhibit Index

 

 
27

 

EX-31.1 2 scwo_ex311.htm CERTIFICATION scwo_ex311.htm

 

EXHIBIT 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

RULE 13a-14(a)/15d-14(a) CERTIFICATIONS

 

I, Christian Gannon, certify that:

 

1.

I have reviewed this Form 10-Q of 374Water Inc. for the quarterly period ending March 31, 2024;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

 

 

 

 

b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

 

 

 

 

d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

 

a)

all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: May 15, 2024

 

 

 

 

By:

/s/ Christian Gannon

 

 

 Chief Executive Officer

 

 

(Principal Executive Officer)

 

 

EX-31.2 3 scwo_ex312.htm CERTIFICATION scwo_ex312.htm

 

EXHIBIT 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

RULE 13a-14(a)/15d-14(a) CERTIFICATIONS

 

I, Adrienne Anderson, certify that:

 

1.

I have reviewed this Form 10-Qof 374Water Inc. for the quarterly period ending March 31, 2024;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

 

 

 

 

b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

 

 

 

 

d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

 

a)

all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: May 15, 2024

 

 

 

 

By:

/s/ Adrienne Anderson

 

 

Chief Financial Officer

 

 

EX-32.1 4 scwo_ex321.htm CERTIFICATION scwo_ex321.htm

 

EXHIBIT 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

 

In connection with the Form 10-Q of 374Water Inc. for 374Water Inc., (the “Company”) for the period ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Christian Gannon , Interim Chief Executive Officer, of the Company certify pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002 that:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 15, 2024

 

 

 

 

By:

/s/ Christian Gannon

 

 

Chief Executive Officer

 

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-32.2 5 scwo_ex322.htm CERTIFICATION scwo_ex322.htm

 

EXHIBIT 32.2

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

 

In connection with the Form 10-Q of 374Water Inc. for 374Water Inc., (the “Company”) for the period ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Adrienne Anderson, Chief Financial Officer, of the Company certify pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002 that:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 15, 2024

 

 

 

 

By:

/s/ Adrienne Anderson

 

 

Chief Financial Officer

 

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-101.SCH 6 scwo-20240331.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - Condensed Consolidated Changes in Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - Nature of Business and Presentation of Financial Statements link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - Liquidity Capital Resources and Going Concern link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - Stockholder Equity link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - Commitments link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 000017 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 000018 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 000020 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 000021 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 000022 - Disclosure - Stockholder Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 000023 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 000024 - Disclosure - Summary of Significant Accounting Policies (Details 1) link:presentationLink link:calculationLink link:definitionLink 000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000026 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000027 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 000028 - Disclosure - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 000029 - Disclosure - Intangible Assets (Details 1) link:presentationLink link:calculationLink link:definitionLink 000030 - Disclosure - Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000031 - Disclosure - Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 000032 - Disclosure - Revenue (Details 1) link:presentationLink link:calculationLink link:definitionLink 000033 - Disclosure - Revenue (Details 2) link:presentationLink link:calculationLink link:definitionLink 000034 - Disclosure - Stockholder Equity (Details) link:presentationLink link:calculationLink link:definitionLink 000035 - Disclosure - Stockholder Equity (Details 1) link:presentationLink link:calculationLink link:definitionLink 000036 - Disclosure - Stockholder Equity (Details 2) link:presentationLink link:calculationLink link:definitionLink 000037 - Disclosure - Stockholder Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000038 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000039 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000040 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 7 scwo-20240331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Ex Transition Period Entity Common Stock Shares Outstanding Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Security 12b Title Trading Symbol Security Exchange Name Document Quarterly Report Document Transition Report Entity Interactive Data Current Condensed Consolidated Balance Sheets Assets Current Assets: Cash Accounts receivable, net of allowance Unbilled accounts receivable Other accounts receivable Inventory, net Prepaid expenses Total Current Assets [Assets, Current] Long-Term Assets: Property, and Equipment, net Intangible asset, net Total Long-Term Assets [Assets, Noncurrent] Total Assets [Assets] Liabilities and Stockholders' Equity Current Liabilities: Accounts payable and accrued expenses Accrued contract loss provision Accrued legal settlement Unearned revenue Other liabilities Total Current Liabilities [Liabilities, Current] Total Liabilities [Liabilities] Stockholders' Equity Preferred stock: 50,000,000 convertible Series D preferred shares authorized; par value $0.0001 per share, nil issued and outstanding at March 31, 2024 and December 31, 2023 Common stock: 200,000,000 common shares authorized, par value $0.0001 per share, 132,670,446 and 132,667,107 shares outstanding at March 31, 2024 and December 31, 2023, respectively Additional paid-in capital Accumulated deficit Accumulated other comprehensive loss Total Stockholders' Equity [Stockholders' Equity Attributable to Parent] Total Liabilities and Stockholders' Equity [Liabilities and Equity] Preferred Stock, Shares Authorized Preferred Stock Par Value Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Shares Authorized Common Stock, Par Value Common Stock, Shares issued Common Stock, Shares Outstanding Condensed Consolidated Statements of Operations (Unaudited) Revenue [Revenues] Cost of goods sold Gross margin [Gross Profit] Operating Expenses Research and development Compensation and related expenses Professional fees General and administrative Total Operating Expenses [Operating Expenses] Loss from Operations [Operating Income (Loss)] Interest income Other income Total Other Income [Other Nonoperating Income (Expense)] Net Loss before Income Taxes [Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest] Provision for Income Taxes Net Loss [Net Income (Loss), Including Portion Attributable to Noncontrolling Interest] Foreign currency translation gain Unrealized gain on marketable securities Total other comprehensive loss [Other Comprehensive Income (Loss), Net of Tax] Total comprehensive loss [Comprehensive Income (Loss), Net of Tax, Attributable to Parent] Net Loss per Share - Basic and Diluted Weighted Average Common Shares Outstanding - Basic and Diluted Condensed Consolidated Changes in Stockholders' Equity (Unaudited) Statement [Table] Statement [Line Items] Statement Equity Components [Axis] Preferred Stock [Member] Common Stock Additional Paid-In Capital Retained Earnings (Accumulated Deficit) Other Comprehensive Income Balance, shares [Shares, Issued] Balance, amount Issuance of shares of common stock for cash, shares Issuance of shares of common stock for cash, amount Stock-based compensation Foreign currency gain Unrealized gain on investments Net loss Issuance of shares for services, shares Issuance of shares for services, amount Balance, shares Balance, amount Condensed Consolidated Statements of Cash Flows (Unaudited) Cash Flows from Operating Activities Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization expense Issuance of common stock for services Stock-based compensation [Stock-based compensation] Gain on foreign currency translation [Foreign Currency Transaction Gain (Loss), before Tax] Increase in inventory reserve Changes in operating assets and liabilities: Accounts receivable [Increase (Decrease) in Accounts Receivable] Unbilled accounts receivable [Increase (Decrease) in Unbilled Receivables] Other receivables [Increase (Decrease) in Other Receivables] Inventory [Increase (Decrease) in Inventories] Prepaid expenses [Increase (Decrease) in Prepaid Expense] Accounts payable and accrued expenses [Increase (Decrease) in Accounts Payable and Accrued Liabilities] Accrued contract loss provision [Gain (Loss) on Contract Termination] Unearned revenue [Increase (Decrease) in Deferred Revenue] Other liabilities [Increase (Decrease) in Other Operating Liabilities] Net Cash Used In Operating Activities [Net Cash Provided by (Used in) Operating Activities] Cash Flows from Investing Activities Purchase of equipment [Payments to Acquire Property, Plant, and Equipment] Increase in intangible assets [Payments to Acquire Intangible Assets] Cash Used In Investing Activities [Net Cash Provided by (Used in) Investing Activities] Proceeds from the sale of common stock Cash Provided by Financing Activities [Net Cash Provided by (Used in) Financing Activities] Net (Decrease) Increase in Cash [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect] Cash, Beginning of the Period Cash, End of the Period SUPPLEMENTAL CASH FLOW DISCLOSURES: Cash paid for interest Cash paid for taxes Nature of Business and Presentation of Financial Statements Nature of Business and Presentation of Financial Statements Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Summary of Significant Accounting Policies Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Liquidity Capital Resources and Going Concern Liquidity, Capital Resources and Going Concern Inventory Inventory Inventory Disclosure [Text Block] Intangible Assets Intangible Assets Intangible Assets Disclosure [Text Block] Revenue Revenue Deferred Revenue Disclosure [Text Block] Stockholder Equity Stockholder' Equity Related Party Transactions Related Party Transactions Related Party Transactions Disclosure [Text Block] Commitments Commitments Commitments Disclosure [Text Block] Subsequent Events Subsequent Events Subsequent Events [Text Block] Cash and Cash Equivalents Accounts Receivable and Unbilled Accounts Receivable Other Accounts Receivable Inventories Property and Equipment Intangible Assets Intangible Assets, Finite-Lived, Policy [Policy Text Block] Long-lived Assets Concentrations of Credit Risk Revenue Recognition Accrued Contract Loss Provision and Onerous Contracts Stock-based Compensation and Change in Accounting Policy Income Tax Policy Accounting for Uncertainty in Income Taxes Research And Development Costs Loss Per Share Financial Instruments Use Of Estimates Recent Accounting Pronouncements - Not Yet Adopted Schedule of property and equipment Schedule of depreciation in property and equipment Schedule Of Inventory Schedule Of Intangible Assets Schedule Of Future Amortization Expense Schedule Of revenue by type Schedule Of unearned revenue activity Schedule Of unbilled accounts receivable Schedule of stock option activity Schedule of stock option assumtion Schedule of warrant activity Long-Lived Tangible Asset [Axis] Computers [Member] Equipment [Member] Vehicles [Member] Total Property Plant And Equipment Less: accumulated depreciations [SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation] Total property and equipment, net Depreciation Major Customers Axis Concentration Risk By Benchmark Axis Financial Instrument [Axis] Award Type Axis One Customer [Member] Revenue [Member] Options [Member] Warrants [Member] Research and Development Cost Cash and cash equivalents Revenues from sale of treatability services Revenues from sales Inventory allowance Concentrations of Credit Risk [Concentration Risk, Percentage] Contract loss provision Share based description Antidilutive Excluded from Computation of Earnings Per Share, Amount Accumulated Deficit Net Income (loss) Net Cash Used In Operations Working Capital Raw materials Work-in-process Less: inventory reserves [Inventory Valuation Reserves] Total Finite Lived Intangible Assets By Major Class Axis License Agreement [Member] Patents [Member] Intangible Assets, Net, Beginning balance [Finite-Lived Intangible Assets, Net] Additions Amortization [Amortization of Intangible Assets] Estimated Life Intangible Assets, Net, Ending balance 2024 2025 2026 2027 2028 Thereafter Intangible Assets, Net Accounts Notes Loans And Financing Receivables By Billing Status Type Axis Equipment revenue [Member] Service revenue [Member] Revenue Revenue percentage Revenue percentage [Revenue percentage] Unearned revenue at beginning of the period [Contract with Customer, Liability, Current] Billings deferred Recognition of prior unearned revenue [Recognition of Deferred Revenue] Unearned revenue at end of period Unbilled accounts receivable at beginning of year [Accounts Receivable, after Allowance for Credit Loss] Services performed but unbilled Services billed Unbilled accounts receivable at end of year Options Outstanding, beginning balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number] Granted Exercised [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period] Expired/forfeited [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period] Options Outstanding, ending balance Options Outstanding Exercisable, ending balance Weighted Average Exercise Price, beginning balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price] Weighted Average Exercise Price, Granted Weighted Average Exercise Price, Exercised [Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price] Weighted Average Exercise Price, Expired/forfeit Weighted Average Exercise Price, ending balance Weighted Average Exercise Price Exercisable, ending balance Aggregate Intrinsic Value, beginning balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value] Aggregate Intrinsic Value, ending balance Aggregate Intrinsic Value Exercisable, ending balance Weighted Average Remaining Contractual Life (years) Beginning Weighted Average Remaining Contractual Life (years) Ending Weighted Average Remaining Contractual Life (years) Exercisable Ending Range Axis Minimum [Member] Options [Member] Options Held [Member] Maximum [Member] Dividend Yield Expected Life Expected Volatility Risk-free Interest Rate Balance At Beginning balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number] Shares Issued Shares Exercised [Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised] Balance At Ending balance Weighted Average Exercise Price Issued Weighted Average Exercise Price Exercised Weighted Average Exercise Price, ending balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price] Weighted Average Remaining Contractual Life(years), beginning balance Weighted Average Remaining Contractual Life(years), ending balance Plan Name Axis Equity Distribution Agreement [Member] Consultant [Member] Sale of common stock shares Unrecognized Compensation Expense, Unvested Options Preferred Stock Shares Authorized Common Stock Shares Authorized Preferred Stock, Shares designated Preferred Stock, Shares Issued Warrants Outstanding Warrant exercise Price Common stock fair value Options granted Market Price of common stock Preferred Stock, Par Value Common Stock Value Per Share Common Stock, Shares issue Gross Process From Private Placement Of Stocks Commission fees Legal fees Market public facility Stock-based Compensation Common Stock, Shares Outstanding Research And Development General And Administrative Blank check preferred stock issued Related Party Transaction, Expenses from Transactions with Related Party Accounts payable and accrued expenses [Accounts payable and accrued expenses] Stock In Excess Percentage Of Outstanding Share Indefinite-Lived Intangible Assets [Axis] License Agreement [Member] Licensing Agreements [Member] Expenses Legal settlement upon issuance of common stock Stock issued during period Accrued legal settlement [Accrued legal settlement] Stock price Exercise price Risk free rate Volatility Subsequent Event Type Axis Title of Individual [Axis] Subsequent Events [Member] Mr. Gannon [Member] Initial annual salary Subsequent Event, Description EX-101.CAL 8 scwo-20240331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 9 scwo-20240331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 10 scwo-20240331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 15, 2024
Cover [Abstract]    
Entity Registrant Name 374WATER INC.  
Entity Central Index Key 0000933972  
Document Type 10-Q  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company true  
Entity Current Reporting Status Yes  
Document Period End Date Mar. 31, 2024  
Entity Filer Category Non-accelerated Filer  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
Entity Ex Transition Period false  
Entity Common Stock Shares Outstanding   132,670,446
Entity File Number 000-27866  
Entity Incorporation State Country Code DE  
Entity Tax Identification Number 88-0271109  
Entity Address Address Line 1 701 W Main Street  
Entity Address Address Line 2 Suite 410  
Entity Address City Or Town Durham  
Entity Address State Or Province NC  
Entity Address Postal Zip Code 27701  
City Area Code 919  
Local Phone Number 888-8194  
Security 12b Title Common Stock, par value $0.0001  
Trading Symbol SCWO  
Security Exchange Name NASDAQ  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash $ 7,936,161 $ 10,445,404
Accounts receivable, net of allowance 84,324 64,792
Unbilled accounts receivable 1,771,609 1,494,553
Other accounts receivable 34,161 39,749
Inventory, net 2,601,658 2,276,677
Prepaid expenses 921,365 581,085
Total Current Assets 13,349,278 14,902,260
Long-Term Assets:    
Property, and Equipment, net 223,339 230,971
Intangible asset, net 971,691 988,029
Total Long-Term Assets 1,195,030 1,219,000
Total Assets 14,544,308 16,121,260
Current Liabilities:    
Accounts payable and accrued expenses 755,721 572,297
Accrued contract loss provision 600,000 500,000
Accrued legal settlement 135,000 135,000
Unearned revenue 132,768 130,000
Other liabilities 10,408 36,787
Total Current Liabilities 1,633,897 1,374,084
Total Liabilities 1,633,897 1,374,084
Stockholders' Equity    
Preferred stock: 50,000,000 convertible Series D preferred shares authorized; par value $0.0001 per share, nil issued and outstanding at March 31, 2024 and December 31, 2023 0 0
Common stock: 200,000,000 common shares authorized, par value $0.0001 per share, 132,670,446 and 132,667,107 shares outstanding at March 31, 2024 and December 31, 2023, respectively 13,266 13,266
Additional paid-in capital 30,872,643 30,684,943
Accumulated deficit (17,977,969) (15,953,504)
Accumulated other comprehensive loss 2,471 2,471
Total Stockholders' Equity 12,910,411 14,747,176
Total Liabilities and Stockholders' Equity $ 14,544,308 $ 16,121,260
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Condensed Consolidated Balance Sheets    
Preferred Stock, Shares Authorized 50,000,000 50,000,000
Preferred Stock Par Value $ 0.0001 $ 0.0001
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Common Stock, Shares Authorized 200,000,000 200,000,000
Common Stock, Par Value $ 0.0001 $ 0.0001
Common Stock, Shares issued 132,670,446 132,667,107
Common Stock, Shares Outstanding 132,670,446 132,667,107
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Condensed Consolidated Statements of Operations (Unaudited)    
Revenue $ 315,278 $ 801,458
Cost of goods sold 617,298 720,146
Gross margin (302,020) 81,312
Operating Expenses    
Research and development 535,147 355,905
Compensation and related expenses 651,604 718,760
Professional fees 252,705 99,572
General and administrative 459,727 585,659
Total Operating Expenses 1,899,183 1,759,896
Loss from Operations (2,201,203) (1,678,584)
Interest income 104,620 37,859
Other income 72,118 382
Total Other Income 176,738 38,241
Net Loss before Income Taxes (2,024,465) (1,640,343)
Provision for Income Taxes 0 0
Net Loss (2,024,465) (1,640,343)
Foreign currency translation gain 0 824
Unrealized gain on marketable securities 0 18,967
Total other comprehensive loss 0 19,791
Total comprehensive loss $ (2,024,465) $ (1,620,552)
Net Loss per Share - Basic and Diluted $ (0.02) $ (0.01)
Weighted Average Common Shares Outstanding - Basic and Diluted 132,668,777 127,146,695
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Changes in Stockholders' Equity (Unaudited) - USD ($)
Total
Preferred Stock [Member]
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Other Comprehensive Income
Balance, shares at Dec. 31, 2022     126,702,545      
Balance, amount at Dec. 31, 2022 $ 8,253,612 $ 0 $ 12,669 $ 16,110,221 $ (7,849,982) $ (19,296)
Issuance of shares of common stock for cash, shares     2,137,876      
Issuance of shares of common stock for cash, amount 8,294,708 0 $ 214 8,294,494 0 0
Stock-based compensation 214,924 0 0 214,924 0 0
Foreign currency gain 824 0 0 0 0 824
Unrealized gain on investments 18,967 0 0 0 0 18,967
Net loss (1,640,343) 0 $ 0 0 (1,640,343) 0
Balance, shares at Mar. 31, 2023     128,840,421      
Balance, amount at Mar. 31, 2023 15,142,692 0 $ 12,883 24,619,639 (9,490,325) 495
Balance, shares at Dec. 31, 2023     132,667,107      
Balance, amount at Dec. 31, 2023 $ 14,747,176 0 $ 13,266 30,684,943 (15,953,504) 2,471
Issuance of shares of common stock for cash, shares 175,000          
Stock-based compensation $ 183,200 0 0 183,200 0 0
Net loss (2,024,465) 0 $ 0 0 (2,024,465) 0
Issuance of shares for services, shares     3,339      
Issuance of shares for services, amount 4,500 0 $ 0 4,500 0 0
Balance, shares at Mar. 31, 2024     132,670,446      
Balance, amount at Mar. 31, 2024 $ 12,910,411 $ 0 $ 13,266 $ 30,872,643 $ (17,977,969) $ 2,471
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities    
Net loss $ (2,024,465) $ (1,640,343)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 24,560 29,105
Issuance of common stock for services 4,500 0
Stock-based compensation 183,200 214,924
Gain on foreign currency translation 0 824
Increase in inventory reserve 50,000 0
Changes in operating assets and liabilities:    
Accounts receivable (19,532) (26,188)
Unbilled accounts receivable (277,056) (754,290)
Other receivables 5,588 (308,374)
Inventory (374,981) (127,309)
Prepaid expenses (340,280) 23,285
Accounts payable and accrued expenses 183,424 (581,582)
Accrued contract loss provision 100,000 0
Unearned revenue 2,768 5,000
Other liabilities (26,379) (13,528)
Net Cash Used In Operating Activities (2,508,653) (3,178,176)
Cash Flows from Investing Activities    
Purchase of equipment 0 (7,303)
Increase in intangible assets (590) (2,705)
Cash Used In Investing Activities (590) (10,008)
Proceeds from the sale of common stock 0 8,294,708
Cash Provided by Financing Activities 0 8,294,708
Net (Decrease) Increase in Cash (2,509,243) 5,106,224
Cash, Beginning of the Period 10,445,404 4,046,937
Cash, End of the Period 7,936,161 9,153,161
SUPPLEMENTAL CASH FLOW DISCLOSURES:    
Cash paid for interest 0 0
Cash paid for taxes $ 0 $ 0
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Nature of Business and Presentation of Financial Statements
3 Months Ended
Mar. 31, 2024
Nature of Business and Presentation of Financial Statements  
Nature of Business and Presentation of Financial Statements

Note 1 – Nature of Business and Presentation of Financial Statements

 

Description of the Company

 

374Water Inc. (the “Company”, “374Water”, “We”, or “Our”) is a Delaware corporation which was formed in September 2005 as PowerVerde, Inc. At that time, the Company was focused on developing, commercializing and marketing a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a pressure-driven expander motor and related organic rankine cycle technology.

 

On April 16, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger”) with 374Water Inc., a privately held company based in Durham, North Carolina, (“374Water Private Company”) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde.

 

Following the Merger, 374Water offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., “per-and polyfluoroalkyl substances” or “PFAS”) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals.  We are developing AirSCWO, a proprietary treatment system based on “supercritical water oxidation.”

 

Presentation of Financial Statements

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) for interim financial information. It is management’s opinion that the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q and include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report on Form 10-K of 374Water Inc. as of and for the year ended December 31, 2023 filed with the SEC on March 29, 2024.

 

The results of operations for the three months ended March 31, 2024, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of 374Water Inc., 374Water Systems Inc, and 374Water Sustainability Israel LTD, each a wholly-owned subsidiary of 374 Water. Intercompany balances and transactions have been eliminated in consolidation.

XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2024
Summary of Significant Accounting Policies  
Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held $7,936,161 and $10,445,404 in cash and cash equivalents as of March 31, 2024 and December 31, 2023, respectively.

Accounts Receivable and Unbilled Accounts Receivable

 

Accounts receivables consist of balances due from service revenues. Unbilled accounts receivables are from revenues earned but not yet billed. The Company monitors accounts receivable and provides allowances for expected credit losses when considered necessary. As of  March 31, 2024 and December 31, 2023, accounts receivable were considered to be fully collectible but in accordance with the allowance for credit losses, the Company recorded an allowance for credit losses based on a reserve of current and aged receivables which was not significant as of March 31, 2024 and December 31, 2023.  

 

Other Accounts Receivable

 

Other accounts receivable consist of accrued interest income from the cash held in an interest bearing money market account with a financial institution. We typically receive payment for accrued interest one month in arrears. 

 

Inventories

 

Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. The majority of our inventory is raw materials and work in progress.  Net realizable value is the value of an asset that can be realized upon the sale of the asset, less a reasonable estimate of the costs associated with either the eventual sale or the disposal of the asset in question.  We utilize third-party suppliers to produce our products. Costs associated with fabrication, and other costs associated with the manufacturing of products, are recorded as inventory. We periodically evaluate the carrying value of our inventories in relation to estimated forecasts of product demand, which takes into consideration the life cycle of product releases. Further, as we continue to hence and develop are AirSCWO systems we may replace materials and parts with upgrades to enhance the units. If it is not probable that the replacement part will be used , we establish a reserve against the material or part or dispose of it. When quantities on hand exceed estimated sales forecasts, we perform an analysis to determine if a write-down for such excess inventories is required.  Once inventory has been written down, it creates a new cost basis for inventory.  Inventories are classified as current assets in accordance with recognized industry practice. Based on our evaluation we estimated an inventory allowance of $50,000 and $0 as of March 31, 2024 and December 31, 2023, respectively.

 

Property and Equipment

 

Property and Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred. 

 

The following table presents property and equipment as of March 31, 2024 and December 31, 2023:

 

 

 

March 31,

2024

 

 

December 31,

2023

 

Computers

 

$16,489

 

 

$16,489

 

Equipment

 

 

190,748

 

 

 

190,748

 

Vehicles

 

 

44,510

 

 

 

44,510

 

Total property and equipment

 

 

251,747

 

 

 

251,747

 

Less: accumulated depreciation

 

 

(28,408 )

 

 

(20,776 )

Total property and equipment, net

 

$223,339

 

 

$230,971

 

 

Depreciation expense related to property and equipment was as follows:

 

 

 

Period Ended March 31,

 

 

 

2024

 

 

2023

 

Depreciation

 

$7,632

 

 

$9,525

 

 

Intangible Assets

 

Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment.” Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. As of March 31, 2024 and December 31, 2023, there was no impairment.

 

Long-Lived Assets

 

The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2024 and December 31, 2023, there were no impairments.

 

Concentrations of Credit Risk

 

Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (“FDIC”). The Company’s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.

 

Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues and purchases.  One customer made up approximately 94% and 99% of revenue for the three month periods ended March 31, 2024 and 2023, respectively.

 

During the three months ended March 31, 2024 and 2023, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros Fabrication, LLC (“Merrell Bros.”) (see Note 8).

 

Refer to Note 9 for a license agreement we have with Duke University for the SCWO technology used in our systems.

  

Revenue Recognition

 

The Company follows the revenue standards of Codification (ASC) Topic 606: “Revenue from Contracts with Customers (Topic 606).” The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation using the input method.

 

The Company generates revenue from the sale of equipment (AirSCWO units) and services, specifically the completion of treatability studies. In the case of equipment revenues, the Company’s performance obligations are satisfied over time over the life of the contract which are typically long-term fixed price contracts. Revenue is recognized over time by measuring the progress toward complete satisfaction of the performance obligation using specific milestones. These milestones within the contract are assigned revenue recognition percentages, based on overall expected cost-plus margin estimates of those milestones compared to the total cost of the contract. Equipment sale related contract revenues are recognized in the proportion that contract costs incurred bear to total estimated costs. This method is used because management considers the input method to be the best available measure of progress on these contracts.

 

Changes in our overall expected cost estimates are recognized as a cumulative adjustment for the inception-to-date effective of such change. If these changes in estimates result in a possible loss being incurred on the contract, we accrue for such a loss in the period such an outcome becomes probable. 

 

Services revenues are recognized when all five revenue recognition criteria have been completed which is generally when we deliver a completed treatability study report to the customer.

 

Contract costs include all direct material, labor and subcontractor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs, and depreciation. General, selling, and administrative costs are charged to expenses as incurred.

 

Revenues for the three-month period ended March 31, 2024 in the amount of $296,096 was generated from the progress towards completion of the AirSCWO system and $19,182 was generated from the sale of treatability services.

 

Revenues for the three-month period ended March 31, 2023 in the amount of $793,458 was generated from the sale of the AirSCWO system and $8,000 was generated from the sale of treatability services. 

 

Accrued Contract Loss Provision and Onerous Contracts

 

Onerous contracts are those where the costs to fulfill a contract exceed the consideration expected to be received under the contract. The revenue standard does not provide guidance on the accounting for onerous contracts or onerous performance obligations. US GAAP contains other applicable guidance on the accounting for onerous contracts, and those requirements should be used to identify and measure onerous contracts.

 

Our outstanding equipment manufacturing contract is a fixed price contract. Due to the nature of the contract, including customer specific equipment design, we applied ASC 605-35, Revenue Recognition—Provision for Losses on Construction-Type and Production-Type Contract (ASC 605-35). ASC 605-35 requires the recognition of a liability for anticipated losses on contracts prior to those losses being incurred when a loss is probable and can be estimated.

 

As of March 31, 2024 and December 31, 2023, we evaluated the total costs incurred on this contract to date and the estimated costs we anticipate incurring to complete the contract.  Based on this analysis, we accrued a total accrued loss provision of $600,000 and $500,000 as of March 31, 2024 and December 31, 2023, respectively, which has been presented on the accompanying unaudited condensed consolidated balance sheets and is recorded within cost of revenues on the accompanying unaudited condensed consolidated statements of operations.

 

Stock-based Compensation and Change in Accounting Policy

 

The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

 

Prior to January 1, 2024, the Company had elected to estimate options granted for which the requisite service period would not be rendered, due to the option being forfeited or expiring. The forfeiture rate estimate was based on the percentage of cumulative forfeitures to the total award grants.  During the quarter ended December 31, 2023, we compared our actual forfeiture rate to our estimated forfeiture rate and made a cumulative adjustment of approximately $55,000 in the quarter ended December 31, 2023 to reduce our forfeiture rate estimate to approximately 5% of the total stock-based compensation recognized during the year. 

 

Effective January 1, 2024, the Company made a change in their accounting policy to recognize forfeitures on service-based stock award instruments as they occur.  Due to the lack of history available to adequately estimate our forfeiture rate and the fact that the majority of our serviced based options include a one-year cliff vesting and monthly vesting after, we believe recognizing forfeitures as they occur will result in more accurate financial reporting. The change in this accounting policy did not have a significant impact on the current or prior period financial statements. During the three months ended March 31, 2024, no forfeitures occurred.

 

Income Tax Policy

 

The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.

 

Accounting for Uncertainty in Income Taxes

 

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2024 and December 31, 2023.

 

Research and Development Costs

 

The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $535,147 and $355,905 for the three months ended March 31, 2024 and 2023, respectively.

 

Loss Per Share

 

Loss per share is computed in accordance with ASC Topic 260, “Earnings per Share” Basic weighted-average number of shares of common stock outstanding for the three- months ended March 31, 2024 and 2023  include the shares of the Company issued and outstanding during such periods, each on a weighted average basis. The basic weighted average number of shares of common stock outstanding excludes common stock equivalent incremental shares, while diluted weighted average number of shares outstanding includes such incremental shares. However, as the Company was in a loss position for all periods presented, basic and diluted weighted average shares outstanding are the same, as the inclusion of the incremental shares would be anti-dilutive.  As of March 31, 2024 and March 31, 2023, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 10,740,250 and 13,025,000  shares of common stock and 1,235,000 and 1,250,000 warrants, respectively.

 

Financial Instruments

 

The Company carries cash, accounts, unbilled and other receivables, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.

  

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, service revenue, accrued contract loss provisions, and valuation allowance against deferred tax assets.

 

Recent Accounting Pronouncements - Not Yet Adopted

 

In December 2023 FASB issued Accounting Standards Update (ASU) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09). The ASU focuses on income tax disclosures around effective tax rates and cash income taxes paid. ASU 2023-09 requires public business entities to disclose, on an annual basis, a rate reconciliation presented in both dollars and percentages. The guidance requires the rate reconciliation to include specific categories and provides further guidance on disaggregation of those categories based on a quantitative threshold equal to 5% or more of the amount determined by multiplying pretax income (loss) from continuing operations by the applicable statutory rate. For entities reconciling to the US statutory rate of 21%, this would generally require disclosing any reconciling items that impact the rate by 1.05% or more. ASU 2023-09 is effective for public business entities for annual periods beginning after December  15, 2024 (generally, calendar year 2025) and effective for all other business entities one year later. Entities should adopt this guidance on a prospective basis, though retrospective application is permitted. The adoption of ASU 2023-09 is expected to have a financial statement disclosure impact only and is not expected to have a material impact on the Company’s financial statements.

 

In November 2023 the FASB issued ASU 2023-07, Segment Reporting – Improvements to Reportable Segment Disclosures.  The ASU will now require public entities to disclose its significant segment expenses categories and amounts for each reportable segment. Under the ASU, a significant segment expense is an expense that is:

 

 

·

significant to the segment,

 

·

regularly provided to or easily computed from information regularly provided to the chief operating decision maker (CODM), and

 

·

included in the reported measure of segment profit or loss.

 

The ASU is effective for public entities for fiscal years beginning after December 15, 2023 and interim periods in fiscal years beginning after December 15, 2024 (calendar year public entity will adopt the ASU in its 2024 Form 10 K). The ASU should be adopted retrospectively unless it’s impracticable to do so. Early adoption of the ASU is permitted, including in an interim period. The adoption of ASU 2023-07 is expected to have a financial statement disclosure impact only and is not expected to have a material impact on the Company’s financial statements.

 

The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Liquidity Capital Resources and Going Concern
3 Months Ended
Mar. 31, 2024
Liquidity Capital Resources and Going Concern  
Liquidity, Capital Resources and Going Concern

Note 3 – Liquidity, Capital Resources and Going Concern

 

As of March 31, 2024, the Company had working capital of $11,715,381 and an accumulated deficit of $17,977,969. For the three months ended March 31, 2024, the Company incurred a net loss of $2,024,465 and used $2,508,653 of net cash in operations for the period.  These conditions raise substantial doubt regarding our ability to continue as a going concern.

  

Since inception, we have financed our operations principally through the sale of debt and equity securities and operating cash flows. We have an at-the-market (ATM) equity offering under which we may issue up to $100 million of common stock, which is not currently active. However, we are in the process of activating the ATM. During the year end December 31, 2023, we raised approximately $13.4 million of net proceeds through this ATM.

While no assurance can be provided, management believes that these actions provide the opportunity for the Company to continue as a going concern and to grow its business and achieve profitability with access to additional capital funding. Ultimately, the success of the Company as a going concern is dependent upon the ability of the Company to continue executing its plan and obtaining capital that will enable the Company to complete its in-process AirSCWO units and begin manufacturing further units. If the Company is unable to obtain additional financing in sufficient amounts or under acceptable terms, the Company's operating results could be adversely affected.

 

These consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Based upon the Company’s current business plan, we believe that our current cash balance and access to liquidity are sufficient for the Company to meet its financial obligations as they become due for at least the next 12 months from the date of the report. 

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Inventory
3 Months Ended
Mar. 31, 2024
Inventory  
Inventory

Note 4 – Inventory

 

Inventory, net consists of:

 

Name

 

Balance at

March 31,

2024

 

 

Balance at

December 31,

2023

 

Raw materials

 

$717,052

 

 

$457,393

 

Work-in-process

 

 

1,934,606

 

 

 

1,819,284

 

Less: inventory reserves

 

 

(50,000)

 

 

 

Total

 

$2,601,658

 

 

$2,276,677

 

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Intangible Assets
3 Months Ended
Mar. 31, 2024
Intangible Assets  
Intangible Assets

Note 5 – Intangible Assets

 

Intangible assets, net,  are comprised of the following as of March 31, 2024 and December 31, 2023 :

 

Name

 

Estimated

Life

 

Balance at

December 31,

2023

 

 

Additions

 

 

Amortization

 

 

Balance at

March 31,

2024

 

License agreement

 

17 Years

 

$901,929

 

 

$

 

 

$(15,732)

 

$886,197

 

Patents

 

20 Years

 

 

86,100

 

 

 

590

 

 

 

(1,196)

 

 

85,494

 

Total

 

 

 

$988,029

 

 

$590

 

 

$(16,928)

 

$971,691

 

 

Amortization expense for the three months ended March 31, 2024 and 2023, was $16,928 and $16,910, respectively.

Estimated future amortization expense as of March 31, 2024:

 

 

 

March 31,

 

 

 

2024

 

2024 (remaining)

 

$50,784

 

2025

 

 

67,933

 

2026

 

 

67,933

 

2027

 

 

67,933

 

2028

 

 

67,933

 

Thereafter

 

 

649,175

 

Intangible assets, Net

 

$971,691

 

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Revenue
3 Months Ended
Mar. 31, 2024
Revenue  
Revenue

Note 6 – Revenue 

 

The following is a summary of our revenues by type for the period ended March 31, 2024 and March 31, 2023:

 

Name

 

March 31,

2024

 

 

%

 

 

March 31,

2023

 

 

%

 

Equipment revenue

 

$296,096

 

 

 

94%

 

$793,458

 

 

 

99%

Service revenue

 

 

19,182

 

 

 

6%

 

 

8,000

 

 

 

1%

Total

 

$315,278

 

 

 

100%

 

$801,458

 

 

 

100%

 

Unearned Revenue

 

The following is a summary of our unearned revenue activity for the period ended March 31, 2024 and year ended December 31, 2023: 

 

Name

 

Balance at

March 31,

2024

 

 

Balance at

December 31,

2023

 

Unearned revenue at beginning of the period

 

$130,000

 

 

$200,109

 

Billings deferred

 

 

2,768

 

 

 

58,000

 

Recognition of prior unearned revenue

 

 

 

 

 

(128,109 )

Unearned revenue at end of period

 

$132,768

 

 

$130,000

 

Unbilled Accounts Receivable

 

The following is a summary of our unbilled accounts receivable activity for the period ended March 31, 2024 and the year ended December 31, 2023:

 

Name

 

Balance at

March 31,

2024

 

 

Balance at

December 31,

2023

 

Unbilled accounts receivable at beginning of the period

 

$1,494,553

 

 

$918,164

 

Services performed but unbilled

 

 

296,096

 

 

 

1,061,612

 

Services billed

 

 

(19,040 )

 

 

(485,223)

Unbilled accounts receivable at end of the period

 

$1,771,609

 

 

$1,494,553

 

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholder Equity
3 Months Ended
Mar. 31, 2024
Stockholder Equity  
Stockholder' Equity

Note 7 – Stockholder’ Equity

 

The Company is authorized to issue 50,000,000 preferred stock shares and 200,000,000 common stock shares both with a par value of $0.0001.

 

Preferred Stock

 

On October 30, 2020, the Company designated 1,000,000 shares as Series D Convertible Preferred Stock with a par value of $0.0001.

 

As of March 31, 2024, there were no shares of Preferred Stock issued and outstanding.

 

Common Stock

 

The holders of common stock are entitled to one vote per share on all matters submitted to a vote of shareholders, including the directors’ election. There is no right to cumulative voting in the election of directors. The holders of common stock are entitled to any dividends that may be declared by the board of directors out of funds legally available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions the Company has against the payment of dividends on common stock. In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and have no right to convert their common stock into any other securities. As of March 31, 2024, there were 132,670,446 shares of common stock issued and outstanding.

 

In December 2022, the Company entered into an equity distribution agreement with an underwriter pursuant to which the Company may offer and sell shares of its common stock from time to time through the underwriter as its sales agent. Sales of common stock, if any, will be made at market prices by any method permitted by law deemed to be an “at-the-market” offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended. The Company has no obligation to sell any shares of common stock under the equity distribution agreement, and may at any time suspend offers under the equity distribution agreement, in whole or in part, or terminate the equity distribution agreement.

 

During the three months ended March 31, 2024, we issued 3,339 fully vested shares of common stock to a service provider with a fair value of $4,500 based on the market price of our common stock on date of grant.

 

During the three months ended March 31, 2023, a total of 2,137,876 shares of common stock were sold pursuant to the open market sale agreement resulting in a total of $8.35 million in proceeds, net of $0.11 million of commission fees and $0.05 million of accounting and legal fees. No such common stock sales occurred during the three months ended March 31, 2024.

 

As of March 31, 2024, a total of 3,766,422 shares of common stock have been sold pursuant to the open market sale agreement and approximately 86,560,000 remained available under the Company’s at-the-market public facility, subject to various limitations.

 

Stock-based compensation

 

During the three months ended March 31, 2024, and 2023, the Company recorded stock-based compensation of $183,200 and $214,924, respectively, related to common stock issued or vested options to employees and various consultants of the Company. For the three months ended March 31, 2024, $138,586 was charged as general and administrative expenses and $44,614 as research and development expenses in the accompanying unaudited condensed consolidated statements of operations.  For the three months ended March 31, 2023, $189,283 was charged as general and administrative expenses and $25,641 as research and development expenses in the accompanying unaudited condensed consolidated statements of operations.

 

Stock Options

 

Stock option activity for the three months ended March 31, 2024 is summarized as follows:

 

 

 

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Aggregate

Intrinsic

Value

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

Options outstanding at December 31, 2023

 

 

10,828,174*

 

$0.83

 

 

$6,374,433

 

 

 

4.66

 

Granted

 

 

50,000

 

 

$1.40

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Expired/forfeit

 

 

(137,924)

 

$2.65

 

 

 

 

 

 

 

Options outstanding at March 31, 2024

 

 

10,740,250 *

 

$0.81

 

 

$4,826,248

 

 

 

4.35

 

Options Exercisable at March 31, 2024

 

 

8,696,519*

 

$0.50

 

 

$6,609,354

 

 

 

1.74

 

 

*Includes 6,700,000 options granted in connection with the Merger (see Note 1) and were not granted under the 2021 Plan.

 

As of March 31, 2024, intrinsic value is computed based on the difference between weighted average exercise price and the market price of our common stock as of March 31, 2024 of $1.26 per share multiplied by the total common stock options outstanding and exercisable.

 

Total unrecognized compensation associated with these unvested options is approximately $1,696,066 which will be recognized over a period of 2.82 years.

 

The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:

 

 

 

March 31,

2024

 

Dividend yield

 

 

0.00%

Expected life

 

6.25 Years

 

Expected volatility

 

26.36–26.38%

 

Risk-free interest rate

 

4.09–4.31%

 

 

Stock Warrants

 

As of March 31, 2024, there were 1,235,000 warrants outstanding which relate to the Series 1 offering executed in December 2021, where investors were offered a warrant for every two common shares purchased during the offering at an exercise price of $2.50 per share.

 

During the three months ended March 31, 2024 and 2023, no warrants were issued or exercised. 

 

A summary of warrant activity during the three months ended March 31, 2024, is as follows:

 

 

 

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Aggregate

Intrinsic

Value

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

Balance at December 31, 2023

 

 

1,235,000

 

 

 

2.50

 

 

$

 

 

 

0.96

 

Issued

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Balance at March 31, 2024

 

 

1,235,000

 

 

 

2.50

 

 

$

 

 

 

0.71

 

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions
3 Months Ended
Mar. 31, 2024
Related Party Transactions  
Related Party Transactions

Note 8 - Related Party Transactions

 

In 2021, the Company entered into a manufacturing and service agreement to fabricate and manufacture the AirSCWO systems (the “Original M&S Agreement”) with Merrell Bros. The initial term of the Original M&A Agreement ends July 7, 2024 with a one-year automatic renewal unless terminated by either party with at least a sixty-day notice prior to expiration. As part of the agreement, the Company appointed Terry Merrell to its board of directors. As of March 31, 2024, Merrell Bros. or their affiliates own stock below 5% of the outstanding common stock.

 

During the period ended March 31, 2024, the Company incurred $130,321 in related party expenses related to the manufacturing of the AirSCWO systems. As of March 31, 2024, accounts payable and accrued expenses includes $119,343 of amounts owed to Merrell Bros. for the manufacturing services provided.

 

On March 27, 2024, we executed a supplemental manufacturing and services agreement (the “Supplemental M&S Agreement”) with Merrell Bros. as Merrell Bros. has indicated to us their intent to not renew the Original M&S Agreement and we have indicated our desire to relocate to a larger manufacturer facility with more square footage dedicated to expanding our manufacturing operations. Simultaneous to executing the Supplement M&S Agreement, Merrell Bros. provided us with a written non-renewal notice. Accordingly, the manufacturing and service agreement will terminate on its original expiration date of July 7, 2024 and will not be renewed.

 

The Supplemental M&S Agreement will become effective on July 7, 2024 and will replace the Original M&S Agreement. Under the Supplemental M&S Agreement, our relationship and the manufacturing services provided by Merrell Bros. will continue on an as needed basis based on statements of work to be agreed upon by both parties to fulfill future and current manufacturing orders.  The term of the Supplemental M&S Agreement is one year from July 7, 2024 with a one-year renewal upon a mutually executed written extension.  Either party may terminate this Supplement M&S Agreement upon written notice of such a termination, specifying the extent to which performance of work is terminated and the effective date of termination.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments
3 Months Ended
Mar. 31, 2024
Commitments  
Commitments

Note 9 - Commitments

 

License Agreement

The patented technology underlying 374Water’s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (“Duke”), where Dr. Deshusses is a professor. The SCWO technology is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the “License Agreement”). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small number of common stock in the Company (See Note 5). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. As of March 31, 2024, the Company has not incurred any expenses in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days’ written notice. 

 

Legal Settlement

In 2023, the Company was named in a lawsuit filed against our former stock transfer agent (“Former TA”) by certain unrelated individuals asserting claims for negligence, conversion, and various breaches. Our Former TA issued 175,000 shares of our common stock to the State of Delaware in accordance with escheat laws after the Former TA was unable to issue the shares of common stock to the individuals. While the Company was not at fault in the matter, due to certain indemnification clauses between the Company and the Former TA, we are in the process of settling the matter with the individuals.

 

Based on the settlement discussions currently in process, we believe this matter will be settled with 275,000 common stock options with an exercise price equal to the market price when granted and an exercise period of five years. As of March 31, 2024 and December 31, 2023, we have $135,000 as an accrued legal settlement, as presented on the accompanying unaudited condensed consolidated balance sheet, for this pending settlement based on the estimated grant-date fair value of these options using a Black-Scholes valuation model and the following assumptions: stock price and exercise price of $1.33, risk free rate 4.43%, expected term five years, and volatility of 26.36%. 

 

We note that in the ordinary course of business we may be the subject of, or party to, various pending or threatened legal actions which could result in a material adverse outcome for which the related damages may not be estimable.  We do not believe any legal action would have a significant impact on the financials other than the matter disclosed above.  However, there is inherent uncertainty regarding such matters.  

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Subsequent Events
3 Months Ended
Mar. 31, 2024
Subsequent Events  
Subsequent Events

Note 10 - Subsequent Events

 

Employment Agreement

 

On April 19, 2024, 374Water Inc. the Company entered into an employment agreement with Christian Gannon (the “Employment Agreement”), for Mr. Gannon to serve as President and Chief Executive Officer of the Company effective April 22, 2024 (the “Start Date”). The Employment Agreement provides for an initial annual salary for Mr. Gannon of $450,000. Mr. Gannon is also eligible to earn an annual fiscal year performance bonus for each whole or partial fiscal year of his employment period with the Company; for the initial year under the Employment Agreement in accordance with certain milestones set forth by the Company, and thereafter as determined by the compensation Committee of the Company and the Board of Directors of the Company. Mr. Gannon is eligible to earn a performance bonus up to 125% of Mr. Gannon's then-current base salary (the “Annual Bonus”) if certain milestones are met as defined in the Employment Agreement.

  

Under the Employment Agreement and subject to the terms of the Company's 2021 Equity Incentive Plan (the “Plan”), Mr. Gannon was granted up to 2,250,000 Restricted Stock Units (as defined in the Plan) under the Plan, vesting as follows: (a) 250,000, on the first annual anniversary of the Start Date; (b) 750,000, in equal increments on the last day of every month thereafter over the following 36 months, subject to Mr. Gannon's continued employment with the Company on each vesting date; and (c) 1,250,000, pursuant to certain milestones set forth by the Company and defined in the Employment Agreement (collectively, the “Gannon Restricted Stock Units”). Additionally, pursuant to the Employment Agreement and the terms of the Plan, Mr. Gannon was granted 5,250,000 Options (as defined in the Plan) under the Plan vesting as follows: (a) 625,000, on the first annual anniversary of the Start Date; (b) 1,875,000, in equal installments on the last day of every month thereafter over the following 36 months subject to Mr. Gannon's continued employment with the Company on each vesting date; and (c) 2,750,000, pursuant to certain milestones set forth by the Company  and defined in the Employment Agreement (collectively, the “Gannon Options”, and together with the Gannon Restricted Stock Units, the “Gannon Equity Awards”).

 

If the Employment Agreement is terminated by the Company without “Cause” or by Mr. Gannon for “Good Reason” (each as defined in the Employment Agreement, subject to the Company’s right to cure), he will be entitled to termination benefits, pursuant to which the Company will be obligated to (i) pay Mr. Gannon 100% of his then-current annual base salary in 12 equal installments; (ii) any earned but unpaid Annual Bonus; (iii) coverage to Mr. Gannon and his dependents under the Company’s then current medical, health, and vision insurance plans for 12 months; and (iv) if such separation occurs on the day of Mr. Gannon’s first year anniversary of employment or after the first anniversary of the Start Date, (x) a pro-rated Annual Bonus for the fiscal year in which the employment is terminated equal to the pro-rated Annual Bonus that Mr. Gannon would have received based on actual performance for such fiscal year if Mr. Gannon was employed by the Company, and (y) accelerated vesting with respect to the Gannon Equity Awards as if Mr. Gannon had remained employed by the Company through the first anniversary of the date of such separation.

 

The Employment Agreement contains covenants for the benefit of the Company relating to the protection of the Company’s confidential information and standard Company indemnification obligations.

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2024
Summary of Significant Accounting Policies  
Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held $7,936,161 and $10,445,404 in cash and cash equivalents as of March 31, 2024 and December 31, 2023, respectively.

Accounts Receivable and Unbilled Accounts Receivable

Accounts receivables consist of balances due from service revenues. Unbilled accounts receivables are from revenues earned but not yet billed. The Company monitors accounts receivable and provides allowances for expected credit losses when considered necessary. As of  March 31, 2024 and December 31, 2023, accounts receivable were considered to be fully collectible but in accordance with the allowance for credit losses, the Company recorded an allowance for credit losses based on a reserve of current and aged receivables which was not significant as of March 31, 2024 and December 31, 2023.  

Other Accounts Receivable

Other accounts receivable consist of accrued interest income from the cash held in an interest bearing money market account with a financial institution. We typically receive payment for accrued interest one month in arrears. 

Inventories

Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. The majority of our inventory is raw materials and work in progress.  Net realizable value is the value of an asset that can be realized upon the sale of the asset, less a reasonable estimate of the costs associated with either the eventual sale or the disposal of the asset in question.  We utilize third-party suppliers to produce our products. Costs associated with fabrication, and other costs associated with the manufacturing of products, are recorded as inventory. We periodically evaluate the carrying value of our inventories in relation to estimated forecasts of product demand, which takes into consideration the life cycle of product releases. Further, as we continue to hence and develop are AirSCWO systems we may replace materials and parts with upgrades to enhance the units. If it is not probable that the replacement part will be used , we establish a reserve against the material or part or dispose of it. When quantities on hand exceed estimated sales forecasts, we perform an analysis to determine if a write-down for such excess inventories is required.  Once inventory has been written down, it creates a new cost basis for inventory.  Inventories are classified as current assets in accordance with recognized industry practice. Based on our evaluation we estimated an inventory allowance of $50,000 and $0 as of March 31, 2024 and December 31, 2023, respectively.

Property and Equipment

Property and Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred. 

 

The following table presents property and equipment as of March 31, 2024 and December 31, 2023:

 

 

 

March 31,

2024

 

 

December 31,

2023

 

Computers

 

$16,489

 

 

$16,489

 

Equipment

 

 

190,748

 

 

 

190,748

 

Vehicles

 

 

44,510

 

 

 

44,510

 

Total property and equipment

 

 

251,747

 

 

 

251,747

 

Less: accumulated depreciation

 

 

(28,408 )

 

 

(20,776 )

Total property and equipment, net

 

$223,339

 

 

$230,971

 

 

Depreciation expense related to property and equipment was as follows:

 

 

 

Period Ended March 31,

 

 

 

2024

 

 

2023

 

Depreciation

 

$7,632

 

 

$9,525

 

Intangible Assets

Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment.” Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. As of March 31, 2024 and December 31, 2023, there was no impairment.

Long-lived Assets

The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2024 and December 31, 2023, there were no impairments.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (“FDIC”). The Company’s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.

 

Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues and purchases.  One customer made up approximately 94% and 99% of revenue for the three month periods ended March 31, 2024 and 2023, respectively.

 

During the three months ended March 31, 2024 and 2023, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros Fabrication, LLC (“Merrell Bros.”) (see Note 8).

 

Refer to Note 9 for a license agreement we have with Duke University for the SCWO technology used in our systems.

Revenue Recognition

The Company follows the revenue standards of Codification (ASC) Topic 606: “Revenue from Contracts with Customers (Topic 606).” The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation using the input method.

 

The Company generates revenue from the sale of equipment (AirSCWO units) and services, specifically the completion of treatability studies. In the case of equipment revenues, the Company’s performance obligations are satisfied over time over the life of the contract which are typically long-term fixed price contracts. Revenue is recognized over time by measuring the progress toward complete satisfaction of the performance obligation using specific milestones. These milestones within the contract are assigned revenue recognition percentages, based on overall expected cost-plus margin estimates of those milestones compared to the total cost of the contract. Equipment sale related contract revenues are recognized in the proportion that contract costs incurred bear to total estimated costs. This method is used because management considers the input method to be the best available measure of progress on these contracts.

 

Changes in our overall expected cost estimates are recognized as a cumulative adjustment for the inception-to-date effective of such change. If these changes in estimates result in a possible loss being incurred on the contract, we accrue for such a loss in the period such an outcome becomes probable. 

 

Services revenues are recognized when all five revenue recognition criteria have been completed which is generally when we deliver a completed treatability study report to the customer.

 

Contract costs include all direct material, labor and subcontractor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs, and depreciation. General, selling, and administrative costs are charged to expenses as incurred.

 

Revenues for the three-month period ended March 31, 2024 in the amount of $296,096 was generated from the progress towards completion of the AirSCWO system and $19,182 was generated from the sale of treatability services.

 

Revenues for the three-month period ended March 31, 2023 in the amount of $793,458 was generated from the sale of the AirSCWO system and $8,000 was generated from the sale of treatability services. 

Accrued Contract Loss Provision and Onerous Contracts

Onerous contracts are those where the costs to fulfill a contract exceed the consideration expected to be received under the contract. The revenue standard does not provide guidance on the accounting for onerous contracts or onerous performance obligations. US GAAP contains other applicable guidance on the accounting for onerous contracts, and those requirements should be used to identify and measure onerous contracts.

 

Our outstanding equipment manufacturing contract is a fixed price contract. Due to the nature of the contract, including customer specific equipment design, we applied ASC 605-35, Revenue Recognition—Provision for Losses on Construction-Type and Production-Type Contract (ASC 605-35). ASC 605-35 requires the recognition of a liability for anticipated losses on contracts prior to those losses being incurred when a loss is probable and can be estimated.

 

As of March 31, 2024 and December 31, 2023, we evaluated the total costs incurred on this contract to date and the estimated costs we anticipate incurring to complete the contract.  Based on this analysis, we accrued a total accrued loss provision of $600,000 and $500,000 as of March 31, 2024 and December 31, 2023, respectively, which has been presented on the accompanying unaudited condensed consolidated balance sheets and is recorded within cost of revenues on the accompanying unaudited condensed consolidated statements of operations.

Stock-based Compensation and Change in Accounting Policy

The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

 

Prior to January 1, 2024, the Company had elected to estimate options granted for which the requisite service period would not be rendered, due to the option being forfeited or expiring. The forfeiture rate estimate was based on the percentage of cumulative forfeitures to the total award grants.  During the quarter ended December 31, 2023, we compared our actual forfeiture rate to our estimated forfeiture rate and made a cumulative adjustment of approximately $55,000 in the quarter ended December 31, 2023 to reduce our forfeiture rate estimate to approximately 5% of the total stock-based compensation recognized during the year. 

 

Effective January 1, 2024, the Company made a change in their accounting policy to recognize forfeitures on service-based stock award instruments as they occur.  Due to the lack of history available to adequately estimate our forfeiture rate and the fact that the majority of our serviced based options include a one-year cliff vesting and monthly vesting after, we believe recognizing forfeitures as they occur will result in more accurate financial reporting. The change in this accounting policy did not have a significant impact on the current or prior period financial statements. During the three months ended March 31, 2024, no forfeitures occurred.

Income Tax Policy

The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.

Accounting for Uncertainty in Income Taxes

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2024 and December 31, 2023.

Research And Development Costs

The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $535,147 and $355,905 for the three months ended March 31, 2024 and 2023, respectively.

Loss Per Share

Loss per share is computed in accordance with ASC Topic 260, “Earnings per Share” Basic weighted-average number of shares of common stock outstanding for the three- months ended March 31, 2024 and 2023  include the shares of the Company issued and outstanding during such periods, each on a weighted average basis. The basic weighted average number of shares of common stock outstanding excludes common stock equivalent incremental shares, while diluted weighted average number of shares outstanding includes such incremental shares. However, as the Company was in a loss position for all periods presented, basic and diluted weighted average shares outstanding are the same, as the inclusion of the incremental shares would be anti-dilutive.  As of March 31, 2024 and March 31, 2023, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 10,740,250 and 13,025,000  shares of common stock and 1,235,000 and 1,250,000 warrants, respectively.

Financial Instruments

The Company carries cash, accounts, unbilled and other receivables, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.

Use Of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, service revenue, accrued contract loss provisions, and valuation allowance against deferred tax assets.

Recent Accounting Pronouncements - Not Yet Adopted

In December 2023 FASB issued Accounting Standards Update (ASU) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09). The ASU focuses on income tax disclosures around effective tax rates and cash income taxes paid. ASU 2023-09 requires public business entities to disclose, on an annual basis, a rate reconciliation presented in both dollars and percentages. The guidance requires the rate reconciliation to include specific categories and provides further guidance on disaggregation of those categories based on a quantitative threshold equal to 5% or more of the amount determined by multiplying pretax income (loss) from continuing operations by the applicable statutory rate. For entities reconciling to the US statutory rate of 21%, this would generally require disclosing any reconciling items that impact the rate by 1.05% or more. ASU 2023-09 is effective for public business entities for annual periods beginning after December  15, 2024 (generally, calendar year 2025) and effective for all other business entities one year later. Entities should adopt this guidance on a prospective basis, though retrospective application is permitted. The adoption of ASU 2023-09 is expected to have a financial statement disclosure impact only and is not expected to have a material impact on the Company’s financial statements.

 

In November 2023 the FASB issued ASU 2023-07, Segment Reporting – Improvements to Reportable Segment Disclosures.  The ASU will now require public entities to disclose its significant segment expenses categories and amounts for each reportable segment. Under the ASU, a significant segment expense is an expense that is:

 

 

·

significant to the segment,

 

·

regularly provided to or easily computed from information regularly provided to the chief operating decision maker (CODM), and

 

·

included in the reported measure of segment profit or loss.

 

The ASU is effective for public entities for fiscal years beginning after December 15, 2023 and interim periods in fiscal years beginning after December 15, 2024 (calendar year public entity will adopt the ASU in its 2024 Form 10 K). The ASU should be adopted retrospectively unless it’s impracticable to do so. Early adoption of the ASU is permitted, including in an interim period. The adoption of ASU 2023-07 is expected to have a financial statement disclosure impact only and is not expected to have a material impact on the Company’s financial statements.

 

The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2024
Summary of Significant Accounting Policies  
Schedule of property and equipment

 

 

March 31,

2024

 

 

December 31,

2023

 

Computers

 

$16,489

 

 

$16,489

 

Equipment

 

 

190,748

 

 

 

190,748

 

Vehicles

 

 

44,510

 

 

 

44,510

 

Total property and equipment

 

 

251,747

 

 

 

251,747

 

Less: accumulated depreciation

 

 

(28,408 )

 

 

(20,776 )

Total property and equipment, net

 

$223,339

 

 

$230,971

 

Schedule of depreciation in property and equipment

 

 

Period Ended March 31,

 

 

 

2024

 

 

2023

 

Depreciation

 

$7,632

 

 

$9,525

 

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Inventory (Tables)
3 Months Ended
Mar. 31, 2024
Inventory  
Schedule Of Inventory

Name

 

Balance at

March 31,

2024

 

 

Balance at

December 31,

2023

 

Raw materials

 

$717,052

 

 

$457,393

 

Work-in-process

 

 

1,934,606

 

 

 

1,819,284

 

Less: inventory reserves

 

 

(50,000)

 

 

 

Total

 

$2,601,658

 

 

$2,276,677

 

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Intangible Assets (Tables)
3 Months Ended
Mar. 31, 2024
Intangible Assets  
Schedule Of Intangible Assets

Name

 

Estimated

Life

 

Balance at

December 31,

2023

 

 

Additions

 

 

Amortization

 

 

Balance at

March 31,

2024

 

License agreement

 

17 Years

 

$901,929

 

 

$

 

 

$(15,732)

 

$886,197

 

Patents

 

20 Years

 

 

86,100

 

 

 

590

 

 

 

(1,196)

 

 

85,494

 

Total

 

 

 

$988,029

 

 

$590

 

 

$(16,928)

 

$971,691

 

Schedule Of Future Amortization Expense

 

 

March 31,

 

 

 

2024

 

2024 (remaining)

 

$50,784

 

2025

 

 

67,933

 

2026

 

 

67,933

 

2027

 

 

67,933

 

2028

 

 

67,933

 

Thereafter

 

 

649,175

 

Intangible assets, Net

 

$971,691

 

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Revenue (Tables)
3 Months Ended
Mar. 31, 2024
Revenue  
Schedule Of revenue by type

Name

 

March 31,

2024

 

 

%

 

 

March 31,

2023

 

 

%

 

Equipment revenue

 

$296,096

 

 

 

94%

 

$793,458

 

 

 

99%

Service revenue

 

 

19,182

 

 

 

6%

 

 

8,000

 

 

 

1%

Total

 

$315,278

 

 

 

100%

 

$801,458

 

 

 

100%
Schedule Of unearned revenue activity

Name

 

Balance at

March 31,

2024

 

 

Balance at

December 31,

2023

 

Unearned revenue at beginning of the period

 

$130,000

 

 

$200,109

 

Billings deferred

 

 

2,768

 

 

 

58,000

 

Recognition of prior unearned revenue

 

 

 

 

 

(128,109 )

Unearned revenue at end of period

 

$132,768

 

 

$130,000

 

Schedule Of unbilled accounts receivable

Name

 

Balance at

March 31,

2024

 

 

Balance at

December 31,

2023

 

Unbilled accounts receivable at beginning of the period

 

$1,494,553

 

 

$918,164

 

Services performed but unbilled

 

 

296,096

 

 

 

1,061,612

 

Services billed

 

 

(19,040 )

 

 

(485,223)

Unbilled accounts receivable at end of the period

 

$1,771,609

 

 

$1,494,553

 

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholder Equity (Tables)
3 Months Ended
Mar. 31, 2024
Stockholder Equity  
Schedule of stock option activity

 

 

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Aggregate

Intrinsic

Value

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

Options outstanding at December 31, 2023

 

 

10,828,174*

 

$0.83

 

 

$6,374,433

 

 

 

4.66

 

Granted

 

 

50,000

 

 

$1.40

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Expired/forfeit

 

 

(137,924)

 

$2.65

 

 

 

 

 

 

 

Options outstanding at March 31, 2024

 

 

10,740,250 *

 

$0.81

 

 

$4,826,248

 

 

 

4.35

 

Options Exercisable at March 31, 2024

 

 

8,696,519*

 

$0.50

 

 

$6,609,354

 

 

 

1.74

 

Schedule of stock option assumtion

 

 

March 31,

2024

 

Dividend yield

 

 

0.00%

Expected life

 

6.25 Years

 

Expected volatility

 

26.36–26.38%

 

Risk-free interest rate

 

4.09–4.31%

 

Schedule of warrant activity

 

 

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Aggregate

Intrinsic

Value

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

Balance at December 31, 2023

 

 

1,235,000

 

 

 

2.50

 

 

$

 

 

 

0.96

 

Issued

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Balance at March 31, 2024

 

 

1,235,000

 

 

 

2.50

 

 

$

 

 

 

0.71

 

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Total Property Plant And Equipment $ 251,747 $ 251,747
Less: accumulated depreciations (28,408) (20,776)
Total property and equipment, net 223,339 230,971
Computers [Member]    
Total property and equipment, net 16,489 16,489
Equipment [Member]    
Total property and equipment, net 44,510 44,510
Vehicles [Member]    
Total property and equipment, net $ 190,748 $ 190,748
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Details 1) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Summary of Significant Accounting Policies    
Depreciation $ 7,632 $ 9,525
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Research and Development Cost $ 535,147 $ 355,905 $ 355,905
Cash and cash equivalents 7,936,161   10,445,404
Revenues from sale of treatability services 19,182 8,000  
Revenues from sales 296,096 $ 793,458  
Inventory allowance 50,000   0
Contract loss provision $ 600,000   $ 500,000
Share based description cumulative adjustment of approximately $55,000 in the quarter ended December 31, 2023 to reduce our forfeiture rate estimate to approximately 5% of the total stock-based compensation recognized during the year    
Warrants [Member]      
Antidilutive Excluded from Computation of Earnings Per Share, Amount 1,235,000 1,250,000  
Options [Member]      
Antidilutive Excluded from Computation of Earnings Per Share, Amount 10,740,250 13,025,000  
One Customer [Member] | Revenue [Member]      
Concentrations of Credit Risk 94.00%   99.00%
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Liquidity Capital Resources and Going Concern (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Liquidity Capital Resources and Going Concern      
Accumulated Deficit $ (17,977,969)   $ (15,953,504)
Net Income (loss) (2,024,465) $ (1,640,343)  
Net Cash Used In Operations 2,508,653    
Working Capital $ 11,715,381    
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Inventory (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Inventory    
Raw materials $ 717,052 $ 457,393
Work-in-process 1,934,606 1,819,284
Less: inventory reserves (50,000) 0
Total $ 2,601,658 $ 2,276,677
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Intangible Assets (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Intangible Assets, Net, Beginning balance $ 988,029  
Additions 590  
Amortization (16,928) $ (16,910)
Intangible Assets, Net, Ending balance 971,691  
License Agreement [Member]    
Intangible Assets, Net, Beginning balance 901,929  
Additions 0  
Amortization $ (15,732)  
Estimated Life 17 years  
Intangible Assets, Net, Ending balance $ 886,197  
Patents [Member]    
Intangible Assets, Net, Beginning balance 86,100  
Additions 590  
Amortization $ (1,196)  
Estimated Life 20 years  
Intangible Assets, Net, Ending balance $ 85,494  
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Intangible Assets (Details 1) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Intangible Assets    
2024 $ 50,784  
2025 67,933  
2026 67,933  
2027 67,933  
2028 67,933  
Thereafter 649,175  
Intangible Assets, Net $ 971,691 $ 988,029
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Intangible Assets (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Intangible Assets    
Amortization $ (16,928) $ (16,910)
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Revenue (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue $ 315,278 $ 801,458
Revenue percentage 100.00% 100.00%
Equipment revenue [Member]    
Revenue $ 296,096 $ 793,458
Revenue percentage 94.00% 99.00%
Service revenue [Member]    
Revenue $ 19,182 $ 8,000
Revenue percentage 6.00% 1.00%
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Revenue (Details 1) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Revenue    
Unearned revenue at beginning of the period $ 130,000 $ 200,109
Billings deferred 2,768 58,000
Recognition of prior unearned revenue 0 (128,109)
Unearned revenue at end of period $ 132,768 $ 130,000
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Revenue (Details 2) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Revenue    
Unbilled accounts receivable at beginning of year $ 1,494,553 $ 918,164
Services performed but unbilled 296,096 1,061,612
Services billed (19,040) (485,223)
Unbilled accounts receivable at end of year $ 1,771,609 $ 1,494,553
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholder Equity (Details)
3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Granted | shares 0
Weighted Average Exercise Price, beginning balance $ 2.50
Aggregate Intrinsic Value, beginning balance | $ $ 0
Aggregate Intrinsic Value, ending balance | $ $ 0
Options [Member]  
Options Outstanding, beginning balance | shares 10,828,174
Granted | shares 50,000
Expired/forfeited | shares (137,924)
Options Outstanding, ending balance | shares 10,740,250
Options Outstanding Exercisable, ending balance | shares 8,696,519
Weighted Average Exercise Price, beginning balance $ 0.83
Weighted Average Exercise Price, Granted 1.40
Weighted Average Exercise Price, Exercised 0
Weighted Average Exercise Price, Expired/forfeit 2.65
Weighted Average Exercise Price, ending balance 0.81
Weighted Average Exercise Price Exercisable, ending balance $ 0.50
Aggregate Intrinsic Value, beginning balance | $ $ 6,374,433
Aggregate Intrinsic Value, ending balance | $ 4,826,248
Aggregate Intrinsic Value Exercisable, ending balance | $ $ 6,609,354
Weighted Average Remaining Contractual Life (years) Beginning 4 years 7 months 28 days
Weighted Average Remaining Contractual Life (years) Ending 4 years 4 months 6 days
Weighted Average Remaining Contractual Life (years) Exercisable Ending 1 year 8 months 26 days
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholder Equity (Details 1) - Options [Member]
3 Months Ended
Mar. 31, 2024
Dividend Yield 0.00%
Minimum [Member]  
Expected Life 6 years 3 months
Expected Volatility 26.36%
Risk-free Interest Rate 4.09%
Maximum [Member]  
Expected Volatility 26.38%
Risk-free Interest Rate 4.31%
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholder Equity (Details 2)
3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Stockholder Equity  
Balance At Beginning balance | shares 1,235,000
Shares Issued | shares 0
Shares Exercised | shares 0
Balance At Ending balance | shares 1,235,000
Weighted Average Exercise Price, beginning balance | $ / shares $ 2.50
Weighted Average Exercise Price Issued | $ / shares 0
Weighted Average Exercise Price Exercised | $ / shares 0
Weighted Average Exercise Price, ending balance | $ / shares $ 2.50
Aggregate Intrinsic Value, beginning balance | $ $ 0
Aggregate Intrinsic Value, ending balance | $ $ 0
Weighted Average Remaining Contractual Life(years), beginning balance 11 months 15 days
Weighted Average Remaining Contractual Life(years), ending balance 8 months 15 days
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholder Equity (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Oct. 30, 2020
Unrecognized Compensation Expense, Unvested Options $ 1,696,066      
Preferred Stock Shares Authorized 50,000,000   50,000,000  
Common Stock Shares Authorized 200,000,000   200,000,000  
Preferred Stock, Shares designated       1,000,000
Preferred Stock, Shares Issued 0   0  
Warrants Outstanding 1,235,000   1,235,000  
Warrant exercise Price $ 2.50      
Common stock fair value $ 4,500      
Options granted 6,700,000      
Market Price of common stock $ 1.26      
Preferred Stock, Par Value 0.0001   $ 0.0001 $ 0.0001
Common Stock Value Per Share $ 0.0001   $ 0.0001  
Common Stock, Shares issue 132,670,446   132,667,107  
Stock-based Compensation $ 183,200 $ 214,924    
Common Stock, Shares Outstanding 132,670,446   132,667,107  
Research And Development $ 535,147 355,905 $ 355,905  
General And Administrative $ 459,727 585,659    
Blank check preferred stock issued 3,339      
Consultant [Member]        
Stock-based Compensation $ 183,200 214,924    
Research And Development 44,614 25,641    
General And Administrative $ 138,586 $ 189,283    
Equity Distribution Agreement [Member]        
Sale of common stock shares 3,766,422 2,137,876    
Gross Process From Private Placement Of Stocks   $ 8,350,000    
Commission fees   110,000    
Legal fees   $ 50,000.00    
Market public facility 86,560,000      
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions (Details Narrative)
3 Months Ended
Mar. 31, 2024
USD ($)
Related Party Transactions  
Related Party Transaction, Expenses from Transactions with Related Party $ 130,321
Accounts payable and accrued expenses $ 119,343
Stock In Excess Percentage Of Outstanding Share 5.00%
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies (Details Narrative)
3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Legal settlement upon issuance of common stock | shares 275,000
Stock issued during period | shares 175,000
Accrued legal settlement | $ $ 135,000
Stock price | $ / shares $ 1.33
Exercise price | $ / shares $ 1.33
Risk free rate 4.43%
Volatility 26.36%
License Agreement [Member]  
Expenses | $ $ 0
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Subsequent Events (Details Narrative) - Subsequent Events [Member] - Mr. Gannon [Member]
$ in Millions
1 Months Ended
Apr. 19, 2024
USD ($)
Initial annual salary $ 450,000
Subsequent Event, Description 152285
EXCEL 52 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( +F(KU@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " "YB*]86*]M/N\ K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M3L,P#(=?!>7>NG\HAZC+98@32$A, G&+'&^+:-HH,6KW]J1EZX3@ 3C&_N7S M9\DM>HE#H.

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end XML 53 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 54 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 56 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 72 239 1 false 24 0 false 4 false false R1.htm 000001 - Document - Cover Sheet http://scwo.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://scwo.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://scwo.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 000005 - Statement - Condensed Consolidated Changes in Stockholders' Equity (Unaudited) Sheet http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited Condensed Consolidated Changes in Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 000007 - Disclosure - Nature of Business and Presentation of Financial Statements Sheet http://scwo.com/role/NatureOfBusinessAndPresentationOfFinancialStatements Nature of Business and Presentation of Financial Statements Notes 7 false false R8.htm 000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://scwo.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 000009 - Disclosure - Liquidity Capital Resources and Going Concern Sheet http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern Liquidity Capital Resources and Going Concern Notes 9 false false R10.htm 000010 - Disclosure - Inventory Sheet http://scwo.com/role/Inventory Inventory Notes 10 false false R11.htm 000011 - Disclosure - Intangible Assets Sheet http://scwo.com/role/IntangibleAssets Intangible Assets Notes 11 false false R12.htm 000012 - Disclosure - Revenue Sheet http://scwo.com/role/Revenue Revenue Notes 12 false false R13.htm 000013 - Disclosure - Stockholder Equity Sheet http://scwo.com/role/StockholderEquity Stockholder Equity Notes 13 false false R14.htm 000014 - Disclosure - Related Party Transactions Sheet http://scwo.com/role/RelatedPartyTransactions Related Party Transactions Notes 14 false false R15.htm 000015 - Disclosure - Commitments Sheet http://scwo.com/role/Commitments Commitments Notes 15 false false R16.htm 000016 - Disclosure - Subsequent Events Sheet http://scwo.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 000017 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://scwo.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 000018 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://scwo.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 000019 - Disclosure - Inventory (Tables) Sheet http://scwo.com/role/InventoryTables Inventory (Tables) Tables http://scwo.com/role/Inventory 19 false false R20.htm 000020 - Disclosure - Intangible Assets (Tables) Sheet http://scwo.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://scwo.com/role/IntangibleAssets 20 false false R21.htm 000021 - Disclosure - Revenue (Tables) Sheet http://scwo.com/role/RevenueTables Revenue (Tables) Tables http://scwo.com/role/Revenue 21 false false R22.htm 000022 - Disclosure - Stockholder Equity (Tables) Sheet http://scwo.com/role/StockholderEquityTables Stockholder Equity (Tables) Tables http://scwo.com/role/StockholderEquity 22 false false R23.htm 000023 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables 23 false false R24.htm 000024 - Disclosure - Summary of Significant Accounting Policies (Details 1) Sheet http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1 Summary of Significant Accounting Policies (Details 1) Details http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables 24 false false R25.htm 000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables 25 false false R26.htm 000026 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative) Sheet http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative Liquidity Capital Resources and Going Concern (Details Narrative) Details http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern 26 false false R27.htm 000027 - Disclosure - Inventory (Details) Sheet http://scwo.com/role/InventoryDetails Inventory (Details) Details http://scwo.com/role/InventoryTables 27 false false R28.htm 000028 - Disclosure - Intangible Assets (Details) Sheet http://scwo.com/role/IntangibleAssetsDetails Intangible Assets (Details) Details http://scwo.com/role/IntangibleAssetsTables 28 false false R29.htm 000029 - Disclosure - Intangible Assets (Details 1) Sheet http://scwo.com/role/IntangibleAssetsDetails1 Intangible Assets (Details 1) Details http://scwo.com/role/IntangibleAssetsTables 29 false false R30.htm 000030 - Disclosure - Intangible Assets (Details Narrative) Sheet http://scwo.com/role/IntangibleAssetsDetailsNarrative Intangible Assets (Details Narrative) Details http://scwo.com/role/IntangibleAssetsTables 30 false false R31.htm 000031 - Disclosure - Revenue (Details) Sheet http://scwo.com/role/RevenueDetails Revenue (Details) Details http://scwo.com/role/RevenueTables 31 false false R32.htm 000032 - Disclosure - Revenue (Details 1) Sheet http://scwo.com/role/RevenueDetails1 Revenue (Details 1) Details http://scwo.com/role/RevenueTables 32 false false R33.htm 000033 - Disclosure - Revenue (Details 2) Sheet http://scwo.com/role/RevenueDetails2 Revenue (Details 2) Details http://scwo.com/role/RevenueTables 33 false false R34.htm 000034 - Disclosure - Stockholder Equity (Details) Sheet http://scwo.com/role/StockholderEquityDetails Stockholder Equity (Details) Details http://scwo.com/role/StockholderEquityTables 34 false false R35.htm 000035 - Disclosure - Stockholder Equity (Details 1) Sheet http://scwo.com/role/StockholderEquityDetails1 Stockholder Equity (Details 1) Details http://scwo.com/role/StockholderEquityTables 35 false false R36.htm 000036 - Disclosure - Stockholder Equity (Details 2) Sheet http://scwo.com/role/StockholderEquityDetails2 Stockholder Equity (Details 2) Details http://scwo.com/role/StockholderEquityTables 36 false false R37.htm 000037 - Disclosure - Stockholder Equity (Details Narrative) Sheet http://scwo.com/role/StockholderEquityDetailsNarrative Stockholder Equity (Details Narrative) Details http://scwo.com/role/StockholderEquityTables 37 false false R38.htm 000038 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://scwo.com/role/RelatedPartyTransactions 38 false false R39.htm 000039 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details 39 false false R40.htm 000040 - Disclosure - Subsequent Events (Details Narrative) Sheet http://scwo.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://scwo.com/role/SubsequentEvents 40 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 19 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityExTransitionPeriod, scwo:ExercisePrice, scwo:WeightedAverageExercisePriceExercised, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesOutstanding, us-gaap:OtherExpenses, us-gaap:PreferredStockParOrStatedValuePerShare, us-gaap:PreferredStockSharesAuthorized, us-gaap:PreferredStockSharesIssued, us-gaap:PreferredStockSharesOutstanding, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue, us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice, us-gaap:SubsequentEventDescription - scwo_10q.htm 1 [dqc-0004-Element-Values-Are-Equal] CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect with a value of 5106224 is not equal to the total of NetCashProvidedByUsedInOperatingActivities, NetCashProvidedByUsedInInvestingActivities, NetCashProvidedByUsedInFinancingActivities with a value of -3178176 + -10008 + 8294708. These values should be equal. The properties of this CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect fact are Context: From2023-01-01to2023-03-31, Unit: USD, Rule Element Id: 9286. scwo_10q.htm 1 [DQC.US.0043.9873] The company has reported the concept ProfitLoss as part of the cash flow statement. This income item is being deducted from the value of operating cash flows in the calculation defined by the filer. This implies that the resulting operating cash flow calculation excludes this income item from cash flow from operations. If ProfitLoss represents income from discontinued operations then the element NetCashProvidedByUsedInOperatingActivitiesContinuingOperations should be used as the total rather than the current total element of NetCashProvidedByUsedInOperatingActivities. If the item is an income item and is being deducted because the value is negative then consider changing the sign and weight of the element. - https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd 4602, 9356 - https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd 4602, 9356 scwo-20240331.xsd scwo-20240331_cal.xml scwo-20240331_def.xml scwo-20240331_lab.xml scwo-20240331_pre.xml scwo_10q.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 59 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "scwo_10q.htm": { "nsprefix": "scwo", "nsuri": "http://scwo.com/20240331", "dts": { "schema": { "local": [ "scwo-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "scwo-20240331_cal.xml" ] }, "definitionLink": { "local": [ "scwo-20240331_def.xml" ] }, "labelLink": { "local": [ "scwo-20240331_lab.xml" ] }, "presentationLink": { "local": [ "scwo-20240331_pre.xml" ] }, "inline": { "local": [ "scwo_10q.htm" ] } }, "keyStandard": 198, "keyCustom": 41, "axisStandard": 13, "axisCustom": 0, "memberStandard": 14, "memberCustom": 10, "hidden": { "total": 24, "http://fasb.org/us-gaap/2023": 16, "http://xbrl.sec.gov/dei/2023": 6, "http://scwo.com/20240331": 2 }, "contextCount": 72, "entityCount": 1, "segmentCount": 24, "elementCount": 319, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 390, "http://xbrl.sec.gov/dei/2023": 31 }, "report": { "R1": { "role": "http://scwo.com/role/Cover", "longName": "000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R2": { "role": "http://scwo.com/role/CondensedConsolidatedBalanceSheets", "longName": "000002 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "unique": true } }, "R3": { "role": "http://scwo.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "longName": "000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true }, "uniqueAnchor": null }, "R4": { "role": "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "longName": "000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "strong", "td", "tr", "tbody", "table", "scwo:ScheduleOfRevenueByTypeTableTextBlock", "us-gaap:DeferredRevenueDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "unique": true } }, "R5": { "role": "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited", "longName": "000005 - Statement - Condensed Consolidated Changes in Stockholders' Equity (Unaudited)", "shortName": "Condensed Consolidated Changes in Stockholders' Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_CommonStockMember", "name": "us-gaap:SharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_CommonStockMember", "name": "us-gaap:SharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R6": { "role": "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "longName": "000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DepreciationAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "unique": true } }, "R7": { "role": "http://scwo.com/role/NatureOfBusinessAndPresentationOfFinancialStatements", "longName": "000007 - Disclosure - Nature of Business and Presentation of Financial Statements", "shortName": "Nature of Business and Presentation of Financial Statements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R8": { "role": "http://scwo.com/role/SummaryOfSignificantAccountingPolicies", "longName": "000008 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R9": { "role": "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern", "longName": "000009 - Disclosure - Liquidity Capital Resources and Going Concern", "shortName": "Liquidity Capital Resources and Going Concern", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R10": { "role": "http://scwo.com/role/Inventory", "longName": "000010 - Disclosure - Inventory", "shortName": "Inventory", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R11": { "role": "http://scwo.com/role/IntangibleAssets", "longName": "000011 - Disclosure - Intangible Assets", "shortName": "Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R12": { "role": "http://scwo.com/role/Revenue", "longName": "000012 - Disclosure - Revenue", "shortName": "Revenue", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DeferredRevenueDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DeferredRevenueDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R13": { "role": "http://scwo.com/role/StockholderEquity", "longName": "000013 - Disclosure - Stockholder Equity", "shortName": "Stockholder Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R14": { "role": "http://scwo.com/role/RelatedPartyTransactions", "longName": "000014 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R15": { "role": "http://scwo.com/role/Commitments", "longName": "000015 - Disclosure - Commitments", "shortName": "Commitments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CommitmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CommitmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R16": { "role": "http://scwo.com/role/SubsequentEvents", "longName": "000016 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R17": { "role": "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "000017 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "17", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R18": { "role": "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "000018 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "18", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R19": { "role": "http://scwo.com/role/InventoryTables", "longName": "000019 - Disclosure - Inventory (Tables)", "shortName": "Inventory (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R20": { "role": "http://scwo.com/role/IntangibleAssetsTables", "longName": "000020 - Disclosure - Intangible Assets (Tables)", "shortName": "Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R21": { "role": "http://scwo.com/role/RevenueTables", "longName": "000021 - Disclosure - Revenue (Tables)", "shortName": "Revenue (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "scwo:ScheduleOfRevenueByTypeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DeferredRevenueDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "scwo:ScheduleOfRevenueByTypeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DeferredRevenueDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R22": { "role": "http://scwo.com/role/StockholderEquityTables", "longName": "000022 - Disclosure - Stockholder Equity (Tables)", "shortName": "Stockholder Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R23": { "role": "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails", "longName": "000023 - Disclosure - Summary of Significant Accounting Policies (Details)", "shortName": "Summary of Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R24": { "role": "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1", "longName": "000024 - Disclosure - Summary of Significant Accounting Policies (Details 1)", "shortName": "Summary of Significant Accounting Policies (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "scwo:ScheduleOfDepreciationInPropertyAndEquipmentTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "scwo:ScheduleOfDepreciationInPropertyAndEquipmentTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R25": { "role": "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ResearchAndDevelopmentExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:Cash", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "unique": true } }, "R26": { "role": "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative", "longName": "000026 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative)", "shortName": "Liquidity Capital Resources and Going Concern (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:NetCashProvidedByUsedInContinuingOperations", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "unique": true } }, "R27": { "role": "http://scwo.com/role/InventoryDetails", "longName": "000027 - Disclosure - Inventory (Details)", "shortName": "Inventory (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R28": { "role": "http://scwo.com/role/IntangibleAssetsDetails", "longName": "000028 - Disclosure - Intangible Assets (Details)", "shortName": "Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "strong", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "strong", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "unique": true } }, "R29": { "role": "http://scwo.com/role/IntangibleAssetsDetails1", "longName": "000029 - Disclosure - Intangible Assets (Details 1)", "shortName": "Intangible Assets (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R30": { "role": "http://scwo.com/role/IntangibleAssetsDetailsNarrative", "longName": "000030 - Disclosure - Intangible Assets (Details Narrative)", "shortName": "Intangible Assets (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true }, "uniqueAnchor": null }, "R31": { "role": "http://scwo.com/role/RevenueDetails", "longName": "000031 - Disclosure - Revenue (Details)", "shortName": "Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "strong", "td", "tr", "tbody", "table", "scwo:ScheduleOfRevenueByTypeTableTextBlock", "us-gaap:DeferredRevenueDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "scwo:PremiumsRevenuePercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "strong", "td", "tr", "tbody", "table", "scwo:ScheduleOfRevenueByTypeTableTextBlock", "us-gaap:DeferredRevenueDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "unique": true } }, "R32": { "role": "http://scwo.com/role/RevenueDetails1", "longName": "000032 - Disclosure - Revenue (Details 1)", "shortName": "Revenue (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "scwo:ScheduleOfUnearnedRevenueActivityTableTextBlock", "us-gaap:DeferredRevenueDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "scwo:ScheduleOfUnearnedRevenueActivityTableTextBlock", "us-gaap:DeferredRevenueDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "unique": true } }, "R33": { "role": "http://scwo.com/role/RevenueDetails2", "longName": "000033 - Disclosure - Revenue (Details 2)", "shortName": "Revenue (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:AccountsReceivableNet", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "scwo:ScheduleOfUnbilledAccountsReceivableTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:AccountsReceivableNet", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "scwo:ScheduleOfUnbilledAccountsReceivableTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "unique": true } }, "R34": { "role": "http://scwo.com/role/StockholderEquityDetails", "longName": "000034 - Disclosure - Stockholder Equity (Details)", "shortName": "Stockholder Equity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_scwo_OptionsMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "unique": true } }, "R35": { "role": "http://scwo.com/role/StockholderEquityDetails1", "longName": "000035 - Disclosure - Stockholder Equity (Details 1)", "shortName": "Stockholder Equity (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31_scwo_OptionsMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31_scwo_OptionsMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R36": { "role": "http://scwo.com/role/StockholderEquityDetails2", "longName": "000036 - Disclosure - Stockholder Equity (Details 2)", "shortName": "Stockholder Equity (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "unique": true } }, "R37": { "role": "http://scwo.com/role/StockholderEquityDetailsNarrative", "longName": "000037 - Disclosure - Stockholder Equity (Details Narrative)", "shortName": "Stockholder Equity (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R38": { "role": "http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "000038 - Disclosure - Related Party Transactions (Details Narrative)", "shortName": "Related Party Transactions (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "scwo:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParties", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "scwo:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParties", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R39": { "role": "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative", "longName": "000039 - Disclosure - Commitments and Contingencies (Details Narrative)", "shortName": "Commitments and Contingencies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "scwo:LegalSettlementIssuableShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:CommitmentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "scwo:LegalSettlementIssuableShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:CommitmentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } }, "R40": { "role": "http://scwo.com/role/SubsequentEventsDetailsNarrative", "longName": "000040 - Disclosure - Subsequent Events (Details Narrative)", "shortName": "Subsequent Events (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "From2024-04-01to2024-04-19_us-gaap_SubsequentEventMember_scwo_MrGannonMember", "name": "scwo:InitialAnnualSalary", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-04-01to2024-04-19_us-gaap_SubsequentEventMember_scwo_MrGannonMember", "name": "scwo:InitialAnnualSalary", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "scwo_10q.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies" } } }, "auth_ref": [] }, "us-gaap_AccountsAndOtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsAndOtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other accounts receivable", "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis", "presentation": [ "http://scwo.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Notes Loans And Financing Receivables By Billing Status Type Axis", "documentation": "Information by billing status of receivables." } } }, "auth_ref": [ "r24" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued expenses", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r19" ] }, "us-gaap_AccountsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNet", "crdr": "debit", "presentation": [ "http://scwo.com/role/RevenueDetails2" ], "lang": { "en-us": { "role": { "periodStartLabel": "Unbilled accounts receivable at beginning of year", "label": "[Accounts Receivable, after Allowance for Credit Loss]", "periodEndLabel": "Unbilled accounts receivable at end of year", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r464", "r516", "r542", "r637" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, net of allowance", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r182", "r183" ] }, "scwo_AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://scwo.com/20240331", "localname": "AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accrued Contract Loss Provision and Onerous Contracts" } } }, "auth_ref": [] }, "scwo_AccruedLegalSettlementCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://scwo.com/20240331", "localname": "AccruedLegalSettlementCurrent", "crdr": "credit", "presentation": [ "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued legal settlement", "label": "[Accrued legal settlement]" } } }, "auth_ref": [] }, "scwo_AccruedLegalSettlementNew": { "xbrltype": "monetaryItemType", "nsuri": "http://scwo.com/20240331", "localname": "AccruedLegalSettlementNew", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued legal settlement" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive loss", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r25", "r26", "r68", "r125", "r413", "r430", "r431" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r11", "r26", "r335", "r338", "r357", "r426", "r427", "r570", "r571", "r572", "r576", "r577", "r578" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r60", "r537", "r641" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Additional Paid-In Capital", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r307", "r308", "r309", "r443", "r576", "r577", "r578", "r623", "r645" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "scwo_AggregateIntrinsicValueExercisableEndingBalance": { "xbrltype": "monetaryItemType", "nsuri": "http://scwo.com/20240331", "localname": "AggregateIntrinsicValueExercisableEndingBalance", "crdr": "debit", "presentation": [ "http://scwo.com/role/StockholderEquityDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value Exercisable, ending balance" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://scwo.com/role/IntangibleAssetsDetails", "http://scwo.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization", "label": "[Amortization of Intangible Assets]", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r8", "r40", "r44" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Antidilutive Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r165" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "label": "[Assets]", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r97", "r124", "r151", "r167", "r173", "r177", "r217", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r328", "r332", "r344", "r409", "r469", "r537", "r549", "r591", "r592", "r628" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "[Assets, Current]", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r120", "r129", "r151", "r217", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r328", "r332", "r344", "r537", "r591", "r592", "r628" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrent", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Long-Term Assets", "label": "[Assets, Noncurrent]", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r151", "r217", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r328", "r332", "r344", "r591", "r592", "r628" ] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-Term Assets:" } } }, "auth_ref": [] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Award Type Axis", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r278", "r279", "r280", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r302", "r303", "r304", "r305", "r306" ] }, "scwo_BillingsDeferredUnearnedRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://scwo.com/20240331", "localname": "BillingsDeferredUnearnedRevenue", "crdr": "credit", "presentation": [ "http://scwo.com/role/RevenueDetails1" ], "lang": { "en-us": { "role": { "label": "Billings deferred" } } }, "auth_ref": [] }, "scwo_BlankCheckPreferredStock": { "xbrltype": "sharesItemType", "nsuri": "http://scwo.com/20240331", "localname": "BlankCheckPreferredStock", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Blank check preferred stock issued" } } }, "auth_ref": [] }, "us-gaap_Capital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Capital", "crdr": "credit", "presentation": [ "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Working Capital", "documentation": "Amount of total capital as defined by regulatory framework." } } }, "auth_ref": [ "r408" ] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r108", "r410", "r444", "r463", "r537", "r549", "r565" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r30" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets", "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cash", "periodStartLabel": "Cash, Beginning of the Period", "periodEndLabel": "Cash, End of the Period", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r29", "r79", "r148" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net (Decrease) Increase in Cash", "label": "[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r79" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant exercise Price", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r269" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments" } } }, "auth_ref": [] }, "us-gaap_CommitmentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsDisclosureTextBlock", "presentation": [ "http://scwo.com/role/Commitments" ], "lang": { "en-us": { "role": { "verboseLabel": "Commitments", "label": "Commitments Disclosure [Text Block]", "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights." } } }, "auth_ref": [ "r89" ] }, "scwo_CommonStockFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://scwo.com/20240331", "localname": "CommonStockFairValue", "crdr": "debit", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock fair value" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Common Stock", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r539", "r540", "r541", "r543", "r544", "r545", "r546", "r576", "r577", "r623", "r640", "r645" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par Value", "verboseLabel": "Common Stock Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r59" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "verboseLabel": "Common Stock Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r59", "r455" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares issued", "verboseLabel": "Common Stock, Shares issue", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r59" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Outstanding", "verboseLabel": "Common Stock, Shares Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r12", "r59", "r455", "r475", "r645", "r646" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock: 200,000,000 common shares authorized, par value $0.0001 per share, 132,670,446 and 132,667,107 shares outstanding at March 31, 2024 and December 31, 2023, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r59", "r412", "r537" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive loss", "label": "[Comprehensive Income (Loss), Net of Tax, Attributable to Parent]", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r27", "r132", "r134", "r141", "r405", "r423" ] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerEquipmentMember", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Computers [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r34", "r35", "r50", "r51", "r181", "r517" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk By Benchmark Axis", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r34", "r35", "r50", "r51", "r181", "r432", "r517" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentrations of Credit Risk", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r53", "r112" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Concentrations of Credit Risk", "label": "[Concentration Risk, Percentage]", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r34", "r35", "r50", "r51", "r181" ] }, "scwo_ConsultantMember": { "xbrltype": "domainItemType", "nsuri": "http://scwo.com/20240331", "localname": "ConsultantMember", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consultant [Member]" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "presentation": [ "http://scwo.com/role/RevenueDetails1" ], "lang": { "en-us": { "role": { "periodStartLabel": "Unearned revenue at beginning of the period", "label": "[Contract with Customer, Liability, Current]", "periodEndLabel": "Unearned revenue at end of period", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r272", "r273", "r274" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cost of goods sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r73", "r401" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueCurrent", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Unearned revenue", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r566" ] }, "us-gaap_DeferredRevenueDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueDisclosureTextBlock", "presentation": [ "http://scwo.com/role/Revenue" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenue", "label": "Deferred Revenue Disclosure [Text Block]", "documentation": "The entire disclosure for deferred revenues at the end of the reporting period, and description and amounts of significant changes that occurred during the reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP." } } }, "auth_ref": [ "r106" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r8", "r45" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization expense", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r8", "r45" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r553" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r554" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "scwo_EarningPerShareBasicAndDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://scwo.com/20240331", "localname": "EarningPerShareBasicAndDiluted", "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "label": "Net Loss per Share - Basic and Diluted" } } }, "auth_ref": [] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Loss Per Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r32", "r33" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized Compensation Expense, Unvested Options", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r621" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 1", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 2", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address City Or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r551" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r551" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r556" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r551" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r555" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r551" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r551" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r551" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r551" ] }, "scwo_EquipmentRevenuesMember": { "xbrltype": "domainItemType", "nsuri": "http://scwo.com/20240331", "localname": "EquipmentRevenuesMember", "presentation": [ "http://scwo.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "label": "Equipment revenue [Member]" } } }, "auth_ref": [] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Stockholder Equity" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r12", "r118", "r136", "r137", "r138", "r152", "r153", "r154", "r156", "r161", "r163", "r166", "r218", "r219", "r270", "r307", "r308", "r309", "r324", "r325", "r334", "r335", "r336", "r337", "r338", "r339", "r342", "r349", "r351", "r352", "r353", "r354", "r355", "r357", "r426", "r427", "r428", "r443", "r499" ] }, "scwo_EquityDistributionAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://scwo.com/20240331", "localname": "EquityDistributionAgreementMember", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Distribution Agreement [Member]" } } }, "auth_ref": [] }, "scwo_ExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://scwo.com/20240331", "localname": "ExercisePrice", "presentation": [ "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise price" } } }, "auth_ref": [] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Financial Instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r10", "r17" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://scwo.com/role/StockholderEquityDetails", "http://scwo.com/role/StockholderEquityDetails1", "http://scwo.com/role/StockholderEquityDetailsNarrative", "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r254", "r267", "r340", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r422", "r531", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r584", "r585", "r586", "r587" ] }, "scwo_FiniteLivedIntangibleAssetUsefulLifeDuringPeriod": { "xbrltype": "durationItemType", "nsuri": "http://scwo.com/20240331", "localname": "FiniteLivedIntangibleAssetUsefulLifeDuringPeriod", "presentation": [ "http://scwo.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Estimated Life" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "crdr": "debit", "presentation": [ "http://scwo.com/role/IntangibleAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Thereafter", "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://scwo.com/role/IntangibleAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "2024", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r85" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "presentation": [ "http://scwo.com/role/IntangibleAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "2028", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r85" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://scwo.com/role/IntangibleAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "2027", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r85" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://scwo.com/role/IntangibleAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "2026", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r85" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://scwo.com/role/IntangibleAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "2025", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r85" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://scwo.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite Lived Intangible Assets By Major Class Axis", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r234", "r237", "r238", "r240", "r402", "r403" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://scwo.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r41", "r43" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "presentation": [ "http://scwo.com/role/IntangibleAssetsDetails", "http://scwo.com/role/IntangibleAssetsDetails1" ], "lang": { "en-us": { "role": { "periodStartLabel": "Intangible Assets, Net, Beginning balance", "label": "[Finite-Lived Intangible Assets, Net]", "periodEndLabel": "Intangible Assets, Net, Ending balance", "verboseLabel": "Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r84", "r402" ] }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinitelivedIntangibleAssetsAcquired1", "crdr": "debit", "presentation": [ "http://scwo.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Additions", "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition." } } }, "auth_ref": [ "r235" ] }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain on foreign currency translation", "label": "[Foreign Currency Transaction Gain (Loss), before Tax]", "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r345", "r346", "r347", "r348", "r496" ] }, "us-gaap_ForeignCurrencyTransactionGainLossRealized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossRealized", "crdr": "credit", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Foreign currency gain", "documentation": "Amount, before tax, of realized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r477", "r547", "r625", "r626", "r644" ] }, "us-gaap_GainLossOnContractTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnContractTermination", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Accrued contract loss provision", "label": "[Gain (Loss) on Contract Termination]", "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform." } } }, "auth_ref": [ "r81" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "General and administrative", "verboseLabel": "General And Administrative", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r75", "r480" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Intangible Assets" } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Gross margin", "label": "[Gross Profit]", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r72", "r151", "r167", "r172", "r176", "r178", "r217", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r344", "r529", "r591" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Long-lived Assets", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r88" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net Loss before Income Taxes", "label": "[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r1", "r69", "r99", "r167", "r172", "r176", "r178", "r406", "r418", "r529" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Operations (Unaudited)" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "label": "Provision for Income Taxes", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r107", "r117", "r162", "r163", "r170", "r319", "r326", "r424" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Tax Policy", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r135", "r317", "r318", "r320", "r321", "r322", "r323", "r436" ] }, "us-gaap_IncomeTaxUncertaintiesPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxUncertaintiesPolicy", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounting for Uncertainty in Income Taxes", "documentation": "Disclosure of accounting policy for tax positions taken in the tax return filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other types of contingencies related to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaid", "crdr": "credit", "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cash paid for taxes", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income." } } }, "auth_ref": [ "r28", "r31" ] }, "scwo_IncreaseDecreaseInAccountPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://scwo.com/20240331", "localname": "IncreaseDecreaseInAccountPayableAndAccruedLiabilities", "crdr": "debit", "presentation": [ "http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued expenses", "label": "[Accounts payable and accrued expenses]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued expenses", "label": "[Increase (Decrease) in Accounts Payable and Accrued Liabilities]", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "[Increase (Decrease) in Accounts Receivable]", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredRevenue", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Unearned revenue", "label": "[Increase (Decrease) in Deferred Revenue]", "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r521" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "[Increase (Decrease) in Inventories]", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r7" ] }, "scwo_IncreaseDecreaseInInventoriesReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://scwo.com/20240331", "localname": "IncreaseDecreaseInInventoriesReserve", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Increase in inventory reserve" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Other liabilities", "label": "[Increase (Decrease) in Other Operating Liabilities]", "documentation": "Amount of increase (decrease) in operating liabilities classified as other." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherReceivables", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Other receivables", "label": "[Increase (Decrease) in Other Receivables]", "documentation": "Amount of increase (decrease) in receivables classified as other." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidExpense", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses", "label": "[Increase (Decrease) in Prepaid Expense]", "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInUnbilledReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInUnbilledReceivables", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Unbilled accounts receivable", "label": "[Increase (Decrease) in Unbilled Receivables]", "documentation": "The increase (decrease) during the reporting period of the amount of revenue for work performed for which billing has not occurred, net of uncollectible accounts." } } }, "auth_ref": [ "r105" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r236", "r239" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r42", "r86" ] }, "scwo_InitialAnnualSalary": { "xbrltype": "monetaryItemType", "nsuri": "http://scwo.com/20240331", "localname": "InitialAnnualSalary", "crdr": "debit", "presentation": [ "http://scwo.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Initial annual salary" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsCurrent", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible asset, net", "documentation": "The current portion of nonphysical assets, excluding financial assets, if these assets are classified into the current and noncurrent portions." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsDisclosureTextBlock", "presentation": [ "http://scwo.com/role/IntangibleAssets" ], "lang": { "en-us": { "role": { "verboseLabel": "Intangible Assets", "label": "Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for all or part of the information related to intangible assets." } } }, "auth_ref": [ "r233" ] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Intangible Assets", "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r43", "r398", "r399", "r400", "r402", "r525" ] }, "us-gaap_InterestIncomeOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeOther", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "label": "Interest income", "documentation": "Amount of interest income earned from interest bearing assets classified as other." } } }, "auth_ref": [] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cash paid for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r143", "r146", "r147" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://scwo.com/role/Inventory" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Inventory Disclosure [Text Block]", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r228" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets", "http://scwo.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Inventory, net", "verboseLabel": "Total", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r127", "r523", "r537" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Inventories", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r109", "r122", "r126", "r228", "r229", "r230", "r397", "r526" ] }, "us-gaap_InventoryRawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterials", "crdr": "debit", "presentation": [ "http://scwo.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Raw materials", "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r568" ] }, "us-gaap_InventoryRecallExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRecallExpense", "crdr": "debit", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventory allowance", "documentation": "Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise." } } }, "auth_ref": [ "r74" ] }, "us-gaap_InventoryValuationReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryValuationReserves", "crdr": "credit", "presentation": [ "http://scwo.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: inventory reserves", "label": "[Inventory Valuation Reserves]", "documentation": "Amount of valuation reserve for inventory." } } }, "auth_ref": [ "r39", "r569" ] }, "us-gaap_InventoryWorkInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcess", "crdr": "debit", "presentation": [ "http://scwo.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Work-in-process", "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r567" ] }, "us-gaap_LaborAndRelatedExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LaborAndRelatedExpense", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "label": "Compensation and related expenses", "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit." } } }, "auth_ref": [ "r573" ] }, "us-gaap_LegalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LegalFees", "crdr": "debit", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal fees", "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings." } } }, "auth_ref": [ "r74" ] }, "scwo_LegalSettlementIssuableShares": { "xbrltype": "sharesItemType", "nsuri": "http://scwo.com/20240331", "localname": "LegalSettlementIssuableShares", "presentation": [ "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal settlement upon issuance of common stock" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities", "label": "[Liabilities]", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r20", "r151", "r217", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r329", "r332", "r333", "r344", "r454", "r528", "r549", "r591", "r628", "r629" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities and Stockholders' Equity", "label": "[Liabilities and Equity]", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r64", "r98", "r415", "r537", "r575", "r588", "r624" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' Equity" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "[Liabilities, Current]", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r22", "r121", "r151", "r217", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r329", "r332", "r333", "r344", "r537", "r591", "r628", "r629" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "auth_ref": [] }, "scwo_LicenseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://scwo.com/20240331", "localname": "LicenseAgreementMember", "presentation": [ "http://scwo.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "License Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_LicensingAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LicensingAgreementsMember", "presentation": [ "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "License Agreement [Member]", "label": "Licensing Agreements [Member]", "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory)." } } }, "auth_ref": [ "r49", "r316", "r622" ] }, "scwo_LiquidityCapitalResourcesAndGoingConcernAbstract": { "xbrltype": "stringItemType", "nsuri": "http://scwo.com/20240331", "localname": "LiquidityCapitalResourcesAndGoingConcernAbstract", "lang": { "en-us": { "role": { "label": "Liquidity Capital Resources and Going Concern" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LossContingencyAccrualProvision": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyAccrualProvision", "crdr": "debit", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Contract loss provision", "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges." } } }, "auth_ref": [ "r590" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Major Customers Axis" } } }, "auth_ref": [ "r181", "r533", "r594", "r638", "r639" ] }, "scwo_MarketRiskBenefitLiabilityShares": { "xbrltype": "sharesItemType", "nsuri": "http://scwo.com/20240331", "localname": "MarketRiskBenefitLiabilityShares", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Market public facility" } } }, "auth_ref": [] }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesUnrealizedGainLoss", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "label": "Unrealized gain on marketable securities", "documentation": "Amount of unrealized gain (loss) on investment in marketable security." } } }, "auth_ref": [ "r71" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://scwo.com/role/StockholderEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r241", "r242", "r243", "r244", "r276", "r396", "r425", "r446", "r447", "r506", "r507", "r508", "r509", "r513", "r519", "r520", "r530", "r532", "r534", "r538", "r593", "r630", "r631", "r632", "r633", "r634", "r635" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://scwo.com/role/StockholderEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r241", "r242", "r243", "r244", "r276", "r396", "r425", "r446", "r447", "r506", "r507", "r508", "r509", "r513", "r519", "r520", "r530", "r532", "r534", "r538", "r593", "r630", "r631", "r632", "r633", "r634", "r635" ] }, "scwo_MrGannonMember": { "xbrltype": "domainItemType", "nsuri": "http://scwo.com/20240331", "localname": "MrGannonMember", "presentation": [ "http://scwo.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Mr. Gannon [Member]" } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r181", "r533", "r594", "r638", "r639" ] }, "us-gaap_NetCashProvidedByUsedInContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInContinuingOperations", "presentation": [ "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net Cash Used In Operations", "documentation": "The increase (decrease) in cash associated with the entity's continuing operating, investing, and financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label." } } }, "auth_ref": [ "r574" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Cash Provided by Financing Activities", "label": "[Net Cash Provided by (Used in) Financing Activities]", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r145" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Cash Used In Investing Activities", "label": "[Net Cash Provided by (Used in) Investing Activities]", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r145" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cash Flows from Investing Activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net Cash Used In Operating Activities", "label": "[Net Cash Provided by (Used in) Operating Activities]", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r79", "r80", "r81" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cash Flows from Operating Activities" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited", "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net loss", "verboseLabel": "Net Income (loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r70", "r81", "r100", "r119", "r130", "r133", "r138", "r151", "r155", "r157", "r158", "r159", "r160", "r162", "r163", "r164", "r167", "r172", "r176", "r178", "r217", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r343", "r344", "r420", "r478", "r497", "r498", "r529", "r547", "r591" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent Accounting Pronouncements - Not Yet Adopted", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OfficeEquipmentMember", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Equipment [Member]", "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine." } } }, "auth_ref": [] }, "scwo_OneCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://scwo.com/20240331", "localname": "OneCustomerMember", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "One Customer [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total Operating Expenses", "label": "[Operating Expenses]", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "label": "Operating Expenses" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from Operations", "label": "[Operating Income (Loss)]", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r167", "r172", "r176", "r178", "r529" ] }, "us-gaap_OptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OptionMember", "presentation": [ "http://scwo.com/role/StockholderEquityDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Options [Member]", "label": "Options Held [Member]", "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific commodity, or financial or equity instrument, at a specified price during a specified period (an American option) or at a specified date (a European option) which were purchased or otherwise acquired, excluding options written (for which a premium was received)." } } }, "auth_ref": [ "r96", "r465", "r470", "r486", "r492", "r510", "r511", "r512", "r539", "r540" ] }, "scwo_OptionsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://scwo.com/20240331", "localname": "OptionsGranted", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Options granted" } } }, "auth_ref": [] }, "scwo_OptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://scwo.com/20240331", "localname": "OptionsMember", "presentation": [ "http://scwo.com/role/StockholderEquityDetails", "http://scwo.com/role/StockholderEquityDetails1", "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Options [Member]" } } }, "auth_ref": [] }, "scwo_OptionsOutstandingExercisableEndingBalance": { "xbrltype": "sharesItemType", "nsuri": "http://scwo.com/20240331", "localname": "OptionsOutstandingExercisableEndingBalance", "presentation": [ "http://scwo.com/role/StockholderEquityDetails" ], "lang": { "en-us": { "role": { "label": "Options Outstanding Exercisable, ending balance" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Nature of Business and Presentation of Financial Statements" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://scwo.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" ], "lang": { "en-us": { "role": { "verboseLabel": "Nature of Business and Presentation of Financial Statements", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r56", "r95", "r433", "r434" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation gain", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive loss", "label": "[Other Comprehensive Income (Loss), Net of Tax]", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r12", "r16", "r131", "r134", "r140", "r349", "r350", "r355", "r404", "r421", "r570", "r571" ] }, "us-gaap_OtherExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherExpenses", "crdr": "debit", "presentation": [ "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expenses", "documentation": "Amount of expense classified as other." } } }, "auth_ref": [ "r76" ] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other liabilities", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r21", "r537" ] }, "us-gaap_OtherNonoperatingIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncome", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "label": "Other income", "documentation": "Amount of income related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r142" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total Other Income", "label": "[Other Nonoperating Income (Expense)]", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r77" ] }, "us-gaap_PatentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PatentsMember", "presentation": [ "http://scwo.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Patents [Member]", "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law." } } }, "auth_ref": [ "r94" ] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 18.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Increase in intangible assets", "label": "[Payments to Acquire Intangible Assets]", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r78" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of equipment", "label": "[Payments to Acquire Property, Plant, and Equipment]", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r78" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Plan Name Axis", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r539", "r540", "r543", "r544", "r545", "r546", "r640", "r645" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Par Value", "verboseLabel": "Preferred Stock, Par Value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r58", "r256" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "verboseLabel": "Preferred Stock Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r58", "r455" ] }, "scwo_PreferredStockSharesDesignated": { "xbrltype": "sharesItemType", "nsuri": "http://scwo.com/20240331", "localname": "PreferredStockSharesDesignated", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares designated" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Issued", "verboseLabel": "Preferred Stock, Shares Issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r58", "r256" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r58", "r455", "r475", "r645", "r646" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred stock: 50,000,000 convertible Series D preferred shares authorized; par value $0.0001 per share, nil issued and outstanding at March 31, 2024 and December 31, 2023", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r58", "r411", "r537" ] }, "scwo_PremiumsRevenuePercentage": { "xbrltype": "percentItemType", "nsuri": "http://scwo.com/20240331", "localname": "PremiumsRevenuePercentage", "presentation": [ "http://scwo.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenue percentage", "label": "[Revenue percentage]" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r128", "r231", "r232", "r524" ] }, "scwo_PriceOfMarket": { "xbrltype": "perShareItemType", "nsuri": "http://scwo.com/20240331", "localname": "PriceOfMarket", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Market Price of common stock" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Issuance of common stock for services", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r6" ] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gross Process From Private Placement Of Stocks", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r6" ] }, "us-gaap_ProceedsFromSaleOfOtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfOtherInvestments", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Proceeds from the sale of common stock", "documentation": "Amount of cash inflow from the sale of investments classified as other." } } }, "auth_ref": [ "r557" ] }, "us-gaap_ProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfessionalFees", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "label": "Professional fees", "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer." } } }, "auth_ref": [ "r547", "r642", "r643" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 }, "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net Loss", "label": "[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]", "verboseLabel": "Net loss", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r119", "r130", "r133", "r144", "r151", "r155", "r162", "r163", "r167", "r172", "r176", "r178", "r217", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r327", "r330", "r331", "r343", "r344", "r406", "r419", "r442", "r478", "r497", "r498", "r529", "r535", "r536", "r548", "r572", "r591" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r9" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Total Property Plant And Equipment", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r87", "r123", "r417" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets", "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Property, and Equipment, net", "verboseLabel": "Total property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r9", "r407", "r417", "r537" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property and Equipment", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r9", "r113", "r116", "r416" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r87" ] }, "us-gaap_ProvisionForLossOnContracts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForLossOnContracts", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued contract loss provision", "documentation": "Cumulative provision for contract losses not offset against related costs accumulated on the balance sheet." } } }, "auth_ref": [ "r271" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://scwo.com/role/StockholderEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Range Axis" } } }, "auth_ref": [ "r241", "r242", "r243", "r244", "r275", "r276", "r303", "r304", "r305", "r372", "r396", "r425", "r446", "r447", "r506", "r507", "r508", "r509", "r513", "r519", "r520", "r530", "r532", "r534", "r538", "r541", "r589", "r593", "r631", "r632", "r633", "r634", "r635" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://scwo.com/role/StockholderEquityDetails1" ], "auth_ref": [ "r241", "r242", "r243", "r244", "r275", "r276", "r303", "r304", "r305", "r372", "r396", "r425", "r446", "r447", "r506", "r507", "r508", "r509", "r513", "r519", "r520", "r530", "r532", "r534", "r538", "r541", "r589", "r593", "r631", "r632", "r633", "r634", "r635" ] }, "us-gaap_RealEstateAccumulatedDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateAccumulatedDepreciation", "crdr": "credit", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: accumulated depreciations", "label": "[SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation]", "documentation": "Amount of accumulated depreciation pertaining to real estate investments for entities with a substantial portion of business acquiring and holding investment real estate." } } }, "auth_ref": [ "r518" ] }, "us-gaap_ReceivablesBillingStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesBillingStatusDomain", "presentation": [ "http://scwo.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "documentation": "Amounts due from customers (or dealers) within the next year (or operating cycle, if longer) for goods or services that have been delivered or used, but not yet paid." } } }, "auth_ref": [] }, "us-gaap_ReceivablesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesPolicyTextBlock", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable and Unbilled Accounts Receivable", "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable." } } }, "auth_ref": [ "r580", "r581", "r582", "r583" ] }, "us-gaap_RecognitionOfDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RecognitionOfDeferredRevenue", "crdr": "credit", "presentation": [ "http://scwo.com/role/RevenueDetails1" ], "lang": { "en-us": { "role": { "negatedLabel": "Recognition of prior unearned revenue", "label": "[Recognition of Deferred Revenue]", "documentation": "The amount of previously reported deferred or unearned revenue that was recognized as revenue during the period. For cash flows, this element primarily pertains to amortization of deferred credits on long-term arrangements. As a noncash item, it is deducted from net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r104" ] }, "scwo_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://scwo.com/20240331", "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParties", "crdr": "debit", "presentation": [ "http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction, Expenses from Transactions with Related Party" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://scwo.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "verboseLabel": "Related Party Transactions", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r358", "r359", "r360", "r361", "r362", "r439", "r440", "r441", "r481", "r482", "r483", "r503", "r505" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://scwo.com/role/StockholderEquityDetailsNarrative", "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Research and development", "verboseLabel": "Research and Development Cost", "terseLabel": "Research And Development", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r55", "r315", "r636" ] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Research And Development Costs", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r314" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets", "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "verboseLabel": "Accumulated Deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r61", "r91", "r414", "r429", "r431", "r438", "r456", "r537" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r118", "r152", "r153", "r154", "r156", "r161", "r163", "r218", "r219", "r307", "r308", "r309", "r324", "r325", "r334", "r336", "r337", "r339", "r342", "r426", "r428", "r443", "r645" ] }, "scwo_RevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://scwo.com/20240331", "localname": "RevenueAbstract", "lang": { "en-us": { "role": { "label": "Revenue" } } }, "auth_ref": [] }, "scwo_RevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://scwo.com/20240331", "localname": "RevenueMember", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue [Member]" } } }, "auth_ref": [] }, "scwo_RevenuePercentage": { "xbrltype": "percentItemType", "nsuri": "http://scwo.com/20240331", "localname": "RevenuePercentage", "presentation": [ "http://scwo.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "label": "Revenue percentage" } } }, "auth_ref": [] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r479", "r522", "r527" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "http://scwo.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenue", "label": "[Revenues]", "terseLabel": "Revenue", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r139", "r151", "r168", "r169", "r171", "r174", "r175", "r179", "r180", "r181", "r217", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r344", "r406", "r591" ] }, "scwo_RevenuesFromSaleOfTreatabilityServices": { "xbrltype": "monetaryItemType", "nsuri": "http://scwo.com/20240331", "localname": "RevenuesFromSaleOfTreatabilityServices", "crdr": "debit", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenues from sale of treatability services" } } }, "auth_ref": [] }, "scwo_RevenuesFromSales": { "xbrltype": "monetaryItemType", "nsuri": "http://scwo.com/20240331", "localname": "RevenuesFromSales", "crdr": "debit", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenues from sales" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of common stock shares", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_SalesCommissionsAndFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesCommissionsAndFees", "crdr": "debit", "presentation": [ "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Commission fees", "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller)." } } }, "auth_ref": [ "r75" ] }, "scwo_ScheduleOfDepreciationInPropertyAndEquipmentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://scwo.com/20240331", "localname": "ScheduleOfDepreciationInPropertyAndEquipmentTableTextBlock", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of depreciation in property and equipment" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://scwo.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Intangible Assets", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r41", "r43" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://scwo.com/role/InventoryTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Inventory", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r18", "r65", "r66", "r67" ] }, "us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of property and equipment", "documentation": "Tabular disclosure of public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation expense and method used, including composite depreciation, and accumulated depreciation." } } }, "auth_ref": [ "r54" ] }, "scwo_ScheduleOfRevenueByTypeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://scwo.com/20240331", "localname": "ScheduleOfRevenueByTypeTableTextBlock", "presentation": [ "http://scwo.com/role/RevenueTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of revenue by type" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://scwo.com/role/StockholderEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of stock option activity", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r14", "r15", "r48" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://scwo.com/role/StockholderEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of stock option assumtion", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r93" ] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://scwo.com/role/StockholderEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of warrant activity", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r46" ] }, "scwo_ScheduleOfUnbilledAccountsReceivableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://scwo.com/20240331", "localname": "ScheduleOfUnbilledAccountsReceivableTableTextBlock", "presentation": [ "http://scwo.com/role/RevenueTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of unbilled accounts receivable" } } }, "auth_ref": [] }, "scwo_ScheduleOfUnearnedRevenueActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://scwo.com/20240331", "localname": "ScheduleOfUnearnedRevenueActivityTableTextBlock", "presentation": [ "http://scwo.com/role/RevenueTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of unearned revenue activity" } } }, "auth_ref": [] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://scwo.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Future Amortization Expense", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r43" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r550" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r552" ] }, "scwo_ServiceRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://scwo.com/20240331", "localname": "ServiceRevenueMember", "presentation": [ "http://scwo.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "label": "Service revenue [Member]" } } }, "auth_ref": [] }, "scwo_ServicesBilled": { "xbrltype": "monetaryItemType", "nsuri": "http://scwo.com/20240331", "localname": "ServicesBilled", "crdr": "credit", "presentation": [ "http://scwo.com/role/RevenueDetails2" ], "lang": { "en-us": { "role": { "label": "Services billed" } } }, "auth_ref": [] }, "scwo_ServicesPerformedButUnbilled": { "xbrltype": "monetaryItemType", "nsuri": "http://scwo.com/20240331", "localname": "ServicesPerformedButUnbilled", "crdr": "credit", "presentation": [ "http://scwo.com/role/RevenueDetails2" ], "lang": { "en-us": { "role": { "label": "Services performed but unbilled" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited", "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock-based compensation", "verboseLabel": "Stock-based Compensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r7" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://scwo.com/role/StockholderEquityDetails2", "http://scwo.com/role/StockholderEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance At Beginning balance", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number]", "periodEndLabel": "Balance At Ending balance", "verboseLabel": "Warrants Outstanding", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r290", "r291" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://scwo.com/role/StockholderEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Dividend Yield", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r304" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://scwo.com/role/StockholderEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Expected Volatility", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r303" ] }, "scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates": { "xbrltype": "percentItemType", "nsuri": "http://scwo.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates", "presentation": [ "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Volatility" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://scwo.com/role/StockholderEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Risk-free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r305" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "presentation": [ "http://scwo.com/role/StockholderEquityDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares Exercised", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised]", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [ "r13" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://scwo.com/role/StockholderEquityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Expired/forfeited", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period]", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r601" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://scwo.com/role/StockholderEquityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Expired/forfeit", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r601" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://scwo.com/role/StockholderEquityDetails", "http://scwo.com/role/StockholderEquityDetails2" ], "lang": { "en-us": { "role": { "label": "Granted", "verboseLabel": "Shares Issued", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r286" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://scwo.com/role/StockholderEquityDetails2" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Issued", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r296" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://scwo.com/role/StockholderEquityDetails", "http://scwo.com/role/StockholderEquityDetails2" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value, beginning balance", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value]", "periodEndLabel": "Aggregate Intrinsic Value, ending balance", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r47" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://scwo.com/role/StockholderEquityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Options Outstanding, beginning balance", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number]", "periodEndLabel": "Options Outstanding, ending balance", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r282", "r283" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://scwo.com/role/StockholderEquityDetails", "http://scwo.com/role/StockholderEquityDetails2" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price, beginning balance", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price]", "periodEndLabel": "Weighted Average Exercise Price, ending balance", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r282", "r283" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r278", "r279", "r280", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r302", "r303", "r304", "r305", "r306" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://scwo.com/role/StockholderEquityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Weighted Average Exercise Price, Exercised", "label": "[Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price]", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r287" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://scwo.com/role/StockholderEquityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r286" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Stock-based Compensation and Change in Accounting Policy", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r277", "r281", "r300", "r301", "r302", "r303", "r306", "r310", "r311", "r312", "r313" ] }, "scwo_ShareBasedDescription": { "xbrltype": "stringItemType", "nsuri": "http://scwo.com/20240331", "localname": "ShareBasedDescription", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share based description" } } }, "auth_ref": [] }, "scwo_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRates": { "xbrltype": "percentItemType", "nsuri": "http://scwo.com/20240331", "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRates", "presentation": [ "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Risk free rate" } } }, "auth_ref": [] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://scwo.com/role/StockholderEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Expected Life", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r302" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://scwo.com/role/StockholderEquityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Life (years) Beginning", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r47" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://scwo.com/role/StockholderEquityDetails2" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted Average Exercise Price, ending balance", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price]", "documentation": "Weighted average grant-date fair value of non-vested options outstanding." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://scwo.com/role/StockholderEquityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Life (years) Ending", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r92" ] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssued", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "label": "[Shares, Issued]", "periodEndLabel": "Balance, shares", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r12" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Summary of Significant Accounting Policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r82", "r149" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Statement Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r12", "r23", "r118", "r136", "r137", "r138", "r152", "r153", "r154", "r156", "r161", "r163", "r166", "r218", "r219", "r270", "r307", "r308", "r309", "r324", "r325", "r334", "r335", "r336", "r337", "r338", "r339", "r342", "r349", "r351", "r352", "r353", "r354", "r355", "r357", "r426", "r427", "r428", "r443", "r499" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited", "http://scwo.com/role/IntangibleAssetsDetails", "http://scwo.com/role/RevenueDetails", "http://scwo.com/role/StockholderEquityDetails", "http://scwo.com/role/StockholderEquityDetails1", "http://scwo.com/role/StockholderEquityDetailsNarrative", "http://scwo.com/role/SubsequentEventsDetailsNarrative", "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r152", "r153", "r154", "r166", "r401", "r435", "r445", "r448", "r449", "r450", "r451", "r452", "r453", "r455", "r458", "r459", "r460", "r461", "r462", "r465", "r466", "r467", "r468", "r470", "r471", "r472", "r473", "r474", "r476", "r479", "r480", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r499", "r542" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Cash Flows (Unaudited)" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Condensed Consolidated Balance Sheets" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Condensed Consolidated Changes in Stockholders' Equity (Unaudited)" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited", "http://scwo.com/role/IntangibleAssetsDetails", "http://scwo.com/role/RevenueDetails", "http://scwo.com/role/StockholderEquityDetails", "http://scwo.com/role/StockholderEquityDetails1", "http://scwo.com/role/StockholderEquityDetailsNarrative", "http://scwo.com/role/SubsequentEventsDetailsNarrative", "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r152", "r153", "r154", "r166", "r401", "r435", "r445", "r448", "r449", "r450", "r451", "r452", "r453", "r455", "r458", "r459", "r460", "r461", "r462", "r465", "r466", "r467", "r468", "r470", "r471", "r472", "r473", "r474", "r476", "r479", "r480", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r499", "r542" ] }, "scwo_StockBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://scwo.com/20240331", "localname": "StockBasedCompensationExpense", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock-based compensation", "label": "[Stock-based compensation]" } } }, "auth_ref": [] }, "scwo_StockInExcessPercentageOfOutstandingShare": { "xbrltype": "percentItemType", "nsuri": "http://scwo.com/20240331", "localname": "StockInExcessPercentageOfOutstandingShare", "presentation": [ "http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock In Excess Percentage Of Outstanding Share" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Issuance of shares for services, shares", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Issuance of shares of common stock for cash, shares", "verboseLabel": "Stock issued during period", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r12", "r58", "r59", "r91", "r437", "r499", "r514" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://scwo.com/role/StockholderEquityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Exercised", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period]", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r12", "r58", "r59", "r91", "r287" ] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Issuance of shares for services, amount", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Issuance of shares of common stock for cash, amount", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r12", "r58", "r59", "r91", "r443", "r499", "r514", "r548" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 24.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets", "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total Stockholders' Equity", "label": "[Stockholders' Equity Attributable to Parent]", "periodStartLabel": "Balance, amount", "periodEndLabel": "Balance, amount", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r59", "r62", "r63", "r83", "r457", "r475", "r500", "r501", "r537", "r549", "r575", "r588", "r624", "r645" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://scwo.com/role/StockholderEquity" ], "lang": { "en-us": { "role": { "label": "Stockholder' Equity", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r90", "r150", "r255", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r268", "r270", "r341", "r502", "r504", "r515" ] }, "us-gaap_SubsequentEventDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventDescription", "presentation": [ "http://scwo.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event, Description", "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued." } } }, "auth_ref": [ "r52" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://scwo.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r356", "r364" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://scwo.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type Axis", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r356", "r364" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://scwo.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r356", "r364" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://scwo.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "verboseLabel": "Subsequent Events", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r363", "r365" ] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern" ], "lang": { "en-us": { "role": { "label": "Liquidity, Capital Resources and Going Concern", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r57" ] }, "us-gaap_SupplementalCashFlowElementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowElementsAbstract", "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL CASH FLOW DISCLOSURES:" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://scwo.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r579", "r627" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://scwo.com/role/SubsequentEventsDetailsNarrative" ], "auth_ref": [] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Other Accounts Receivable", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r101", "r102", "r103", "r184", "r185", "r186" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://scwo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://scwo.com/role/StockholderEquityDetails", "http://scwo.com/role/StockholderEquityDetails1", "http://scwo.com/role/StockholderEquityDetailsNarrative", "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r254", "r267", "r340", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r422", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r584", "r585", "r586", "r587" ] }, "us-gaap_UnbilledReceivablesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnbilledReceivablesCurrent", "crdr": "debit", "calculation": { "http://scwo.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://scwo.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Unbilled accounts receivable", "documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_UnrealizedGainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrealizedGainLossOnInvestments", "crdr": "credit", "presentation": [ "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Unrealized gain on investments", "documentation": "Amount of unrealized gain (loss) on investment." } } }, "auth_ref": [ "r8" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use Of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r36", "r37", "r38", "r110", "r111", "r114", "r115" ] }, "us-gaap_VehiclesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VehiclesMember", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Vehicles [Member]", "documentation": "Equipment used primarily for road transportation." } } }, "auth_ref": [] }, "scwo_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://scwo.com/20240331", "localname": "WarrantsMember", "presentation": [ "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants [Member]" } } }, "auth_ref": [] }, "scwo_WeightedAverageExercisePriceExercisableEndingBalance": { "xbrltype": "perShareItemType", "nsuri": "http://scwo.com/20240331", "localname": "WeightedAverageExercisePriceExercisableEndingBalance", "presentation": [ "http://scwo.com/role/StockholderEquityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Exercisable, ending balance" } } }, "auth_ref": [] }, "scwo_WeightedAverageExercisePriceExercised": { "xbrltype": "perShareItemType", "nsuri": "http://scwo.com/20240331", "localname": "WeightedAverageExercisePriceExercised", "presentation": [ "http://scwo.com/role/StockholderEquityDetails2" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Exercised" } } }, "auth_ref": [] }, "scwo_WeightedAverageNumberOfSharesOutstandingBasicAndDiluted": { "xbrltype": "sharesItemType", "nsuri": "http://scwo.com/20240331", "localname": "WeightedAverageNumberOfSharesOutstandingBasicAndDiluted", "presentation": [ "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "label": "Weighted Average Common Shares Outstanding - Basic and Diluted" } } }, "auth_ref": [] }, "scwo_WeightedAverageRemainingContractualLifeYearsBeginningBalance": { "xbrltype": "durationItemType", "nsuri": "http://scwo.com/20240331", "localname": "WeightedAverageRemainingContractualLifeYearsBeginningBalance", "presentation": [ "http://scwo.com/role/StockholderEquityDetails2" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Life(years), beginning balance" } } }, "auth_ref": [] }, "scwo_WeightedAverageRemainingContractualLifeYearsEndingBalance": { "xbrltype": "durationItemType", "nsuri": "http://scwo.com/20240331", "localname": "WeightedAverageRemainingContractualLifeYearsEndingBalance", "presentation": [ "http://scwo.com/role/StockholderEquityDetails2" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Life(years), ending balance" } } }, "auth_ref": [] }, "scwo_WeightedAverageRemainingContractualLifeYearsExercisableEnding": { "xbrltype": "durationItemType", "nsuri": "http://scwo.com/20240331", "localname": "WeightedAverageRemainingContractualLifeYearsExercisableEnding", "presentation": [ "http://scwo.com/role/StockholderEquityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Life (years) Exercisable Ending" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(2)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.3,4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-31" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "855", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "980", "SubTopic": "20", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481834/980-20-45-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-40/tableOfContent" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4,6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "83", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480647/815-10-15-83" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "430", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//430/tableOfContent" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-30/tableOfContent" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "605", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481187/605-35-45-2" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480696/942-505-50-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r522": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r523": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r526": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r527": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r528": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r529": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r530": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r531": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r532": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r533": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r534": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r535": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r536": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r537": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r538": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r539": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r541": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r545": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r546": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r547": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r548": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r549": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r550": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r551": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r552": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r554": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r556": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r557": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r558": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r559": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r560": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r561": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r562": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r563": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r564": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r565": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r566": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r567": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r568": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r569": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r570": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r571": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r572": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r573": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r574": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r575": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r576": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r577": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r578": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r579": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r580": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r581": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r582": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2" }, "r583": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4" }, "r584": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r585": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r586": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r587": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r588": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r589": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r590": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r591": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r592": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r593": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r594": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r595": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r596": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r597": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r598": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r599": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r600": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r601": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r602": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r603": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r604": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r605": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r606": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r607": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r608": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r609": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r610": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r611": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r612": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r613": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r614": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r615": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r616": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r617": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r618": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r619": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r620": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r621": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r622": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1" }, "r623": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r624": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r625": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r626": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 60 0001654954-24-006425-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-24-006425-xbrl.zip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end XML 62 scwo_10q_htm.xml IDEA: XBRL DOCUMENT 0000933972 2024-01-01 2024-03-31 0000933972 scwo:MrGannonMember us-gaap:SubsequentEventMember 2024-04-01 2024-04-19 0000933972 us-gaap:LicensingAgreementsMember 2024-01-01 2024-03-31 0000933972 scwo:ConsultantMember 2023-01-01 2023-03-31 0000933972 scwo:ConsultantMember 2024-01-01 2024-03-31 0000933972 scwo:EquityDistributionAgreementMember 2024-03-31 0000933972 2020-10-30 0000933972 scwo:EquityDistributionAgreementMember 2024-01-01 2024-03-31 0000933972 scwo:EquityDistributionAgreementMember 2023-01-01 2023-03-31 0000933972 srt:MaximumMember us-gaap:OptionMember 2024-01-01 2024-03-31 0000933972 srt:MinimumMember us-gaap:OptionMember 2024-01-01 2024-03-31 0000933972 scwo:OptionsMember 2024-03-31 0000933972 scwo:OptionsMember 2023-12-31 0000933972 scwo:ServiceRevenueMember 2023-01-01 2023-03-31 0000933972 scwo:ServiceRevenueMember 2024-01-01 2024-03-31 0000933972 scwo:EquipmentRevenuesMember 2023-01-01 2023-03-31 0000933972 scwo:EquipmentRevenuesMember 2024-01-01 2024-03-31 0000933972 us-gaap:PatentsMember 2024-03-31 0000933972 us-gaap:PatentsMember 2024-01-01 2024-03-31 0000933972 us-gaap:PatentsMember 2023-12-31 0000933972 scwo:LicenseAgreementMember 2024-03-31 0000933972 scwo:LicenseAgreementMember 2024-01-01 2024-03-31 0000933972 scwo:LicenseAgreementMember 2023-12-31 0000933972 scwo:WarrantsMember 2023-01-01 2023-03-31 0000933972 scwo:WarrantsMember 2024-01-01 2024-03-31 0000933972 scwo:OptionsMember 2024-01-01 2024-03-31 0000933972 scwo:OptionsMember 2023-01-01 2023-03-31 0000933972 scwo:OneCustomerMember scwo:RevenueMember 2023-01-01 2023-12-31 0000933972 scwo:OneCustomerMember scwo:RevenueMember 2024-01-01 2024-03-31 0000933972 2023-01-01 2023-12-31 0000933972 us-gaap:ComputerEquipmentMember 2023-12-31 0000933972 us-gaap:ComputerEquipmentMember 2024-03-31 0000933972 us-gaap:OfficeEquipmentMember 2023-12-31 0000933972 us-gaap:OfficeEquipmentMember 2024-03-31 0000933972 us-gaap:VehiclesMember 2023-12-31 0000933972 us-gaap:VehiclesMember 2024-03-31 0000933972 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000933972 us-gaap:RetainedEarningsMember 2024-03-31 0000933972 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000933972 us-gaap:CommonStockMember 2024-03-31 0000933972 us-gaap:PreferredStockMember 2024-03-31 0000933972 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000933972 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000933972 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000933972 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000933972 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0000933972 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000933972 us-gaap:RetainedEarningsMember 2023-12-31 0000933972 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000933972 us-gaap:CommonStockMember 2023-12-31 0000933972 us-gaap:PreferredStockMember 2023-12-31 0000933972 2023-03-31 0000933972 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000933972 us-gaap:RetainedEarningsMember 2023-03-31 0000933972 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000933972 us-gaap:CommonStockMember 2023-03-31 0000933972 us-gaap:PreferredStockMember 2023-03-31 0000933972 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000933972 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000933972 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000933972 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000933972 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0000933972 2022-12-31 0000933972 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000933972 us-gaap:RetainedEarningsMember 2022-12-31 0000933972 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000933972 us-gaap:CommonStockMember 2022-12-31 0000933972 us-gaap:PreferredStockMember 2022-12-31 0000933972 2023-01-01 2023-03-31 0000933972 2023-12-31 0000933972 2024-03-31 0000933972 2024-05-15 iso4217:USD shares iso4217:USD shares pure 0000933972 false --12-31 Q1 2024 false 50000000 0.0001 0 0 0 0 200000000 0.0001 132667107 132670446 0 0 0 0 0 0 1.33 152285 10-Q true 2024-03-31 false 000-27866 374WATER INC. DE 88-0271109 701 W Main Street Suite 410 Durham NC 27701 919 888-8194 Common Stock, par value $0.0001 SCWO NASDAQ Yes Yes Non-accelerated Filer true true false 132670446 7936161 10445404 84324 64792 1771609 1494553 34161 39749 2601658 2276677 921365 581085 13349278 14902260 223339 230971 971691 988029 1195030 1219000 14544308 16121260 755721 572297 600000 500000 135000 135000 132768 130000 10408 36787 1633897 1374084 1633897 1374084 50000000 0.0001 0 0 200000000 0.0001 132670446 132667107 13266 13266 30872643 30684943 -17977969 -15953504 2471 2471 12910411 14747176 14544308 16121260 315278 801458 617298 720146 -302020 81312 535147 355905 651604 718760 252705 99572 459727 585659 1899183 1759896 -2201203 -1678584 104620 37859 72118 382 176738 38241 -2024465 -1640343 0 0 -2024465 -1640343 0 824 0 18967 0 19791 -2024465 -1620552 -0.02 -0.01 132668777 127146695 0 132667107 13266 30684943 -15953504 2471 14747176 0 3339 0 4500 0 0 4500 0 0 183200 0 0 183200 0 0 0 -2024465 0 -2024465 0 132670446 13266 30872643 -17977969 2471 12910411 0 126702545 12669 16110221 -7849982 -19296 8253612 0 2137876 214 8294494 0 0 8294708 0 0 214924 0 0 214924 0 0 0 0 824 824 0 0 0 0 18967 18967 0 0 0 -1640343 0 -1640343 0 128840421 12883 24619639 -9490325 495 15142692 -2024465 -1640343 24560 29105 4500 0 183200 214924 0 -824 50000 0 19532 26188 277056 754290 -5588 308374 374981 127309 340280 -23285 183424 -581582 -100000 0 2768 5000 -26379 -13528 -2508653 -3178176 0 7303 590 2705 -590 -10008 0 8294708 0 8294708 -2509243 5106224 10445404 4046937 7936161 9153161 0 0 0 0 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 1 – Nature of Business and Presentation of Financial Statements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Description of the Company</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">374Water Inc. (the “Company”, “374Water”, “We”, or “Our”) is a Delaware corporation which was formed in September 2005 as PowerVerde, Inc. At that time, the Company was focused on developing, commercializing and marketing a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a pressure-driven expander motor and related organic rankine cycle technology.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 16, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger”) with 374Water Inc., a privately held company based in Durham, North Carolina, (“374Water Private Company”) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Following the Merger, 374Water offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., “per-and polyfluoroalkyl substances” or “PFAS”) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals.  We are developing AirSCWO, a proprietary treatment system based on “supercritical water oxidation.” </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Presentation of Financial Statements</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) for interim financial information. It is management’s opinion that the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q and include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report on Form 10-K of 374Water Inc. as of and for the year ended December 31, 2023 filed with the SEC on March 29, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The results of operations for the three months ended March 31, 2024, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of 374Water Inc., 374Water Systems Inc, and 374Water Sustainability Israel LTD, each a wholly-owned subsidiary of 374 Water. Intercompany balances and transactions have been eliminated in consolidation.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 2 – Summary of Significant Accounting Policies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Cash and Cash Equivalents </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held $7,936,161 and $10,445,404 in cash and cash equivalents as of March 31, 2024 and December 31, 2023, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Accounts Receivable and Unbilled Accounts Receivable</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts receivables consist of balances due from service revenues. Unbilled accounts receivables are from revenues earned but not yet billed. The Company monitors accounts receivable and provides allowances for expected credit losses when considered necessary. As of  March 31, 2024 and December 31, 2023, accounts receivable were considered to be fully collectible but in accordance with the allowance for credit losses, the Company recorded an allowance for credit losses based on a reserve of current and aged receivables which was not significant as of March 31, 2024 and December 31, 2023.   </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Other Accounts Receivable</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other accounts receivable consist of accrued interest income from the cash held in an interest bearing money market account with a financial institution. We typically receive payment for accrued interest one month in arrears. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Inventories</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. The majority of our inventory is raw materials and work in progress.  Net realizable value is the value of an asset that can be realized upon the sale of the asset, less a reasonable estimate of the costs associated with either the eventual sale or the disposal of the asset in question.  We utilize third-party suppliers to produce our products. Costs associated with fabrication, and other costs associated with the manufacturing of products, are recorded as inventory. We periodically evaluate the carrying value of our inventories in relation to estimated forecasts of product demand, which takes into consideration the life cycle of product releases. Further, as we continue to hence and develop are AirSCWO systems we may replace materials and parts with upgrades to enhance the units. If it is not probable that the replacement part will be used , we establish a reserve against the material or part or dispose of it. When quantities on hand exceed estimated sales forecasts, we perform an analysis to determine if a write-down for such excess inventories is required.  Once inventory has been written down, it creates a new cost basis for inventory.  Inventories are classified as current assets in accordance with recognized industry practice. Based on our evaluation we estimated an inventory allowance of $50,000 and $0 as of March 31, 2024 and December 31, 2023, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline"></span> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Property and Equipment</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property and Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table presents property and equipment as of March 31, 2024 and December 31, 2023:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computers</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16,489</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16,489</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">190,748</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">190,748</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vehicles</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">44,510</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">44,510</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.5pt">Total property and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">251,747</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">251,747</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: accumulated depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(28,408 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(20,776 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.5pt">Total property and equipment, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">223,339</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">230,971</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Depreciation expense related to property and equipment was as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Period Ended March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">7,632</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">9,525</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Intangible Assets</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment.” Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. As of March 31, 2024 and December 31, 2023, there was no impairment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Long-Lived Assets</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2024 and December 31, 2023, there were no impairments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline"></span> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Concentrations of Credit Risk</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (“FDIC”). The Company’s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues and purchases.  One customer made up approximately 94% and 99% of revenue for the three month periods ended March 31, 2024 and 2023, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2024 and 2023, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros Fabrication, LLC (“Merrell Bros.”) (see Note 8).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Refer to Note 9 for a license agreement we have with Duke University for the SCWO technology used in our systems. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Revenue Recognition</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the revenue standards of Codification (ASC) Topic 606: “Revenue from Contracts with Customers (Topic 606).” The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation using the input method.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company generates revenue from the sale of equipment (AirSCWO units) and services, specifically the completion of treatability studies. In the case of equipment revenues, the Company’s performance obligations are satisfied over time over the life of the contract which are typically long-term fixed price contracts. Revenue is recognized over time by measuring the progress toward complete satisfaction of the performance obligation using specific milestones. These milestones within the contract are assigned revenue recognition percentages, based on overall expected cost-plus margin estimates of those milestones compared to the total cost of the contract. Equipment sale related contract revenues are recognized in the proportion that contract costs incurred bear to total estimated costs. This method is used because management considers the input method to be the best available measure of progress on these contracts. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Changes in our overall expected cost estimates are recognized as a cumulative adjustment for the inception-to-date effective of such change. If these changes in estimates result in a possible loss being incurred on the contract, we accrue for such a loss in the period such an outcome becomes probable.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Services revenues are recognized when all five revenue recognition criteria have been completed which is generally when we deliver a completed treatability study report to the customer. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Contract costs include all direct material, labor and subcontractor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs, and depreciation. General, selling, and administrative costs are charged to expenses as incurred.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenues for the three-month period ended March 31, 2024 in the amount of $296,096 was generated from the progress towards completion of the AirSCWO system and $19,182 was generated from the sale of treatability services.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenues for the three-month period ended March 31, 2023 in the amount of $793,458 was generated from the sale of the AirSCWO system and $8,000 was generated from the sale of treatability services.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline"></span> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Accrued Contract Loss Provision and Onerous Contracts</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Onerous contracts are those where the costs to fulfill a contract exceed the consideration expected to be received under the contract. The revenue standard does not provide guidance on the accounting for onerous contracts or onerous performance obligations. US GAAP contains other applicable guidance on the accounting for onerous contracts, and those requirements should be used to identify and measure onerous contracts. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our outstanding equipment manufacturing contract is a fixed price contract. Due to the nature of the contract, including customer specific equipment design, we applied ASC 605-35, <em>Revenue Recognition—Provision for Losses on Construction-Type and Production-Type Contract (ASC 605-35). </em>ASC 605-35 requires the recognition of a liability for anticipated losses on contracts prior to those losses being incurred when a loss is probable and can be estimated. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024 and December 31, 2023, we evaluated the total costs incurred on this contract to date and the estimated costs we anticipate incurring to complete the contract.  Based on this analysis, we accrued a total accrued loss provision of $600,000 and $500,000 as of March 31, 2024 and December 31, 2023, respectively, which has been presented on the accompanying unaudited condensed consolidated balance sheets and is recorded within cost of revenues on the accompanying unaudited condensed consolidated statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Stock-based Compensation and Change in Accounting Policy</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Prior to January 1, 2024, the Company had elected to estimate options granted for which the requisite service period would not be rendered, due to the option being forfeited or expiring. The forfeiture rate estimate was based on the percentage of cumulative forfeitures to the total award grants.  During the quarter ended December 31, 2023, we compared our actual forfeiture rate to our estimated forfeiture rate and made a cumulative adjustment of approximately $55,000 in the quarter ended December 31, 2023 to reduce our forfeiture rate estimate to approximately 5% of the total stock-based compensation recognized during the year.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Effective January 1, 2024, the Company made a change in their accounting policy to recognize forfeitures on service-based stock award instruments as they occur.  Due to the lack of history available to adequately estimate our forfeiture rate and the fact that the majority of our serviced based options include a one-year cliff vesting and monthly vesting after, we believe recognizing forfeitures as they occur will result in more accurate financial reporting. The change in this accounting policy did not have a significant impact on the current or prior period financial statements. During the three months ended March 31, 2024, no forfeitures occurred. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Income Tax Policy</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Accounting for Uncertainty in Income Taxes</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2024 and December 31, 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline"></span> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Research and Development Costs</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $535,147 and $355,905 for the three months ended March 31, 2024 and 2023, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Loss Per Share</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Loss per share is computed in accordance with ASC Topic 260, “Earnings per Share” Basic weighted-average number of shares of common stock outstanding for the three- months ended March 31, 2024 and 2023  include the shares of the Company issued and outstanding during such periods, each on a weighted average basis. The basic weighted average number of shares of common stock outstanding excludes common stock equivalent incremental shares, while diluted weighted average number of shares outstanding includes such incremental shares. However, as the Company was in a loss position for all periods presented, basic and diluted weighted average shares outstanding are the same, as the inclusion of the incremental shares would be anti-dilutive.  As of March 31, 2024 and March 31, 2023, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 10,740,250 and 13,025,000  shares of common stock and 1,235,000 and 1,250,000 warrants, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Financial Instruments</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company carries cash, accounts, unbilled and other receivables, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Use of Estimates</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, service revenue, accrued contract loss provisions, and valuation allowance against deferred tax assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline"></span> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Recent Accounting Pronouncements - Not Yet Adopted</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2023 FASB issued Accounting Standards Update (ASU) 2023-09, <em>Income Taxes (Topic 740): Improvements to Income Tax Disclosures </em>(ASU 2023-09). The ASU focuses on income tax disclosures around effective tax rates and cash income taxes paid. ASU 2023-09 requires public business entities to disclose, on an annual basis, a rate reconciliation presented in both dollars and percentages. The guidance requires the rate reconciliation to include specific categories and provides further guidance on disaggregation of those categories based on a quantitative threshold equal to 5% or more of the amount determined by multiplying pretax income (loss) from continuing operations by the applicable statutory rate. For entities reconciling to the US statutory rate of 21%, this would generally require disclosing any reconciling items that impact the rate by 1.05% or more. ASU 2023-09 is effective for public business entities for annual periods beginning after December  15, 2024 (generally, calendar year 2025) and effective for all other business entities one year later. Entities should adopt this guidance on a prospective basis, though retrospective application is permitted. The adoption of ASU 2023-09 is expected to have a financial statement disclosure impact only and is not expected to have a material impact on the Company’s financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In November 2023 the FASB issued ASU 2023-07, <em>Segment Reporting – Improvements to Reportable Segment Disclosures.  </em>The ASU will now require public entities to disclose its significant segment expenses categories and amounts for each reportable segment. Under the ASU, a significant segment expense is an expense that is:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">significant to the segment,</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">regularly provided to or easily computed from information regularly provided to the chief operating decision maker (CODM), and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">included in the reported measure of segment profit or loss.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The ASU is effective for public entities for fiscal years beginning after December 15, 2023 and interim periods in fiscal years beginning after December 15, 2024 (calendar year public entity will adopt the ASU in its 2024 Form 10 K). The ASU should be adopted retrospectively unless it’s impracticable to do so. Early adoption of the ASU is permitted, including in an interim period. The adoption of ASU 2023-07 is expected to have a financial statement disclosure impact only and is not expected to have a material impact on the Company’s financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held $7,936,161 and $10,445,404 in cash and cash equivalents as of March 31, 2024 and December 31, 2023, respectively.</p> 7936161 10445404 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts receivables consist of balances due from service revenues. Unbilled accounts receivables are from revenues earned but not yet billed. The Company monitors accounts receivable and provides allowances for expected credit losses when considered necessary. As of  March 31, 2024 and December 31, 2023, accounts receivable were considered to be fully collectible but in accordance with the allowance for credit losses, the Company recorded an allowance for credit losses based on a reserve of current and aged receivables which was not significant as of March 31, 2024 and December 31, 2023.   </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other accounts receivable consist of accrued interest income from the cash held in an interest bearing money market account with a financial institution. We typically receive payment for accrued interest one month in arrears. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. The majority of our inventory is raw materials and work in progress.  Net realizable value is the value of an asset that can be realized upon the sale of the asset, less a reasonable estimate of the costs associated with either the eventual sale or the disposal of the asset in question.  We utilize third-party suppliers to produce our products. Costs associated with fabrication, and other costs associated with the manufacturing of products, are recorded as inventory. We periodically evaluate the carrying value of our inventories in relation to estimated forecasts of product demand, which takes into consideration the life cycle of product releases. Further, as we continue to hence and develop are AirSCWO systems we may replace materials and parts with upgrades to enhance the units. If it is not probable that the replacement part will be used , we establish a reserve against the material or part or dispose of it. When quantities on hand exceed estimated sales forecasts, we perform an analysis to determine if a write-down for such excess inventories is required.  Once inventory has been written down, it creates a new cost basis for inventory.  Inventories are classified as current assets in accordance with recognized industry practice. Based on our evaluation we estimated an inventory allowance of $50,000 and $0 as of March 31, 2024 and December 31, 2023, respectively. </p> 50000 0 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property and Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table presents property and equipment as of March 31, 2024 and December 31, 2023:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computers</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16,489</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16,489</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">190,748</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">190,748</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vehicles</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">44,510</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">44,510</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.5pt">Total property and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">251,747</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">251,747</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: accumulated depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(28,408 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(20,776 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.5pt">Total property and equipment, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">223,339</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">230,971</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Depreciation expense related to property and equipment was as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Period Ended March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">7,632</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">9,525</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computers</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16,489</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16,489</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">190,748</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">190,748</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vehicles</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">44,510</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">44,510</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.5pt">Total property and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">251,747</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">251,747</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: accumulated depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(28,408 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(20,776 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.5pt">Total property and equipment, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">223,339</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">230,971</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 16489 16489 190748 190748 44510 44510 251747 251747 28408 20776 223339 230971 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Period Ended March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">7,632</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">9,525</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 7632 9525 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment.” Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. As of March 31, 2024 and December 31, 2023, there was no impairment.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2024 and December 31, 2023, there were no impairments.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (“FDIC”). The Company’s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues and purchases.  One customer made up approximately 94% and 99% of revenue for the three month periods ended March 31, 2024 and 2023, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2024 and 2023, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros Fabrication, LLC (“Merrell Bros.”) (see Note 8).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Refer to Note 9 for a license agreement we have with Duke University for the SCWO technology used in our systems. </p> 0.94 0.99 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the revenue standards of Codification (ASC) Topic 606: “Revenue from Contracts with Customers (Topic 606).” The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation using the input method.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company generates revenue from the sale of equipment (AirSCWO units) and services, specifically the completion of treatability studies. In the case of equipment revenues, the Company’s performance obligations are satisfied over time over the life of the contract which are typically long-term fixed price contracts. Revenue is recognized over time by measuring the progress toward complete satisfaction of the performance obligation using specific milestones. These milestones within the contract are assigned revenue recognition percentages, based on overall expected cost-plus margin estimates of those milestones compared to the total cost of the contract. Equipment sale related contract revenues are recognized in the proportion that contract costs incurred bear to total estimated costs. This method is used because management considers the input method to be the best available measure of progress on these contracts. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Changes in our overall expected cost estimates are recognized as a cumulative adjustment for the inception-to-date effective of such change. If these changes in estimates result in a possible loss being incurred on the contract, we accrue for such a loss in the period such an outcome becomes probable.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Services revenues are recognized when all five revenue recognition criteria have been completed which is generally when we deliver a completed treatability study report to the customer. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Contract costs include all direct material, labor and subcontractor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs, and depreciation. General, selling, and administrative costs are charged to expenses as incurred.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenues for the three-month period ended March 31, 2024 in the amount of $296,096 was generated from the progress towards completion of the AirSCWO system and $19,182 was generated from the sale of treatability services.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenues for the three-month period ended March 31, 2023 in the amount of $793,458 was generated from the sale of the AirSCWO system and $8,000 was generated from the sale of treatability services.  </p> 296096 19182 793458 8000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Onerous contracts are those where the costs to fulfill a contract exceed the consideration expected to be received under the contract. The revenue standard does not provide guidance on the accounting for onerous contracts or onerous performance obligations. US GAAP contains other applicable guidance on the accounting for onerous contracts, and those requirements should be used to identify and measure onerous contracts. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our outstanding equipment manufacturing contract is a fixed price contract. Due to the nature of the contract, including customer specific equipment design, we applied ASC 605-35, <em>Revenue Recognition—Provision for Losses on Construction-Type and Production-Type Contract (ASC 605-35). </em>ASC 605-35 requires the recognition of a liability for anticipated losses on contracts prior to those losses being incurred when a loss is probable and can be estimated. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024 and December 31, 2023, we evaluated the total costs incurred on this contract to date and the estimated costs we anticipate incurring to complete the contract.  Based on this analysis, we accrued a total accrued loss provision of $600,000 and $500,000 as of March 31, 2024 and December 31, 2023, respectively, which has been presented on the accompanying unaudited condensed consolidated balance sheets and is recorded within cost of revenues on the accompanying unaudited condensed consolidated statements of operations.</p> 600000 500000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Prior to January 1, 2024, the Company had elected to estimate options granted for which the requisite service period would not be rendered, due to the option being forfeited or expiring. The forfeiture rate estimate was based on the percentage of cumulative forfeitures to the total award grants.  During the quarter ended December 31, 2023, we compared our actual forfeiture rate to our estimated forfeiture rate and made a cumulative adjustment of approximately $55,000 in the quarter ended December 31, 2023 to reduce our forfeiture rate estimate to approximately 5% of the total stock-based compensation recognized during the year.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Effective January 1, 2024, the Company made a change in their accounting policy to recognize forfeitures on service-based stock award instruments as they occur.  Due to the lack of history available to adequately estimate our forfeiture rate and the fact that the majority of our serviced based options include a one-year cliff vesting and monthly vesting after, we believe recognizing forfeitures as they occur will result in more accurate financial reporting. The change in this accounting policy did not have a significant impact on the current or prior period financial statements. During the three months ended March 31, 2024, no forfeitures occurred. </p> cumulative adjustment of approximately $55,000 in the quarter ended December 31, 2023 to reduce our forfeiture rate estimate to approximately 5% of the total stock-based compensation recognized during the year <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2024 and December 31, 2023.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $535,147 and $355,905 for the three months ended March 31, 2024 and 2023, respectively. </p> 535147 355905 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Loss per share is computed in accordance with ASC Topic 260, “Earnings per Share” Basic weighted-average number of shares of common stock outstanding for the three- months ended March 31, 2024 and 2023  include the shares of the Company issued and outstanding during such periods, each on a weighted average basis. The basic weighted average number of shares of common stock outstanding excludes common stock equivalent incremental shares, while diluted weighted average number of shares outstanding includes such incremental shares. However, as the Company was in a loss position for all periods presented, basic and diluted weighted average shares outstanding are the same, as the inclusion of the incremental shares would be anti-dilutive.  As of March 31, 2024 and March 31, 2023, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 10,740,250 and 13,025,000  shares of common stock and 1,235,000 and 1,250,000 warrants, respectively. </p> 10740250 13025000 1235000 1250000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company carries cash, accounts, unbilled and other receivables, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, service revenue, accrued contract loss provisions, and valuation allowance against deferred tax assets.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2023 FASB issued Accounting Standards Update (ASU) 2023-09, <em>Income Taxes (Topic 740): Improvements to Income Tax Disclosures </em>(ASU 2023-09). The ASU focuses on income tax disclosures around effective tax rates and cash income taxes paid. ASU 2023-09 requires public business entities to disclose, on an annual basis, a rate reconciliation presented in both dollars and percentages. The guidance requires the rate reconciliation to include specific categories and provides further guidance on disaggregation of those categories based on a quantitative threshold equal to 5% or more of the amount determined by multiplying pretax income (loss) from continuing operations by the applicable statutory rate. For entities reconciling to the US statutory rate of 21%, this would generally require disclosing any reconciling items that impact the rate by 1.05% or more. ASU 2023-09 is effective for public business entities for annual periods beginning after December  15, 2024 (generally, calendar year 2025) and effective for all other business entities one year later. Entities should adopt this guidance on a prospective basis, though retrospective application is permitted. The adoption of ASU 2023-09 is expected to have a financial statement disclosure impact only and is not expected to have a material impact on the Company’s financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In November 2023 the FASB issued ASU 2023-07, <em>Segment Reporting – Improvements to Reportable Segment Disclosures.  </em>The ASU will now require public entities to disclose its significant segment expenses categories and amounts for each reportable segment. Under the ASU, a significant segment expense is an expense that is:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">significant to the segment,</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">regularly provided to or easily computed from information regularly provided to the chief operating decision maker (CODM), and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">included in the reported measure of segment profit or loss.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The ASU is effective for public entities for fiscal years beginning after December 15, 2023 and interim periods in fiscal years beginning after December 15, 2024 (calendar year public entity will adopt the ASU in its 2024 Form 10 K). The ASU should be adopted retrospectively unless it’s impracticable to do so. Early adoption of the ASU is permitted, including in an interim period. The adoption of ASU 2023-07 is expected to have a financial statement disclosure impact only and is not expected to have a material impact on the Company’s financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 3 – Liquidity, Capital Resources and Going Concern</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024, the Company had working capital of $11,715,381 and an accumulated deficit of $17,977,969. For the three months ended March 31, 2024, the Company incurred a net loss of $2,024,465 and used $2,508,653 of net cash in operations for the period.  These conditions raise substantial doubt regarding our ability to continue as a going concern. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Since inception, we have financed our operations principally through the sale of debt and equity securities and operating cash flows. We have an at-the-market (ATM) equity offering under which we may issue up to $100 million of common stock, which is not currently active. However, we are in the process of activating the ATM. During the year end December 31, 2023, we raised approximately $13.4 million of net proceeds through this ATM.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">While no assurance can be provided, management believes that these actions provide the opportunity for the Company to continue as a going concern and to grow its business and achieve profitability with access to additional capital funding. Ultimately, the success of the Company as a going concern is dependent upon the ability of the Company to continue executing its plan and obtaining capital that will enable the Company to complete its in-process AirSCWO units and begin manufacturing further units. If the Company is unable to obtain additional financing in sufficient amounts or under acceptable terms, the Company's operating results could be adversely affected. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Based upon the Company’s current business plan, we believe that our current cash balance and access to liquidity are sufficient for the Company to meet its financial obligations as they become due for at least the next 12 months from the date of the report. </p> 11715381 -17977969 -2024465 2508653 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 4 – Inventory</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inventory, net consists of:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Raw materials</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">717,052</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">457,393</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Work-in-process</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,934,606</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,819,284</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: inventory reserves </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(50,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>2,601,658</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>2,276,677</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Raw materials</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">717,052</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">457,393</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Work-in-process</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,934,606</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,819,284</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: inventory reserves </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(50,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>2,601,658</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>2,276,677</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr></tbody></table> 717052 457393 1934606 1819284 50000 0 2601658 2276677 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 5 – Intangible Assets</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Intangible assets, net,  are comprised of the following as of March 31, 2024 and December 31, 2023 :</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Estimated</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additions</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amortization</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">License agreement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">17 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">901,929</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(15,732</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">886,197</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Patents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">20 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">86,100</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">590</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,196</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">85,494</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>988,029</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>590</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(16,928</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>971,691</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Amortization expense for the three months ended March 31, 2024 and 2023, was $16,928 and $16,910, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Estimated future amortization expense as of March 31, 2024:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2024 (remaining)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">50,784</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">67,933</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">67,933</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2027</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">67,933</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2028</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">67,933</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">649,175</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Intangible assets, Net</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>971,691</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Estimated</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additions</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amortization</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">License agreement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">17 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">901,929</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(15,732</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">886,197</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Patents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">20 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">86,100</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">590</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,196</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">85,494</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>988,029</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>590</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(16,928</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>971,691</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr></tbody></table> P17Y 901929 0 15732 886197 P20Y 86100 590 1196 85494 988029 590 16928 971691 16928 16910 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2024 (remaining)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">50,784</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">67,933</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">67,933</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2027</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">67,933</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2028</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">67,933</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">649,175</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Intangible assets, Net</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>971,691</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 50784 67933 67933 67933 67933 649175 971691 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 6 – Revenue</strong> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following is a summary of our revenues by type for the period ended March 31, 2024 and March 31, 2023:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>%</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">%</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">296,096</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">94</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">793,458</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">99</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Service revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">19,182</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">6</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">8,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>315,278</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>100</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>%</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>801,458</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>100</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>%</strong></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Unearned Revenue</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following is a summary of our unearned revenue activity for the period ended March 31, 2024 and year ended December 31, 2023:  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unearned revenue at beginning of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">130,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">200,109</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Billings deferred</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,768</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Recognition of prior unearned revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(128,109 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Unearned revenue at end of period</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>132,768</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>130,000</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Unbilled Accounts Receivable </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following is a summary of our unbilled accounts receivable activity for the period ended March 31, 2024 and the year ended December 31, 2023: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unbilled accounts receivable at beginning of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,494,553</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">918,164</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Services performed but unbilled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">296,096</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,061,612</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Services billed </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(19,040 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(485,223</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Unbilled accounts receivable at end of the period </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>1,771,609</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>1,494,553</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>%</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">%</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">296,096</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">94</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">793,458</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">99</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Service revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">19,182</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">6</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">8,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>315,278</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>100</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>%</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>801,458</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>100</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>%</strong></td></tr></tbody></table> 296096 0.94 793458 0.99 19182 0.06 8000 0.01 315278 1 801458 1 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unearned revenue at beginning of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">130,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">200,109</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Billings deferred</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,768</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Recognition of prior unearned revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(128,109 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Unearned revenue at end of period</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>132,768</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>130,000</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 130000 200109 2768 58000 0 128109 132768 130000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unbilled accounts receivable at beginning of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,494,553</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">918,164</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Services performed but unbilled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">296,096</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,061,612</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Services billed </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(19,040 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(485,223</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Unbilled accounts receivable at end of the period </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>1,771,609</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>1,494,553</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1494553 918164 296096 1061612 -19040 -485223 1771609 1494553 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 7 – Stockholder’ Equity</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is authorized to issue 50,000,000 preferred stock shares and 200,000,000 common stock shares both with a par value of $0.0001.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Preferred Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 30, 2020, the Company designated 1,000,000 shares as Series D Convertible Preferred Stock with a par value of $0.0001.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024, there were no shares of Preferred Stock issued and outstanding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The holders of common stock are entitled to one vote per share on all matters submitted to a vote of shareholders, including the directors’ election. There is no right to cumulative voting in the election of directors. The holders of common stock are entitled to any dividends that may be declared by the board of directors out of funds legally available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions the Company has against the payment of dividends on common stock. In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and have no right to convert their common stock into any other securities. As of March 31, 2024, there were 132,670,446 shares of common stock issued and outstanding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2022, the Company entered into an equity distribution agreement with an underwriter pursuant to which the Company may offer and sell shares of its common stock from time to time through the underwriter as its sales agent. Sales of common stock, if any, will be made at market prices by any method permitted by law deemed to be an “at-the-market” offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended. The Company has no obligation to sell any shares of common stock under the equity distribution agreement, and may at any time suspend offers under the equity distribution agreement, in whole or in part, or terminate the equity distribution agreement.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2024, we issued 3,339 fully vested shares of common stock to a service provider with a fair value of $4,500 based on the market price of our common stock on date of grant. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2023, a total of 2,137,876 shares of common stock were sold pursuant to the open market sale agreement resulting in a total of $8.35 million in proceeds, net of $0.11 million of commission fees and $0.05 million of accounting and legal fees. No such common stock sales occurred during the three months ended March 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024, a total of 3,766,422 shares of common stock have been sold pursuant to the open market sale agreement and approximately 86,560,000 remained available under the Company’s at-the-market public facility, subject to various limitations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline"></span> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Stock-based compensation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2024, and 2023, the Company recorded stock-based compensation of $183,200 and $214,924, respectively, related to common stock issued or vested options to employees and various consultants of the Company. For the three months ended March 31, 2024, $138,586 was charged as general and administrative expenses and $44,614 as research and development expenses in the accompanying unaudited condensed consolidated statements of operations.  For the three months ended March 31, 2023, $189,283 was charged as general and administrative expenses and $25,641 as research and development expenses in the accompanying unaudited condensed consolidated statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Stock option activity for the three months ended March 31, 2024 is summarized as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options outstanding at December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,828,174</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.83</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,374,433</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.66</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">50,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.40</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(137,924</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.65</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options outstanding at March 31, 2024</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">10,740,250 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.81</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,826,248</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4.35</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options Exercisable at March 31, 2024</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">8,696,519</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">6,609,354</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.74</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">*Includes 6,700,000 options granted in connection with the Merger (see Note 1) and were not granted under the 2021 Plan. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024, intrinsic value is computed based on the difference between weighted average exercise price and the market price of our common stock as of March 31, 2024 of $1.26 per share multiplied by the total common stock options outstanding and exercisable. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total unrecognized compensation associated with these unvested options is approximately $1,696,066 which will be recognized over a period of 2.82 years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00%</td><td style="width:1%;white-space: nowrap;"></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6.25 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">26.36–26.38%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4.09–4.31%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024, there were 1,235,000 warrants outstanding which relate to the Series 1 offering executed in December 2021, where investors were offered a warrant for every two common shares purchased during the offering at an exercise price of $2.50 per share. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2024 and 2023, no warrants were issued or exercised.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A summary of warrant activity during the three months ended March 31, 2024, is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,235,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.96</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at March 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,235,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.50</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.71</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 50000000 200000000 0.0001 1000000 0.0001 132670446 3339 4500 2137876 8350000 110000 50000.00 3766422 86560000 183200 214924 138586 44614 189283 25641 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options outstanding at December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,828,174</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.83</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,374,433</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.66</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">50,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.40</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(137,924</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.65</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options outstanding at March 31, 2024</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">10,740,250 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.81</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,826,248</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4.35</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options Exercisable at March 31, 2024</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">8,696,519</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.50</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">6,609,354</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.74</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 10828174 0.83 6374433 P4Y7M28D 50000 1.40 137924 2.65 10740250 0.81 4826248 P4Y4M6D 8696519 0.50 6609354 P1Y8M26D 6700000 1.26 1696066 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00%</td><td style="width:1%;white-space: nowrap;"></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6.25 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">26.36–26.38%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4.09–4.31%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0.0000 P6Y3M 0.2636 0.2638 0.0409 0.0431 1235000 2.50 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,235,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.96</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">—</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at March 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,235,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.50</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.71</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1235000 2.50 0 P0Y11M15D 1235000 2.50 0 P0Y8M15D <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 8 - Related Party Transactions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2021, the Company entered into a manufacturing and service agreement to fabricate and manufacture the AirSCWO systems (the “Original M&amp;S Agreement”) with Merrell Bros. The initial term of the Original M&amp;A Agreement ends July 7, 2024 with a one-year automatic renewal unless terminated by either party with at least a sixty-day notice prior to expiration. As part of the agreement, the Company appointed Terry Merrell to its board of directors. As of March 31, 2024, Merrell Bros. or their affiliates own stock below 5% of the outstanding common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the period ended March 31, 2024, the Company incurred $130,321 in related party expenses related to the manufacturing of the AirSCWO systems. As of March 31, 2024, accounts payable and accrued expenses includes $119,343 of amounts owed to Merrell Bros. for the manufacturing services provided.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 27, 2024, we executed a supplemental manufacturing and services agreement (the “Supplemental M&amp;S Agreement”) with Merrell Bros. as Merrell Bros. has indicated to us their intent to not renew the Original M&amp;S Agreement and we have indicated our desire to relocate to a larger manufacturer facility with more square footage dedicated to expanding our manufacturing operations. Simultaneous to executing the Supplement M&amp;S Agreement, Merrell Bros. provided us with a written non-renewal notice. Accordingly, the manufacturing and service agreement will terminate on its original expiration date of July 7, 2024 and will not be renewed.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Supplemental M&amp;S Agreement will become effective on July 7, 2024 and will replace the Original M&amp;S Agreement. Under the Supplemental M&amp;S Agreement, our relationship and the manufacturing services provided by Merrell Bros. will continue on an as needed basis based on statements of work to be agreed upon by both parties to fulfill future and current manufacturing orders.  The term of the Supplemental M&amp;S Agreement is one year from July 7, 2024 with a one-year renewal upon a mutually executed written extension.  Either party may terminate this Supplement M&amp;S Agreement upon written notice of such a termination, specifying the extent to which performance of work is terminated and the effective date of termination.</p> 0.05 130321 119343 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 9 - Commitments</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>License Agreement</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The patented technology underlying 374Water’s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (“Duke”), where Dr. Deshusses is a professor. The SCWO technology is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the “License Agreement”). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small number of common stock in the Company (See Note 5). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. As of March 31, 2024, the Company has not incurred any expenses in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days’ written notice.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Legal Settlement</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2023, the Company was named in a lawsuit filed against our former stock transfer agent (“Former TA”) by certain unrelated individuals asserting claims for negligence, conversion, and various breaches. Our Former TA issued 175,000 shares of our common stock to the State of Delaware in accordance with escheat laws after the Former TA was unable to issue the shares of common stock to the individuals. While the Company was not at fault in the matter, due to certain indemnification clauses between the Company and the Former TA, we are in the process of settling the matter with the individuals.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Based on the settlement discussions currently in process, we believe this matter will be settled with 275,000 common stock options with an exercise price equal to the market price when granted and an exercise period of five years. As of March 31, 2024 and December 31, 2023, we have $135,000 as an accrued legal settlement, as presented on the accompanying unaudited condensed consolidated balance sheet, for this pending settlement based on the estimated grant-date fair value of these options using a Black-Scholes valuation model and the following assumptions: stock price and exercise price of $1.33, risk free rate 4.43%, expected term five years, and volatility of 26.36%.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We note that in the ordinary course of business we may be the subject of, or party to, various pending or threatened legal actions which could result in a material adverse outcome for which the related damages may not be estimable.  We do not believe any legal action would have a significant impact on the financials other than the matter disclosed above.  However, there is inherent uncertainty regarding such matters.  </p> 175000 275000 135000 1.33 0.0443 0.2636 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 10 - Subsequent Events</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Employment Agreement</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 19, 2024, 374Water Inc. the Company entered into an employment agreement with Christian Gannon (the “Employment Agreement”), for Mr. Gannon to serve as President and Chief Executive Officer of the Company effective April 22, 2024 (the “Start Date”). The Employment Agreement provides for an initial annual salary for Mr. Gannon of $450,000. Mr. Gannon is also eligible to earn an annual fiscal year performance bonus for each whole or partial fiscal year of his employment period with the Company; for the initial year under the Employment Agreement in accordance with certain milestones set forth by the Company, and thereafter as determined by the compensation Committee of the Company and the Board of Directors of the Company. Mr. Gannon is eligible to earn a performance bonus up to 125% of Mr. Gannon's then-current base salary (the “Annual Bonus”) if certain milestones are met as defined in the Employment Agreement. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Under the Employment Agreement and subject to the terms of the Company's 2021 Equity Incentive Plan (the “Plan”), Mr. Gannon was granted up to 2,250,000 Restricted Stock Units (as defined in the Plan) under the Plan, vesting as follows: (a) 250,000, on the first annual anniversary of the Start Date; (b) 750,000, in equal increments on the last day of every month thereafter over the following 36 months, subject to Mr. Gannon's continued employment with the Company on each vesting date; and (c) 1,250,000, pursuant to certain milestones set forth by the Company and defined in the Employment Agreement (collectively, the “Gannon Restricted Stock Units”). Additionally, pursuant to the Employment Agreement and the terms of the Plan, Mr. Gannon was granted 5,250,000 Options (as defined in the Plan) under the Plan vesting as follows: (a) 625,000, on the first annual anniversary of the Start Date; (b) 1,875,000, in equal installments on the last day of every month thereafter over the following 36 months subject to Mr. Gannon's continued employment with the Company on each vesting date; and (c) 2,750,000, pursuant to certain milestones set forth by the Company  and defined in the Employment Agreement (collectively, the “Gannon Options”, and together with the Gannon Restricted Stock Units, the “Gannon Equity Awards”). </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If the Employment Agreement is terminated by the Company without “Cause” or by Mr. Gannon for “Good Reason” (each as defined in the Employment Agreement, subject to the Company’s right to cure), he will be entitled to termination benefits, pursuant to which the Company will be obligated to (i) pay Mr. Gannon 100% of his then-current annual base salary in 12 equal installments; (ii) any earned but unpaid Annual Bonus; (iii) coverage to Mr. Gannon and his dependents under the Company’s then current medical, health, and vision insurance plans for 12 months; and (iv) if such separation occurs on the day of Mr. Gannon’s first year anniversary of employment or after the first anniversary of the Start Date, (x) a pro-rated Annual Bonus for the fiscal year in which the employment is terminated equal to the pro-rated Annual Bonus that Mr. Gannon would have received based on actual performance for such fiscal year if Mr. Gannon was employed by the Company, and (y) accelerated vesting with respect to the Gannon Equity Awards as if Mr. Gannon had remained employed by the Company through the first anniversary of the date of such separation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Employment Agreement contains covenants for the benefit of the Company relating to the protection of the Company’s confidential information and standard Company indemnification obligations.</p> 450000000000